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A: Overview 
 
This portfolio thesis consists of three parts: a systematic literature review, an empirical 
report and appendices including a reflective statement.  
 
Part one is a systematic literature review examining the different factors within a 
couples‟ relationship which may impact on the psychological and physical functioning 
of the individual diagnosed with multiple sclerosis (MS).  A systematic search of five 
databases identified 11 papers meeting the inclusion and exclusion criteria. The findings 
are reported as well as a discussion of the clinical implications, quality assessments and 
limitations of the papers reviewed.  
 
Additional factors, other than aspects of the patient‟s relationships, may also impact on 
the patient‟s well-being. In line with the biopsychosocial model, biological changes 
caused by the MS, such as cognitive deficits, may also influence the patient‟s well-
being, specifically their ability to function socially.  
 
Part two is an empirical paper, which investigates the impact of cognitive deficits on the 
individual with MS. More specifically the impact of memory and information 
processing deficits on social functioning are explored, when controlling for mood and 
physical disability. The study also investigated the relationship between memory and 
IPS using the BMIPB. Participants completed a number of questionnaires assessing 
their social functioning and completed the BMIPB. The results from these assessments 
are discussed alongside the clinical implications for the findings and areas for future 
research.  
 
Part three comprises the appendices, which provide further information regarding the 
systematic literature review, empirical paper and also includes a reflective statement. 
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Abstract 
 
A vast amount of previous research has investigated, due to the severity and widespread 
impact of multiple sclerosis (MS), how this disease could hypothetically impact on a 
couple‟s relationship. More recently research has focused on this being a bidirectional 
association, in that aspects within the couple‟s relationship could have a detrimental 
effect on the patient‟s well-being. This systematic review aimed to identify and collate 
the factors within a couple‟s relationship which may impact on the physical and 
psychological well-being of the partner diagnosed with MS. A systematic search of five 
databases identified 11 papers meeting the inclusion and exclusion criteria. The findings 
highlight the importance of taking a biopsychosocial approach when assessing and 
working with MS patients. It may be beneficial to offer partners additional support or to 
involve them in the patient‟s therapeutic input, e.g. couple therapy. The review 
highlighted that more longitudinal and qualitative studies are required, in addition to 
emphasising the need for intervention studies to clarify the direction of the association 
between relationship factors and patient well-being. The review summarises the aspects 
within a couple‟s relationship which may impact on the patient, as well discussing the 
clinical implications, quality assessments and limitations of the papers reviewed.  
 
Keywords: multiple sclerosis, couple, partner, functioning, relationship factors 
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Introduction 
 
Multiple Sclerosis (MS) is disease of the central nervous system which affects the 
individual‟s brain and spinal cord. It is characterised by unpredictable and fluctuating 
symptoms including difficulty walking, visual impairments, fatigue, cognitive 
impairments, sensory disturbance, pain, limb weakness, and problems balancing (NICE, 
2004). MS patients frequently experience social and financial strain subsequent to their 
diagnosis as their MS symptoms often affect their ability to work or socialise (Rao et 
al., 1991; Higginson, Arnett & Voss; 2000). Consequently the individual often becomes 
more dependent on the support of significant others. It has been reported that 60% of 
this support is provided by the individual‟s husband or wife (Carton, Loos, Pacolet, 
Versieck & Vlietinck, 2000).  
 
It has been well documented that an individual‟s health difficulties can impact on their 
social and intimate relationships, yet this is a reciprocal relationship as social 
relationships have also been found to impact on an individual‟s health (Kiecolt-Glaser 
& Newton, 2001). A vast amount of previous research has investigated, due to the 
severity and widespread impact of the individual‟s MS symptoms, how this chronic 
disease could hypothetically impact on the couple‟s relationship (O‟Conner, McCabe & 
Firth, 2008). However, a wave of research has developed which has investigated the 
notion that this association could be bidirectional, in that aspects within the couple‟s 
relationship could have a detrimental effect on the MS patient‟s physical and 
psychological well-being. It is important to investigate this interaction between aspects 
of a couple‟s relationship and patient functioning as it has implications for treatment 
plans for both patients and caregivers. There are now numerous studies exploring the 
various different aspects of the couple relationship in the MS population. Therefore this 
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review aims to explore and summarise which various factors within a couple‟s 
relationship may impact on the individual with MS, in addition to highlighting the 
common limitations and methodological issues in the research found. It is beyond the 
scope of the review to determine the causation of these associations. 
 
The couple relationship is especially influential on the patient‟s well-being as it is the 
„most important social context within which the psychological aspects of the chronic 
illness are managed‟ (Rodgers and Calder, 1990, p.25). When a significant other is 
diagnosed with an illness it disrupts the family dynamic, more specifically it may 
provoke an adjustment of the couple‟s roles within the family and could highlight their 
ability to cope as a unit in the face of adversity (Revenson, 1994). The effectiveness of 
the couple‟s ability to cope and the strengths of their relationship may then determine 
how well the patient functions, both physically and psychologically. The 
biopsychosocial model (Engel, 1977) encapsulates these complex interactions as it takes 
into account how the patient, the illness and wider systems such as the patient‟s 
relationships are interconnected. Subsequently the following section will briefly 
highlight some of the associations found between couple relationships, physical health 
and psychological functioning in studies of patients experiencing a range of health 
difficulties.  
 
The Impact of Relationships on Physical and Psychological Functioning 
The impact of social relationships have been found to be just as influential on a person‟s 
health when compared to other risk factors such as blood pressure, smoking and obesity 
(Campbell, 2003). Merely being in a supportive relationship has been associated to 
better health outcomes (Umberson & Williams, 1993), positive adjustment to chronic 
illness (Cutrona, 1996) and general well-being (Burman & Margolin, 1992). 
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Regrettably, not all individuals who are in a relationship are supported and 
unfortunately certain factors within these relationships may yield detrimental effects on 
the patient. Coyne and Bolger (1990) found that negative aspects of the relationship 
were believed to be more important than the beneficial effects of a supportive 
relationship on the impact to the patient‟s health. Additionally a previous review looked 
at 64 studies and concluded that physical health is indirectly impacted by the marital 
relationship (Kiecolt-Glaser & Newton, 2001). They indicated that there are numerous 
variables within the relationship that may moderate the impact of marital processes on 
the biological system, such as coping congruency and gender trait differences. 
 
Additionally, it has been reported that married individuals engage in more positive 
health behaviours and have better physical and mental health than those who are single 
(Kiecolt-Glaser & Newton, 2001). Furthermore, poorer physical and mental health has 
been related to individuals who have divorced (Umberson & Williams, 1993). High 
marital satisfaction has also been shown to influence survival rates after heart failure 
(Coyne et al., 2001) and kidney disease (Kimmell et al., 2000).  Lastly, Mancini and 
Bonanno (2006) found a link between physical health difficulties, relationships and 
psychological functioning. They found that marital closeness lessened the possibility of 
psychological distress, including depression, anxiety, lacking self-esteem, when 
suffering from high levels of physical disability.  
 
Psychological difficulties such as depression, acceptance of the illness and level of 
adjustment may also impact on the biological and emotional well-being of the patient. It 
has been demonstrated in previous studies that depression can alter a person‟s 
cardiovascular, immune and endocrine functioning (Simonsick, Wallace, Blazer & 
Berkman, 1995; Glassman & Shapiro, 1998). Furthermore higher acceptance of 
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physical disability has been related to improved metabolic control and better coping 
strategies (Richardson, Adner & Nordstrom, 2001). A patient‟s level of acceptance has 
also been shown to be influenced by their partner‟s feedback about their illness and 
appearance. This then impacts on how the patient perceives their disability, as negative 
perceptions (either increased or decreased by their partner‟s perception) have been 
shown to lead to lower levels of acceptance (Taleporos & McCabe, 2002). Acceptance 
is a key feature of a person‟s adjustment to their health difficulty and together can 
influence how engaged they are with their therapy/treatment and thus may affect the 
outcome of their health problem (Keogh & Feehally, 1999; Telford, Kralik & Koch, 
2006). Hence psychological functioning may be influenced by marital relationships 
which in turn could impact on the biological functioning of the patient.  
 
Therefore, previous research using participants from the general population and other 
health groups highlights the interconnection between physical, psychological and social 
factors which may influence how an individual‟s illness impacts their psychological and 
physical well-being. 
 
Specific to Individuals with MS  
Individuals with MS often face losing their physical independence and ability to 
complete daily activities, as a consequence their social interactions become restricted 
and they depend more on their significant others (Carton et al., 2000). The severity and 
unpredictable nature of MS presents a number of considerable challenges to the patient. 
They are confronted with dealing with feelings such as vulnerability, loss, inequality, 
and in some cases shame (Rolland, 1994; Grytten & Maseide, 2006). Therefore support 
from their partner may be of paramount importance when considering the patient‟s 
psychological well-being. 
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As evidenced in previous research with patients diagnosed with different health 
conditions the support or lack of support from a relationship may not only affect an 
individual‟s psychological adjustment but it could also impact on their physical 
symptoms and recovery (Umberson & Williams., 1993; Coyne et al., 2001). Hence in 
patients with MS it is possible that relationship factors may impact on periods of disease 
activity or physical symptoms in addition to their psychological functioning. However, 
it could be argued that the partner is equally affected by the illness as they adopt the role 
of caregiver to their spouse which may be burdensome for the partners. Therefore both 
members of the relationship may become interdependent on one another for support and 
the effectiveness of this relationship/support may impact on both partners‟ adjustment to 
the illness. Hence as the biopsychosocial model suggests, social relationships may be 
interconnected to the physical and psychological functioning, specifically in MS 
patients and their partners.  
 
Previous research in the general population and other health groups highlight the 
numerous aspects within a couple‟s relationship which may also affect the individual 
with MS. For example, coping styles employed by the partner and patient have been 
found to influence and shape each other‟s adjustment (Coyne & Smith, 1991). In 
addition to coping styles, the partner‟s acceptance and perception of the MS may also 
influence the patient‟s level of adjustment (Taleporos & McCabe, 2002). Negative 
interactions between the partner and patient could be a source of stress in itself as the 
patient, already dealing with a number of emotional challenges, may have few 
psychological resources available to manage such interactions..   
 
Illness representations (Leventhal et al., 1997) have also been found to affect the 
patient‟s adaptation to the illness in a wide range of conditions (Orbell & Hagger, 
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2003). It is hoped that by processing information about their illness and developing a 
range of cognitive representations, that patients can make sense of their symptoms and 
develop effective coping strategies. Positive interpretation and seeking emotional 
support has been related to positive psychological outcomes (Moss-Morris, Petrie, & 
Weinman, 1996). However, it is not solely the patient‟s illness representations that may 
influence how they cope with their illness. It has been found in patients suffering from 
psoriasis that if patient and partner illness representations are dissimilar then this can 
lead to increased psychological distress for both (Richards et al., 2004). Illness 
representations, alongside perceived stress and emotion focused coping, have been 
shown to be important to the level of adjustment attained in MS patients (Dennison, 
Moss-Morris & Chalder, 2009). Therefore, illness representations may be another factor 
in the couple‟s relationship that could impact on the patient‟s level of adjustment.   
 
Research has also shown that when faced with adversity such as a chronic illness some 
patients develop positive changes to the self and their philosophy of life; this has been 
termed as posttraumatic or adversarial growth (Tedeschi & Calhoun, 2004). Adversarial 
growth has been shown to occur and to be adaptive in MS patients; this in turn has been 
associated to effective coping strategies and positive adjustment (Mohr et al., 1999). 
However, the factors that influence the development of such an outlook on their illness 
are not well documented. Investigating factors, such as whether partner adversarial 
growth impacts the level of growth in the patients, are important as it could influence 
the patient‟s level of adjustment to their illness. 
 
In summary, studies have found an association between relationship factors and the 
physical and psychological functioning in a wide range of health patients. In addition to 
this research, a number of different factors in a couple‟s relationship may impact on the 
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well-being of an individual with MS. It is important to examine these factors within the 
relationship as they ultimately offer guidance on which systemic factors should be 
considered during assessment and influence the appropriateness of interventions and for 
both the patient and their partner. Therefore it is of paramount importance to MS 
patients that aspects of the couple relationship are investigated. Possible aspects of the 
couple‟s relationship which may impact on the functioning and patient‟s well-being will 
be discussed in this review. 
 
The rationale for the current review was based upon the conclusions of previous studies 
suggesting that aspects of the couple‟s relationship may impact on the patient. There are 
a number of individual studies that have investigated these specific factors in MS 
patients, and which consequently may influence the type of clinical interventions 
offered. Additionally there is a lack of any systematic review which collates and 
critiques the numerous different studies investigating the impact of factors within a 
couple‟s relationship. Therefore the objective of the current review was to undertake a 
systematic literature review of published research which specifically investigates the 
different aspects of the couple‟s relationship which may impact on the physical and 
psychological well-being of the partner diagnosed with MS. The research questions 
addressed in this review were;  
 
1) Which aspects within a couple‟s relationship impact on the patient‟s psychological 
and physical functioning?  
2) What are the clinical implications of these findings?  
3) What are the common limitations and methodological issues of the research in this 
area? 
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Method 
Search Strategy 
An electronic search was carried out up to and including January 2012. Various 
databases which covered a range of disciplines that may conduct research on MS and 
relationships were searched for relevant articles. These included; PsycInfo (via Ebsco), 
Medline, Scopus, Cochrane Library and Web of Science. There was no start date cut-off 
employed in the search. A search for previous literature reviews in this area was 
conducted and none were identified.  
 
In order to assess how much research in this area was available two initial terms were 
entered into the databases; multiple sclerosis AND relationship*. Further search terms 
were then selected by using the most common keywords from relevant articles. The 
final sets of search terms used were as follows; adjust* OR support* OR perceived 
support OR depression OR mental state OR anxi* OR emoi* OR stress OR satisfaction 
OR relationship quality AND relationship OR marital OR marriage OR spouse* OR 
partner* OR wife OR husband OR coupl* OR kin AND multiple sclerosis. Articles that 
featured these terms either in their title, abstract, subject or keywords were then 
identified. When it was unclear from the abstract whether the study would meet the 
selection criteria the full copy of the article was obtained so it could be fully reviewed 
against the inclusion/exclusion criteria. Also, search limits were applied (dependent on 
the database) when possible. These meant that studies were only included which were; 
from peer reviewed journals, in the English language, were not drug trials, and used 
human participants. In addition to the systematic search for research, reference lists 
were also hand searched from the relevant papers found via the electronic databases. 
This was to ensure that research which was not available in an electronic form or hadn‟t 
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been found otherwise was also reviewed, however only one research paper was found 
this way; Lehman and Hemphill (1990).  
 
Study Selection Criteria 
Studies were screened against a selection criterion which was developed and refined 
when reading abstracts from the initial searches. The rationale for the inclusion and 
exclusion criteria can be found in Appendix 4.1. Studies were only included in the 
review if the met all the inclusion and exclusion criteria. 
 
Inclusion Criteria 
 Participants must have a clinically definite diagnosis of MS as determined by the 
McDonald criteria (McDonald, Compston, & Edan, 2001) in either primary 
progressive, secondary progressive or relapsing-remitting MS. 
 Studies were included if the majority of the sample were married or in a couple 
relationship. 
 Participants must not have any other neurological disease or health difficulty 
other than MS.  
 Studies published in peer-reviewed journals. 
 Studies published in the English language. 
 
Exclusion Criteria 
 Studies that aimed to investigate the impact of MS on the caregiver or 
relationship, as opposed to the impact of relationship factors on the individual 
with MS or their partner. 
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 Studies that only focused on the well-being outcomes for the partner and not MS 
patient. 
 Studies that did not include the relationship type of MS patient to significant 
other. 
 Studies investigating the sexual relationship in MS. 
 Studies investigating prevalence of marital relationships in MS patients. 
 Studies investigating the reliability or validity of a new measure/questionnaire. 
 Studies not involving human subjects. 
 Studies investigating the effects of drug therapy in patients with MS. 
 Case reports. 
 Systematic literature reviews. 
 Unpublished studies. 
 
Data Extraction 
Information was extracted from studies using a data extraction form which was 
specifically designed for recording data for this review (Appendix 4.2). 
 
Data Synthesis 
The studies reviewed used numerous different outcome measures and employed a 
diverse range of methodologies. For this reason statistical methods of data synthesis 
were not appropriate. Therefore subsequent to data being extracted it was collated and 
reported qualitatively within the review. The findings of the review are described using 
a narrative approach including a critical analysis of the studies included. 
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Study Quality Assessment 
All articles included in the review underwent a quality assessment. The methodological 
quality of the articles was assessed using a checklist which consisted of questions which 
were adapted from three valid and reliable checklists (Downs & Black, 1998; STROBE, 
2007; NICE, 2007). The quality of the studies used in this review could not be 
appropriately assessed by just one of these checklists due to the varying methodologies. 
Therefore the researcher developed a quality checklist using the most appropriate and 
relevant questions from the three checklists. The adapted checklist can be seen in 
Appendix 4.3 and the source of each item on the checklist can be found in Appendix 
4.4. The adapted checklist consisted of 28 items which were considered relevant for 
assessing the quality of quantitative studies and qualitative studies used in this review. 
A point scoring system was employed to enable comparisons across both quantitative 
and qualitative studies, where a score of 20 was awarded to a study meeting all 20 
criteria of the methodological quality checklist. No studies were excluded from the 
review due to low quality scores. To ensure reliability of the ratings an independent 
rater also assessed all 11 studies used in the review. The ratings and percentage of 
agreement between ratings can be found in Appendix 4.5. Overall, most items when 
rated produced a percentage agreement of between 81.8% and 100% which indicates a 
good level of reliability. Furthermore, inter-rater reliability was assessed using a 
Pearson correlation which also suggests a high level of reliability (r(9) = .883, p < .001). 
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Results 
 
Details of Included and Excluded Studies 
Figure 1 highlights the study selection methodology used in the current review. Using 
the search strategy a total of 3529 studies was produced. The article titles and abstracts 
were then searched for relevance and limits were applied, when possible, which 
included articles from peer reviewed journals, in the English language, were not drug 
trials, and used human participants. This left a total of 94 articles. Duplicate articles 
were removed leaving 69. The abstracts and titles of the remaining 69 articles were 
searched against the inclusion and exclusion criteria. A total of 55 articles were 
subsequently removed. The remaining 14 articles were obtained and full articles read.  
 
The 4 articles excluded and the reasons for the removal of these articles can be found in 
Appendix 4.6. Pozzilli et al.‟s (2004) study recruited a mixed sample of partners and 
other caregivers such as parents. After careful consideration it was decided that this 
study should be included in the review as the study implemented a longitudinal design 
and investigated the impact of caregiver depression on the patient, additionally the 
majority of the sample, 54%, was comprised of partners. This was considered a large 
enough proportion of the sample which would help clarify additional relationship 
factors, such as caregiver depression, which could influence the patient‟s well-being.  
 
One article (Lehman & Hemphill, 1990) was selected from manual reference searches. 
Therefore a total of 11 articles were included in this review, a summary of these studies 
can be found in Table 1. 
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Figure 1. Flow chart demonstrating an overview of systematic review process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Limits applied, titles and abstracts searched for relevancy 
 
Relevant electronic databases searched 
Scopus 
n=234 
Web of 
Science 
n=1824 
MEDLINE 
n=804 
PsycINFO 
n=502 
Cochrane 
Library 
n=165 
Scopus 
n=0 
Web of 
Science 
n=29 
MEDLINE 
n=26 
Cochrane 
Library 
n=0 
PsycINFO 
n=39 
Total n=94 
Full text of articles scanned 
for eligibility (n=14) 
Duplicates removed 
Abstracts searched against 
exclusion/inclusion criteria 
n=25 
n=55 
n=4 
Rejected 
Rejected 
Total studies identified 
for review (n=10) 
Manual search of 
reference sections 
(n=1) 
Total studies identified 
for review (n=11) 
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Table 1. Overview of Included Studies. 
Study Aim Design Participants Measures 
Dyad 
data? 
Findings 
Quality 
Rating (0-
20) 
  Number of 
dyads/MS P, main 
variables 
investigated 
Partner 
(gender, age 
relationship 
duration) 
Person with MS 
(gender, age, type 
of MS, disease 
duration) 
Psychological 
well-being, 
coping outcomes 
 
Physical disability 
measures 
Relationship 
satisfaction/ 
adjustment /quality 
measures 
 
Social network 
measures 
   
Woollett 
& 
Edelmann 
(1988) 
To investigate the 
relationship 
between marital 
satisfaction, 
disability, social 
support and life 
satisfaction. 
Cross-sectional 
Questionnaire 
 
20 dyads 
 
Marital satisfaction, 
disability, social 
support and life 
satisfaction 
g: NR 
(NR), 
r.d:  ̅=24 
years 
r.t: all married 
g: 30 male, 42 female 
( ̅=47.5), 
d.t: 48%=SP, 
52%=RR 
d.d: 10.3 years 
ISS:  ̅=23 (SD, 12.3 
(0-64 higher 
scores=more 
disability) 
 LSI (MS P) 
 
 
 ISS (MS P) 
 GRIMS (couple) 
 
 
 SNL (couple) 
Yes 
 No relationship was found between 
disability, life satisfaction and 
marital satisfaction 
 Partners were found to be less 
martially satisfied than MS 
partner. 
 As life satisfaction and social 
network density increased, marital 
satisfaction also increased. 
 GRIMS score was lower for 
partner but did not reach 
„dissatisfied‟ cut off. 
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Kleiboer, 
Kuijer, 
Hox, 
Jongen, 
Frequin, 
& Bensing 
(2007) 
 
To investigate the 
impact of negative 
responses 
received from 
partner on end-of-
day mood for both 
MS patient and 
their partner. 
 
Diary method over 14 
days 
 
61 dyads 
 
Negative responses, 
end-of-day mood, and 
buffered emotional 
support. 
g: 14% female 
( ̅=49.3), 
r.d:  ̅=22.6 
years 
r.t: „couples 
cohabiting‟ 
 
g: 87% female 
( ̅=46.8), 
d.t: RR=57%, 
SP+PP=43% 
d.d: 8.3 years 
EDSS self-report: 
 ̅=14 (0-64 higher 
scores=more 
disability) 
 
 End of day mood: 
PANAS (couple) 
 
 Kurtzke (1981) 
self-report scale 
(MS P) 
 MS Symptoms 
experienced 10- 
point scale (MS 
P) 
 Negative response 
4-point scale 
(couple) 
 Emotional support 
4-point scale 
(couple) 
 
 
 Daily Hassles 22 
item scale (couple) 
Yes 
 Supported domain specific model 
 Patients and partners who reported 
receiving negative responses had 
higher end-of-day negative mood 
but was not related to end-of-day 
positive mood. 
 The adverse effect of received 
negative responses on end of day 
mood was moderated by receiving 
emotional support on the same day 
for both patients and partners. 
18 
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Study Aim Design Participants Measures 
Dyad 
data? 
Findings 
Quality 
Rating 
(0-20) 
  
Number of 
dyads/MS P, main 
variables 
investigated 
Partner 
(gender, age 
relationship 
duration) 
Person with MS 
(gender, age, type of 
MS, disease duration) 
Psychological well-
being, coping 
outcomes 
 
Physical disability 
measures 
Relationship 
satisfaction/ 
adjustment /quality 
measures 
 
Social network 
measures 
   
Kleiboer, 
Kuijer, Hox, 
Schreurs & 
Bensing (2006) 
To examine the 
relationship 
between 
reciprocity of 
provision and 
receipt of 
emotional and 
instrumental 
support, daily 
mood, and self-
esteem among 
patients and 
partners. 
 
Diary method over 
14 days 
 
61 dyads 
 
Provided and 
received support, 
instrumental and 
emotional support, 
reciprocity of 
support, disability, 
self-esteem and end-
of-day mood. 
g: NR 
( ̅=49), 
r.d:  ̅=23 
r.t: 92% 
married, 8% 
cohabiting 
77% had 
children 
g: 87% female 
( ̅=47), 
d.t: RR=57%, 
SP+PP=43% 
d.d: 8 years 
EDSS: NR 
 
 
 End of day 
mood: PANAS 
(couple) 
 Self-esteem 7-
point scale (1 
item) (couple) 
 
 
 MS Symptoms 
experienced 10-
point scale (MS 
P) 
 
 Scale for emotional 
(3 items) and 
instrumental (1 
item) support 
received and 
provided each day 
(couple) 
 
 
 Daily Hassles 22 
item scale (couple) 
 
Yes 
 When instrumental support was 
reciprocated self-esteem significantly 
increased for both patients and 
partners. 
 No other significant relationships 
were found between reciprocation of 
received and provided support in 
dyads. 
 Patients‟ end of day mood was 
related to providing emotional and 
instrumental support, whereas 
partners‟ end of day mood was 
related to receiving emotional support 
from patients. 
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Pakenham 
(1998) 
To examine the 
relationship 
between coping 
congruency, 
average level of 
coping, 
adjustment and 
psychological 
distress in 
patients and 
partners 
 
Longitudinal: T1 and 
T2 (12 months) 
Questionnaire 
 
45 dyads 
 
Coping congruency, 
average level of 
coping, coping style, 
adjustment and 
psychological well-
being. 
g: 29 male, 
16 female 
( ̅=50.55), 
r.d:  ̅=24 
r.t: 82% 
married, 7% 
immediate 
family 
member, 
11% close 
friend 
g: 12 male, 33 female 
( ̅=50.04), 
d.t: 50%=PP+SP, 
50%=RR 
d.d: 7.64 years 
EDSS:  ̅=5.36 (SD, 
1.99, 0-10 higher 
scores=more 
disability) 
 
 
 BSI (couple) 
 BDI (couple) 
 
 
 
 EDSS (MS P) 
 
 CRA (partner) 
 PAIS-SR (MS P) 
 WCC (couple) 
 
 
 
Yes 
 Coping congruence and average level 
of coping are related to collective and 
individual adjustment. 
 No support that similarity in 
(avoidant) emotional coping style is 
more adaptive. Found higher 
emotional coping scores were related 
to greater collective distress and 
poorer adjustment scores. 
 Greater differences in problem-
solving coping style between partners 
was related to lower levels of 
collective depression and better 
adjustment at individual level. 
Therefore dissimilar problem-solving 
coping style is more adaptive. 
17 
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Study Aim Design Participants Measures 
Dyad 
data? 
Findings 
Quality 
Rating 
(0-20) 
  
Number of 
dyads/MS P, 
main variables 
investigated 
Partner 
(gender, age 
relationship 
duration) 
Person with 
MS (gender, 
age, type of 
MS, disease 
duration) 
Psychological 
well-being, 
coping outcomes 
 
Physical 
disability 
measures 
Relationship 
satisfaction/ 
adjustment 
/quality 
measures 
 
Social network 
measures 
   
Ackroyd, 
Fortune, 
Price, Howell, 
Sharrack, & 
Isaac (2011) 
To investigate 
factors that 
inhibit or 
increase the 
possibility of 
adversarial 
growth in 
patients and 
partners. 
 
Cross-sectional 
Questionnaire 
 
72 dyads 
 
Distress, 
adversarial 
growth, illness 
representation, 
and disability. 
g: 44 male, 28 
female 
( ̅=48.6), 
r.d: NR 
r.t: 93% 
married 
g: 30 male, 42 
female 
( ̅=47.5), 
d.t: 48%=SP, 
52%=RR 
d.d: 10.3 years 
EDSS: 
 ̅=5.17 (SD, 
1.55) 
 
 CMDI 
(couple) 
 
 EDSS-S (MS 
P) 
 MASQ 
(couple) 
 
 PTGI 
(couple) 
 IPQ-R 
(couple) 
Yes 
 
 Patients and partners showed adversarial growth, patients 
had significantly higher adversarial growth scores than 
partners. 
 Partner growth significantly predicted patient adversarial 
growth, and vice versa. 
 Dissimilar scores between patients and partners on illness 
representations – consequences of MS subtest, patient 
mood, and patient growth, significantly predicted partner 
growth. 
 No significant relationship between distress and adversarial 
growth. However, as patient distress increased, partner 
growth also increased. Furthermore, they found that greater 
impairment on patient illness representation and cognition 
was associated to greater partner growth. 
 „Communal search for meaning‟ supported. 
 
18 
Wineman, 
O’Brien, 
Nealon, & 
Kaskel (1993) 
Investigated if 
the degree of 
congruence in 
illness 
uncertainty 
explained 
mood and 
family 
satisfaction of 
patient and 
partner. 
 
Cross-sectional 
Questionnaire 
 
 
61 dyads 
 
Congruence in 
illness 
uncertainty, 
marital 
satisfaction, and 
psychological 
functioning. 
g: 27 male, 34 
female; 
( ̅=55), 
r.d:  ̅=30 
years 
r.t: all spouses 
g: 27 male, 34 
female 
( ̅=54), 
d.t: 18%=SP, 
45.9%=PP, 
1.6%=RR, 
34.4%=unkno
wn; 
d.d: 17.3 years 
ISS:  ̅=NR 
 
 
 POMS 
(couple) 
 
 
 ISS (MS P) 
 
 
 MUIS 
(couple) 
 Family 
Satisfaction 
Scale (couple) 
 
Yes 
 Individual and congruent perceived uncertainty between 
spouses had negative effects on marital partners. 
 For both, those who reported higher levels of uncertainty 
were more likely to have lower moods and feel dissatisfied 
with family life. 
 Main predictor of patients‟ family satisfaction was their own 
perception of illness uncertainty. For partners‟ family 
satisfaction was predicted most by congruence between each 
partner‟s perception of illness uncertainty. 
15 
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Study Aim Design Participants Measures 
Dyad 
data? 
Findings 
Quality 
Rating 
(0-20) 
  
Number of dyads/MS 
P, main variables 
investigated 
Partner 
(gender, age 
relationship 
duration) 
Person with MS 
(gender, age, 
type of MS, 
disease duration) 
Psychological 
well-being, coping 
outcomes 
 
Physical disability 
measures 
Relationship 
satisfaction/ 
adjustment 
/quality 
measures 
 
Social network 
measures 
   
McPheters & 
Sandberg 
(2010) 
To investigate 
the 
relationship 
between 
couple 
relationship, 
depression, 
and physical 
functioning of 
the patient 
with MS. 
Cross-sectional 
Questionnaire 
 
54 dyads 
 
Relationship quality, 
physical functioning 
and depression. 
g: 80% male 
( ̅=54), 
r.d:  ̅=28.7 
years 
r.t: 94% 
married 
g: 80% female 
( ̅=53), 
d.t: 22%=SP, 
11%=PP, 
56%=RR 
d.d: 18 years 
ADL-MS: 
 ̅=50.02 (SD, 
16.50, 0-70, 
higher 
scores=better 
physical 
functioning) 
 
 CES-D (couple) 
 
 
 ADL-MS 
(couple) 
 DAS (couple) Yes 
 
 Couple relationship quality positively 
correlated to MS patient physical functioning 
and depression negatively related to MS 
patient physical functioning. 
 MS patient and partner couple relationship 
quality negatively correlated to depression 
scores in partners. 
 MS patient couple relationship quality 
negatively correlated to MS patient depression 
scores, partner relationship quality was not 
significantly related. 
 Depression and relationship quality were 
associated with MS physical functioning. 
 Couples with higher relationship quality better 
able to cope with stresses of MS? 
 
17 
Pozzilli, 
Palmisano, 
Mainero, 
Tomassini, 
Marinelli, 
Ristori, 
Gasperini, 
Fabiani, & 
Battaglia 
(2004) 
To investigate 
the 
relationship 
between 
caregiver 
depression and 
health status of 
MS patient. 
 
Cross-sectional and 
longitudinal: 
Baseline and one year 
follow-up 
 
Questionnaire 
 
133 dyads 
 
Emotional distress in 
partner, and physical 
health status of MS P. 
g: 67% female 
( ̅=53), 
r.d: NR 
r.t: 54% 
married, 21% 
parents, 11% 
children, 5% 
sibling, 9% 
friends 
g: 30 male, 42 
female 
( ̅=47.5), 
d.t: 27=PP, 
80=SP, 26=RR 
d.d: 58 = 20+ 
years, 
EDSS:  ̅=6 (4-
7) 
 
 POMS (partner) 
 STAI (MS P) 
 CDQ (MS P) 
 MMSE (MS P) 
 
 
 FIM (MS P) 
 FSS (MS P) 
 SF-36 (MS P) 
 EDSS (MS P) 
 Yes (one) 
 Depression in caregivers was related to 
physical, emotional and health status of the 
patients at baseline and 12-month follow-up. 
 Changes in caregiver depression scores were 
associated with changes in disability and 
health status of patients. 
 Depression in carers associated to longer 
disease and increased severity of MS 
symptoms. 
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Study Aim Design Participants Measures 
Dyad 
data? 
Findings 
Quality 
Rating 
(0-20) 
  
Number of dyads/MS 
P, main variables 
investigated 
Partner 
(gender, 
age 
relations-
hip 
duration) 
Person with MS 
(gender, age, type 
of MS, disease 
duration) 
Psychological 
well-being, 
coping outcomes 
 
Physical 
disability 
measures 
Relationship 
satisfaction/ 
adjustment 
/quality 
measures 
 
Social network 
measures 
   
Schwartz & 
Kraft (1999) 
 
Investigated the 
impact of spouse 
responses, patient 
disability, and family 
environment 
predicted 
psychological 
functioning in patient 
with MS.  
 
 
Cross-sectional 
Questionnaire 
 
44 dyads 
 
Family environment, 
spouse responses, 
disability, relationship 
quality, emotional 
distress. 
 
g: 70% 
male, 
( ̅=NR), 
r.d: NR 
r.t: 
married 
or partner 
g: 70% female 
( ̅=44), 
d.t: 48%=SP, 
52%=RR 
d.d: 9.33 years 
EDSS:  ̅=5.6 (SD, 
1.63) 
 
 
 CES-D (MS 
P) 
 SIP (MS P) 
 SF-36 (MS P) 
 
 EDSS (MS P) 
 FES (MS P) 
 DAS (MS P) 
 SRI (MS P) 
 
 
 SPS (MS P) 
 
No 
 
 Solicitous spouse responses to patient 
disability were related to greater MS physical 
disability. 
 Relationship was stronger for those who were 
depressed. 
 Spouse negative responses to physical 
disability were associated to poorer mental 
health, whereas spouses who encouraged 
patient well behaviours were associated with 
lower emotional distress. 
 Poor psychological functioning was found in 
higher conflict and/or controlling family 
environments. 
 Higher levels of independence in families 
were associated with better patient 
psychological and physical functioning. 
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Harrison, 
Stuifbergen, 
Adachi & 
Becker (2004) 
To investigate the 
relationship between 
marital status, 
marital concern, 
perceived 
impairment, health-
promoting 
behaviours and 
acceptance of 
disability in MS 
patients. 
Cross-sectional and 
longitudinal: 5 time 
points over 6 year 
period 
 
454 MS P 
 
Gender, marital status 
and change, acceptance 
of disability, and 
perceived level of 
impairment. 
g: NR 
r.d: NR 
r.t: NR 
g: majority female 
( ̅=48.5), 
d.t: NR 
d.d: NR 
ISS: NR 
66% women, 72% 
men married 
consistently, 
34% women, 28% 
other marital status 
over 6 year period 
 Acceptance 
of Illness 
Scale (MS P) 
 HPLP II (MS 
P) 
 
 ISS (MS P) 
 
 Marital 
Concern 
Scale  (MS P) 
No 
 For both men and women acceptance of 
disability and perceived impairment increased 
significantly over time. 
 Being consistently married is associated with 
higher level of acceptance of disability and 
less perceived impairment over time 
 Men gained mental and physical benefits from 
remaining married compared to men who 
weren‟t consistently married.  
 Acceptance increased over time for women 
but this was not related to marital status 
16 
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Notes: Average age of participants in each group is reported in brackets. Measurement name is followed by who completed the measurement in 
brackets.  ̅ = average; d.t =disease type; RR = Relapsing-Remitting MS; PP = Primary Progressive MS; SP = Secondary Progressive MS; d.d = disease 
duration; r.t = relationship type; r.d = relationship duration; g = gender; NR = not reported in article; MS P = Person with MS completed measure. 
Study Aim Design Participants Measures 
Dyad 
data? 
Findings 
Quality 
Rating 
(0-20) 
  
Number of 
dyads/MS P, 
main variables 
investigated 
Partner 
(gender, 
age 
relationshi
p 
duration) 
Person with 
MS (gender, 
age, type of 
MS, disease 
duration) 
Psychological 
well-being, 
coping 
outcomes 
 
Physical 
disability 
measures 
 
Relationship 
satisfaction/ adjustment 
/quality measures 
 
Social network 
measures 
   
Lehman 
& 
Hemphill 
(1990) 
To explore 
support 
attempts 
from 
partners that 
MS patients 
found 
helpful and 
unhelpful. 
Qualitative 
 
Cross-
sectional 
Questionnaire 
 
151 MS P 
 
Perception 
and 
attributions of 
support 
attempts from 
partner 
 
g: NR 
r.d: NR 
r.t: NR 
g: 75% 
female 
( ̅=46), 
d.t: NR 
d.d: 6 years 
EDSS: mild 
to severe 
70% 
married 
 
 
3 open-ended qus: 
 Helpful 
 Unhelpful 
 Attribution of support 
attempts that failed 
 
(no analysis named, 
category codes for 
questions were 
analysed) 
 
No 
 Expressions of love, concern, and 
understanding were regarded as most helpful. 
 Most unhelpful were two categories: 
- Minimisation (challenging seriousness 
or existence of disease) 
- Maximisation (catastrophising or being 
overly protective) 
 Suggested that partners assess disease state 
based on physical appearance. 
 MS P made benign attributions to harsh and 
unsettling actions from partner. Possibly due to 
patients feeling vulnerable and so do not want 
to be rejected or loose partner by criticising 
their unhelpful support attempt. 
14 
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LSI = Life Satisfaction Index B (Neugarten, Havinghurst & Tobin, 1961); SNL = Social Network List (Hirsch, 1980); ISS = Incapacity Status Scale 
(Kurtzke, 1955, 1984); GRIMS = Golombok Rush Inventory of Marital State (Rust, Bennun, Crowe & Golombok, 1986); PANAS = Positive and 
Negative Affect Schedule (Watson, Clark & Tellegen, 1988); WCC = Ways of Coping Checklist-Revised (Vitaliano, Russo, Carr, Maiuro & Becker, 
1985); BSI = Brief Symptom Inventory (Derogatis & Spencer, 1982); BDI = Beck Depression Inventory (Beck, Ward, Mendelson, Mock & Erbaugh, 
1961); CRA = Caregiver Reaction Assessment (Given et al., 1992); EDSS = Expanded Disability Status Scale (Kurtzke, 1983) PAIS-SR = 
Psychosocial Adjustment to Illness Scare-Self Report (Derogatis & Lopez, 1983); CMDI = Chicago Multi-Scale Depression Inventory (Nyenhuis et 
al., 1998); EDSS-S = Self-report Expanded Disability Status Scale (Bowen, Gibbons, Gianas & Kraft, 2001); MASQ = Multiple Ability Self Report 
Questionnaire (Seidenberg, Haltiner, Taylor, Hermann & Wyler, 1994); PTGI = Posttraumatic Growth Inventory (Tedeschi & Calhoun, 1996); IPQ-R 
= Illness Perception Questionnaire-Revised (Moss-Morris et al., 2002); POMS = Profile of Mood States (McNair, Lorr & Doppleman, 1981); MUIS = 
Mishel Uncertainty in Illness Scale (Mishel & Epstein, 1990); Family Satisfaction Scale (Olson et al.,1985); DAS = Dyadic Adjustment Scale 
(Spanier, 1976); CES-D = Center for Epidemiological Studies Depression Scale (Radloff, 1977); ADL-MS = Activities of Daily Living Self-Care for 
Persons with MS (Gulick, 1988); SF-36 = Short-form Health Survey (Ware & Sherbourne, 1992); MMSE = Mini Mental State Examination (Folstein, 
Folstein & McHugh, 1975);  STAI = State-Trait Anxiety Inventory (Spielberger, Vagg & Barker, 1980); CDQ = Clinical Depression Questionnaire 
(Krugg, Scheier & Cattell, 1976); FIM = Functional Independence Measure (Kidd et al., 1995); FSS = Fatigue Severity Scale (Krupp, La Rocca, Muir-
Nash & Steinberg, 1989); SIP = Sickness Impact Profile (Bergner, Bobbitt, Carter & Gilson, 1981); FES = Family Environment Scale (Moos & Moos, 
1986); SRI = Spouse Response Inventory (Schwartz, Jensen & Romano, 1995); SPS = Social Provisions Scale (Cutrona & Russell, 1987); Acceptance 
of Illness Scale (Stuifbergen, Seraphine & Roberts, 2000); HPLP II = Health Promoting Lifestyle Profile II (Walker, Sechrist & Pender, 1995); Marital 
Concern Scale (Haberman, Woods & Packard, 1990). 
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Overview of Methodological Quality 
The results of the quality assessment from both raters can be found in Appendix 4.5. 
The quality scores for studies ranged from 14 (Lehman & Hemphill, 1990; Woollett & 
Edelmann, 1988) to 19 (Kleiboer et al., 2006). Percentage agreement ranged from 
81.8% to 100% between raters suggesting good reliability. The lowest agreement was 
on item 10 (81.8% agreement) which assessed whether the inclusion and exclusion 
criteria were stated in studies. The raters disagreed on the level of detail needed in the 
selection criteria which would indicate the criterion was „clearly described‟.  Therefore 
item 10 could have been made clearer. The other items used either produced total 
agreement or a difference in one score.  
 
Overall the studies reviewed had coherent background theory, good rationale and 
explicitly stated their research aims. The majority of the studies used reliable and valid 
measures and stated a detailed procedure. Sample sizes varied and the majority of 
participants were recruited from MS Society branches which may indicate a possible 
selection bias as a number of the studies stated their sample consisted of mainly well-
adjusted couples. No studies commented on a power calculation however some studies 
did reflect on the limitations of their findings in relation to low power and small sample 
size. The majority of studies included a detailed account of their inclusion and exclusion 
criteria however some studies did not fully describe their participant selection criteria or 
characteristics of their sample. Consequently, it is difficult to fully compare these 
studies‟ findings to other studies; also the generalisability of their findings is 
questionable (Pozzilli et al., 2004; Harrison et al., 2004; Schwartz & Kraft, 1999; 
Lehman & Hemphill, 1990; Ackroyd et al; 2011). Only three studies (Harrison et al., 
2004; Schwartz & Kraft, 1999; Lehman & Hemphill, 1990) did not include data from 
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both the MS patient and their partner therefore suggesting most studies took into 
account the partner‟s perspective making their findings more reliable and valid. Most 
studies outlined a clear and appropriate statistical analysis although exact p values were 
rarely reported. Studies tended to highlight the clinical implications of their findings in 
relation to previous studies and their own methodological limitations. The 
methodological quality will now be reviewed in more detail.  
 
Study Design 
Only one study used a qualitative design. When assessed this study gained a relatively 
low methodological quality score of 14, mainly due to the qualitative data analysis not 
being rigorous enough or based on a well-recognised qualitative analysis (Lehman & 
Hemphill, 1990). The rest of the 10 studies employed a quantitative design. Of these 10 
studies 5 were cross-sectional studies using questionnaires or scales. Two studies 
(Kleiboer et al., 2006; 2007) used a diary method which required participants to record 
data every day for 14 days. The remaining 3 studies used a longitudinal design; two 
studies collected data at baseline and at one year follow-up (Pozzilli et al., 2004; 
Pakenham, 1998) and Harrison et al., (2004), collected data at five time points over a 6 
year period. All studies collected data from both the MS patient and their partner with 
the exception of three studies (Lehman & Hemphill, 1990; Schwartz & Kraft, 1999; 
Harrison et al., 2004).  
 
Participants 
The sample sizes varied greatly between studies from 20 dyads (Woollett & Edelman, 
1998) to 133 dyads (Pozzilli et al., 2004), or 454 MS patients (Harrison et al., 2004). 
Participant characteristics were similar across all studies. The majority of studies 
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recruited patients with a range of MS disease type although on the whole patients with 
relapsing-remitting MS made up most of the studies‟ samples with the exception of 
Wineman et al., (1993) who had a majority of primary-progressive MS patients and 
Pozzilli et al., (2004) whose sample mainly consisted of secondary progressive MS 
patients. The majority of participants were over the age of 40 years old and had been in 
their relationship for at least 20+ years. Additionally, the MS patients recruited in the 
studies reviewed had been diagnosed for at least 8-10 years and had low to moderate 
physical disability, with the exception of Lehman and Hemphill (1990) whose sample 
consisted of mild to severely disabled MS patients who had been diagnosed for on 
average 6 years. Therefore, on the whole the results from this review can be generalised 
to the different disease types in MS, however the studies lacked MS patients who were 
diagnosed for less than 10 years, younger, and had moderate to severe physical 
disabilities. Also MS patients who had been in a relationship for less than 20 years were 
not represented in the studies reviewed. Lastly, the majority of samples reviewed had a 
majority of female MS patients; however this is reflective of the MS population (Orton 
et al., 2006). 
 
Measures Used 
The studies reviewed assessed a number of different aspects of the couple relationship 
which may impact on the MS patient‟s physical and psychological functioning. These 
various aspects will be discussed in detail in the next section. Due to the wide range of 
aspects investigated the measures used in each study also varied. Some studies focused 
solely on the psychological impact on the MS patient and fewer studies investigated 
both the physical and psychological impact (Woollett & Edelmann, 1988; Pozzilli et al., 
2004; McPheters & Sandberg, 2010; Schwartz & Kraft, 1999). The most commonly 
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used measures (used in two studies) included the Dyadic Adjustment Scale (DAS), 
Short-Form Health Survey (SF-36), Center for Epidemiological Studies Depression 
Scale (CES-D), Incapacity Status Scale (ISS) and Expanded Disability Status Scale 
(EDSS). The other measures used were specific to the aspect being investigated such as 
the Illness Perception Questionnaire–revised (IPQ-R) in Ackroyd et al., (2011), or used 
an alternative measure, such as the Golombok Rush Inventory of Marital State, as 
opposed to the DAS. All measures used had reportedly good reliability and validity and 
were well-known questionnaires with standardised instructions. However in the 
Kleiboer et al. studies (2006; 2007) they used scales and questionnaires which were 
developed by the study (e.g. emotional support and negative responses scales) and 
therefore the measures used are less reliable and valid.  
 
Main Aspects of the Couple Relationship found in the Studies Reviewed 
A number of similar aspects within the couples‟ relationship (e.g. type and level of 
support or coping congruency) were investigated in a number of studies. Therefore the 
review has collated the findings of studies into five different sections, dependent on the 
aspect of the couple relationship investigated. The various aspects and how they impact 
on the MS patient‟s psychological and physical functioning will be discussed and a 
critical analysis of the studies‟ methodologies will also be considered. 
.  
Marital satisfaction/relationship quality 
In line with the biopsychosocial model, a number of studies have specifically 
investigated the relationship between physical functioning, psychological distress and 
relationship satisfaction/quality in MS patients. McPheters and Sandberg (2010) found 
that couple relationship quality strongly related to MS patient physical functioning, 
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furthermore relationship quality scores negatively correlated to MS patient depression 
scores. The researchers suggest that relationship functioning and depression 
significantly predicted patient physical functioning, as increased conflict in a 
relationship may lead to greater depression in the patient which then impacts on their 
physical functioning. Although there was a strong association found between physical 
functioning and relationship quality it is not possible to ascertain a causal link due to 
their cross-sectional design (McPheters & Sandberg, 2010).  
 
Previous research remains inconsistent when investigating the relationship between the 
biopsychosocial factors in MS. Pozzilli et al. (2004) support the findings from 
McPheters and Sandberg (2010) as they found that depression in caregivers was related 
to the physical, emotional and health status of patients, at baseline and a 12 month 
follow up. A change in caregiver depression was associated to changes in the patient‟s 
disabilities and overall health. Furthermore, greater depression in carers was associated 
to longer disease duration and increased severity of MS symptoms. These results 
strengthen the findings that there is a strong association between partner functioning 
and the patient‟s well-being, however again a causal link was not determined. In 
contrast to these findings Woollett and Edelmann (1988) found no relationship between 
physical disability, life satisfaction and marital satisfaction. However, this study did not 
take into consideration caregiver or patient depression and had the smallest sample of 
20 dyads compared to 54 dyads (McPheters & Sandberg, 2010) and 133 dyads (Pozzilli 
et al., 2004). Also, the measures used in Woollett and Edelmann‟s (1988) study were 
not as up-to-date or widely used as the measures used in the other two studies, e.g. 
ADL-MS and EDSS. Additionally, Woollett and Edelmann (1988) obtained 14 on the 
quality assessment compared to 17 (McPheters and Sandberg, 2010) and 18 (Pozzilli et 
al., 2004). Woollett and Edelmann scored lower due to their statistical analysis and 
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selection criteria not being as clearly stated and when interpreting their results they did 
not consider confounding variables, such as depression, or the limitations of the study.   
 
Despite the casual link not being determined an association between relationship 
quality, patient depression and physical functioning was found and is supported by 
Pozzilli et al.‟s (2004) findings. It therefore seems sensible that clinicians should 
involve partners in therapy to facilitate improved communication around difficult topics 
such as the patient‟s‟ physical disabilities and how their relationship may be impacting 
on their day-to-day physical and psychological functioning. The clinician should focus 
on the positive aspects of the couple; their strengths, future expectations and hopes, and 
resiliency, and try to work collaboratively to decrease helplessness and increase 
acceptance of the illness for both the patient and partner. 
 
The studies reviewed also highlighted the differences between men and women in 
relation to their dependence on the couple relationship for support when diagnosed with 
MS. McPheters and Sandberg (2010) found that women tended to seek other forms of 
social support when depressed, whereas the men in their study depended more on the 
support from the relationship. Harrison et al. (2004), also supports this notion as they 
found that men gained mental and physical health benefits from remaining married 
whereas no such relationship was found for women in their study. Therefore male MS 
patients may need more support if they are in an unsupportive relationship or perceive 
their relationship quality to be poor when compared to their partner‟s perspective.    
 
The studies reviewed had similar limitations which should be considered when 
developing future research in this area of MS. All the studies struggled to recruit an 
equal number of men and women, therefore the differences between sexes should be 
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interpreted cautiously. Furthermore, the participants were mostly recruited from the MS 
Society and lacked severe physical disabilities which automatically made them less 
withdrawn and distressed couples as they were already accessing some form of support 
and needed less 1-1 care. Similarly, the length of relationship (20+ years) and disease 
duration (10-18 years) was relatively long and therefore couples were more stable and 
were more likely to have adjusted more effectively to the MS. Hence, couples who were 
distressed or MS patients who were more severely physically disabled were under-
represented in these samples. Lastly, the differences in measures used made comparing 
findings from the different studies difficult, specifically relationship quality measures as 
each study used a different measure; Golombok Rush Inventory of Marital State 
(GRIMS), Marital Concern Scale (MCS), Dyadic Adjustment Scale (DAS). Future 
research should attempt to use a relationship adjustment scale (DAS) and a relationship 
quality scale such as the GRIMS or MCS. The studies reviewed also suggested that 
future research should focus on the effectiveness of interventions in order to clarify the 
causal direction of the association between relationship quality and patient physical 
functioning. In addition, research should include, as well as physical disability, 
relationship quality and depression, other possible risk factors that may impact on the 
patients‟ well-being such as partner responses and type of support offered.  
 
Type of support offered  
Two studies (Kleiboer et al., 2006; Lehman & Hemphill, 1990) have investigated the 
impact of the type and level of support offered on the patient and partner‟s well-being. 
Firstly, Kleiboer et al., (2006) highlighted the importance of distinguishing between two 
types of support; instrumental (the practical help required when one partner is ill) and 
emotional support. For both partners and patients receiving instrumental help was 
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associated to lower levels of self-esteem, possibly as this reminded the patient of their 
increased dependence and for the partner receiving instrumental help may have 
threatened their competence as a caregiver.  
 
Reciprocating instrumental and emotional support was not found to be important to the 
patient‟s and partner‟s mood however the effects of the received or provided emotional 
support were related to the partners‟ role. Patients reported better end-of-day mood 
when they provided emotional support and partners reported better end-of-day mood 
when they received emotional support. Additionally, when patients provided 
instrumental help this associated to better end-of-day mood, regardless of whether it 
was reciprocated. Therefore these findings indicate that immediate reciprocation of 
support was not beneficial to either partner‟s end-of-day mood.  
 
This research suggests that partners receiving emotional support and patients providing 
emotional support are a key way to communicate love and appreciation to one another. 
Clinicians should therefore consider that patients‟ well-being is not only related to 
receiving instrumental and emotional support but that patients should also be 
encouraged to provide emotional support to the healthy partner due to the benefits to 
their own mood and self-esteem. Likewise, more attention and reassurance should be 
given to the partner to welcome emotional support from the patient. Furthermore, 
patients may benefit from discussing how receiving instrumental support makes them 
feel and how the partner may be better able to approach this in the future to avoid the 
patient feeling less independent. 
 
Lehman and Hemphill (1990) found that the most helpful form of support from partners 
was expressions of love, concern and understanding. Patients found it least helpful 
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when partners used two types of support attempts; minimisation (questioning the 
severity or existence of the illness/help requested is made to seem unimportant or 
minor) or maximisation (catastrophising the MS symptoms or its consequences/being 
overly protective). The researchers stated the type of support attempt was dependent on 
the patient‟s physical appearance, for example, the more physically disabled a patient 
was the more likely the partner was to catastrophise. This may be due to people‟s 
stereotypes of how people should function based on the patient‟s appearance.  
 
In addition to these findings, it was also reported that the patient found it difficult to 
confront or even suggest that their partner was using unhelpful or upsetting support 
attempts. The patient often attributed an unhelpful support attempt to the partner‟s lack 
of knowledge about MS. The researchers suggest that MS patients may fear isolation or 
rejection from their partner as they do not want to lose their main caregiver and support, 
they may also feel guilty for needing their partner to care for them and so they „should 
not complain‟. Therefore some MS patients find it difficult to criticise or even consider 
that their partners might not be offering or giving the appropriate support. These 
findings indicate that MS patients, if a problem arises, may need extra support in order 
to elicit more effective support attempts from their partners. 
 
Kleiboer et al.‟s (2006) study obtained a quality score of 19 and was deemed to have a 
strong methodology. The study took into account the confounding variables of daily 
hassles, patient symptoms and previous end-of-day mood on the partners and patients 
scores each day. However, there were a number of limitations to the studies reviewed. 
Lehman and Hemphill (1990) obtained a score of 14 as its data analysis was less 
rigorous and although a rich and detailed amount of information was collected, the 
qualitative analysis for gaining the themes was not well-known and raised issues about 
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the generalisability of their findings. Also, Lehman and Hemphill (1990) did not obtain 
the partner‟s perspective on their own support attempts and this was highlighted as an 
area for future research.  
 
Kleiboer et al. (2006) employed a diary method which could have led to participant 
scores being affected by their overall end-of-day mood (e.g. better patient mood meant 
they scored more helpful support) and so not all confounding variables could be 
controlled for. Also, the findings from the studies reviewed did not investigate the 
effects of being severely physically disabled on the costs and benefits of receiving and 
providing support as their samples only included patients who had low to moderate 
physical disability. The studies reviewed also had a biased sample as the couples 
recruited had on average been together a long period of time and many had been 
accessing support through the MS Society therefore implying they were relatively 
content couples. Hence the samples may have under-represented distressed couples. 
Additionally, the studies could not reliably analyse gender differences due to sample 
size and design, and so could not conclude if the meaning attached to certain types or 
level of support was dependent on type of gender.  
   
Overall the studies reviewed indicate that certain partner support attempts are more 
helpful than others and both patients and partners may benefit from education from 
clinicians around different types of helpful and unhelpful support attempts. Clinicians 
need to be mindful that partners are under a lot of stress themselves and so to work 
collaboratively and in a non-blaming manner, in order to help their support attempts 
become more effective. Clinicians could also encourage patients to offer emotional 
support to their partners and for partners to welcome or take note of this support. 
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Further research should focus on the effects of type and level of support on gender and 
more longitudinal studies in this area would help clarify if certain types of cumulative 
support impacts on the patient‟s mood. Future research should also try and recruit 
participants from more than one centre or hospital and include a range of patients with 
varied physical ability. Also, specific research is needed to investigate whether an 
increase in emotional support could compensate for less instrumental support being 
provided and vice versa. 
 
Coping styles 
Pakenham (1998) used a longitudinal design to investigate the impact of coping styles 
in relationships on level of adjustment to the illness. They found that coping congruence 
and average level of coping was related to collective and individual adjustment. More 
specifically, they examined the difference in two different types of coping styles; 
problem-solving and emotional coping. They found that similarity between the partners 
in emotional coping was adaptive however high emotional coping scores were related to 
greater collective distress and poorer adjustment scores. On the other hand, dissimilarity 
between partners in the problem-solving coping style was related to lower levels of 
collective depression and better adjustment. Therefore it was concluded that the 
problem-solving coping style was more adaptive. The researcher suggested that this 
coping style was more adaptive due to the changeable nature of MS and diverse range 
of difficulties which arise. 
 
However, emotional coping should not be discounted as at certain times it may be 
useful for partners to express their feelings to one another, just not excessively so that it 
is distressing. The researcher reflected that the scale assessing emotional coping style 
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was restricted to mainly focusing on participants‟ level of avoidant emotional coping. 
Therefore, avoiding emotions which are difficult to discuss was found to be maladaptive 
and led to poorer adjustment to the illness. Further research should therefore focus on 
whether „emotional approach coping‟ is more beneficial, e.g. expressing and identifying 
emotions, when compared to the problem-solving coping style.  
 
There are a number of important clinical implications of this research. At assessment the 
couple‟s level and type of coping style should be considered. If the partner and patient‟s 
coping is incongruent and is deemed distressing or to be maladaptive to their level of 
adjustment then clinicians could help facilitate more effective coping styles. Coping 
skills training is one method in which clinicians could help increase the likelihood of 
patients and their partners adjusting more adaptively to the MS through identifying 
problematic coping, modelling, rehearsing and advising on more effective coping styles.  
 
Pakenham‟s (1998) study obtained a score of 17 on the quality assessment checklist. 
Overall it had a number of strengths as it employed a longitudinal design and 
considered a range of confounding variables such as level and congruency of coping in 
addition to coping style. Also, the study recruited participants from a number of 
different research sites making the results more reliable and generalisable. However, 
there were a number of limitations such as the already mentioned emotional coping 
scale which did not fully account for all types of emotional coping. In addition, overall 
level of coping accounted for a significant yet small amount of the variance (11%-13%) 
in individual adjustment, therefore suggesting other factors that were not assessed may 
be impacting more on level of adjustment. However, overall coping congruency 
explained 20% of collective distress in couples suggesting coping is an important factor 
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to consider when assessing relationship factors which may impact on patients‟ well-
being. 
 
Type of partner response and family environment 
Kleiboer et al. (2007) investigated the relationship between negative responses and end-
of-day mood and whether offering emotional support would buffer the detrimental 
impact of negative responses. They found that for both patients and partners receiving 
negative responses led to higher end-of-day negative mood, when controlling for daily 
hassles and MS symptoms. Negative responses were unrelated to end-of-day positive 
mood. The adverse effect of received negative responses on end-of-day mood was 
moderated by receiving emotional support on the same day for both patients and 
partners.  This may be due to partners feeling less rejected or that their relationship is 
less threatened when they received emotional support on the same day as receiving 
negative responses. The researchers suggest that clinicians could help partners and 
patients recognise that it is ok to express how they are feeling, both negative and 
positive emotions. However, the clinician should also offer additional emotional support 
techniques which may moderate against any detrimental effects of their negative 
responses. Furthermore, both patients and partners may benefit from advice on how to 
reduce their negative responses in general such as through relaxation techniques and 
accessing individual support.  
 
Schwartz and Kraft (1999) also investigated the effects of spouse response on 
psychological functioning. However, they investigated whether negative responses 
could be moderated by social support, depression and the type of family environment. 
The researchers examined two types of response from the spouse; solicitous 
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(caring/attentive) and negative response. Solicitous responses were found to be 
associated to greater physical disability. This could be interpreted in two ways, either a 
solicitous response was required more by patients with greater physical disability or the 
spouses encouraged greater disability through providing more solicitous responses. It 
was also found that spouses who encouraged well behaviours were associated with 
lower patient emotional distress and negative responses to patient behaviours were 
associated to poorer mental health. Therefore these findings indicate that if spouses 
encourage well behaviours then patients may feel more supported and less depressed. 
Also, it seems that spousal support could buffer against depression in patients and so it 
may be useful for clinicians to help spouses identify and appropriately reinforce patient 
well behaviours and decrease negative responses to the patient‟s disability.  
 
In addition to their main findings, Schwartz and Kraft (1999) also found that higher 
conflict and/or controlling family environments were associated with poorer 
psychological functioning in patients. Whereas, higher independence levels within the 
family were associated to better patient psychological and physical functioning. 
Therefore clinicians should always be encouraged to work systemically, taking into 
account how the patient‟s family has been affected by the MS and how this may be 
impacting on their well-being. 
 
Schwartz and Kraft (1999) scored 15 on the quality assessment which was a relatively 
low score compared to Kleiboer et al.‟s (2007) study which scored 18. Schwartz and 
Kraft (1999) scored lower because only patient data was used in the analysis and so 
family environment and spouse responses were only measured by the patients‟ 
perspective. In addition to this limitation they also failed to report the full characteristics 
of their sample, such as relationship duration and had a smaller sample size compared to 
Broome – Relationship Factors in MS 
 
 
46 
 
Kleiboer et al. (2007). Schwartz and Kraft (1999) did however take into account the 
impact of the patient‟s wider system, their family environment in addition to the other 
variables considered. They also highlighted the importance of clinician responses when 
working with patients with MS as professionals may also encourage or discourage 
patient behaviour through negative of solicitous responses. Further research is necessary 
in order to clarify whether this association also exists between patients and their key 
workers, e.g. their MS specialist nurse.   
 
As previously mentioned the diary method design used in Kleiboer et al.‟s (2007) study 
is prone to eliciting response bias from participants as their end-of-day mood may 
influence the scores they record. However it is useful to collect the data closer to the 
time it occurs rather than gaining a retrospective response. Yet again the sample under-
represented distressed couples and patients who were more physically disabled and 
there was a bias towards female MS patients. Kleiboer et al. (2007) also suggest that 
other factors could moderate the patient‟s negative end-of-day mood other than 
response from spouse, such as their reaction to the negative response, interpersonal 
sensitivity and level of self-esteem. The researchers also reflect that future research 
should consider the spouses‟ responses during times of patient relapse as 
negative/solicitous responses may vary and impact the patient differently. 
 
The studies reviewed highlight the need to help couples become more aware of how 
they respond to one another and if necessary identify more effective responses to avoid 
deterioration in patient mood. Couples may also need to support to communicate how 
their partner‟s responses make them feel as some responses may inhibit or encourage 
patient behaviour. Therefore couple responses are important when considering the 
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patient‟s well-being but other factors such as their family environment may also be 
influence the patient‟s physical and psychological functioning. 
 
Attitude to illness and adversarial growth 
Three studies reviewed investigated how different patient and partner attitudes to the 
MS may impact on the patient‟s wellbeing. Firstly, Ackroyd et al. (2011) took a unique 
look at the positive growth that can occur subsequent to being diagnosed with MS, 
otherwise known as adversarial growth. They demonstrated that patients with MS and 
their partners do show adversarial growth, with patients showing significantly higher 
adversarial growth than their partners. Furthermore, partner growth significantly 
predicted patient adversarial growth, and vice versa. This research supports the notion 
that patients and partners share a communal search for a positive meaning subsequent to 
being diagnosed with MS and can support one another‟s adjustment to the illness. This 
research is important to highlight as it demonstrates how partners and patients can find 
positive aspects of the MS together and thus not all consequences of MS are negative. 
 
Ackroyd et al. (2011) also investigated the impact of patient and partner illness 
representations on patient mood and adversarial growth.  It was found that dissimilar 
scores between patients and partners illness representations, specifically the 
„consequences of the MS‟ item, were related to partner growth but not patient growth. 
The researchers interpreted this as meaning that patients were slower to adjust to and 
realise the consequences of their MS, whereas partners had a clearer idea of realistic 
goals and what could not be achieved and so impacted on the partner‟s positive growth 
more than patients‟. However the research did find that when patients understood their 
own vulnerabilities and could create a new assumptive world meaning, they could then 
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adopt new perspectives and develop a more positive identity, leading to greater 
adversarial growth. These findings were unrelated to MS type, severity or duration of 
the illness, hence suggesting that the patient‟s perception of their illness is independent 
to disease factors. Also, greater partner growth was associated to increased patient 
distress and greater patient impairment in cognition and illness representations. These 
results indicate that as carers develop clearer, more defined roles then their role 
becomes more rewarding as the care they provide is in more demand. This research 
highlights the diversity in illness representations for both patients and partners and that 
the dissimilarity could affect positive growth. Interventions should aim to increase 
adversarial growth by including both the patient and partner in therapy, specifically 
focusing on patient and partner attitude to the illness and how they feel about a change 
in their roles and identities. 
 
Ackroyd et al. (2011) had a strong methodology and scored 18 on the quality 
assessment. However, they did not report or measure the quality of the couple‟s 
relationship or relationship duration. Therefore the sample may have been biased as 
only stable couples may have put themselves forward for taking part in the study; hence 
these findings may only be applicable to couples who are adjusting well to the MS. 
Further research is needed to help clarify the relationship between perceived control and 
adversarial growth as the researchers highlighted this may also be an important factor 
affecting patient growth.  
 
Wineman et al. (1993) investigated the impact of patient and partner illness uncertainty 
on patient mood. They found that for both those who reported higher levels of 
uncertainty were more likely to have lower moods and feel dissatisfied with family life. 
The main predictor of patient dissatisfaction was their own perception of illness 
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uncertainty; partner uncertainty was unrelated to patient mood. However partner family 
satisfaction was related to congruency between patient and partner illness uncertainty. 
Despite there being a lack of relationship between partner uncertainty on patient mood, 
these results indicate that higher levels of uncertainty may slowly erode the well-being 
of both in the relationship. It may be that patients are focused on managing their MS 
symptoms and so may not be affected by others‟ perceptions of uncertainty; their own 
uncertainties are burdensome enough. Congruence and shared understanding of illness 
uncertainty may be more important to partners because the „togetherness‟ helps them 
better able to manage the changing demands of being a caregiver. A qualitative design 
may help clarify why partner uncertainty does not impact on patient mood or why 
partners feel it is more important to have similar levels of uncertainty.  
 
Despite a lack of interaction found in illness uncertainty it was still found that higher 
individual levels of uncertainty lead to lower mood. Therefore, it is still important for 
clinicians to offer increased education about the illness, include partners and patients in 
support groups and assess whether patients and partners have similar or discrepant 
views about the illness. Wineman et al. (1993) scored 15 on the quality assessment 
which is relatively low compared to the other studies reviewed. They recruited a large 
sample of 61 dyads but these participants were recruited from the MS Society and so 
participants may have been relatively well informed about their illness compared to 
patients who were not part of the support group, hence results may be biased. Also the 
study lacked a critical evaluation of their own limitations and did not include a clear 
inclusion/exclusion criterion making it difficult to compare results to other studies or 
further these findings. Further research into the impact of illness uncertainty is needed 
and how professionals could help alleviate these concerns more effectively. 
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Lastly, Harrison et al. (2004) investigated the differences between gender in acceptance 
of disability and perceived impairment in patients who were married or divorced. For 
both men and women, independent of marital status, acceptance of disability and 
perceived impairment increased significantly over time. For women, acceptance of 
disability increased over time but this was unrelated to marital status. However, for 
men, being consistently married was associated to higher levels of acceptance of 
disability and less perceived impairment. As previously mentioned, this may be due to 
marriage being a source of mental and physical health benefits for men whereas for 
women being married was one of many sources of support. Also men were found to be 
more concerned about how their MS affected their sexual relationship, therefore 
supporting the notion that their well-being is more dependent on being in a relationship 
than female patients‟ well-being. Harrison et al. (2004) scored 16 on the quality 
assessment and was mainly criticised for lacking data from spouses as all the 
information was taken from the patient‟s perspective and may not be as reliable as other 
studies were both partners were assessed. Also, they did not report disease factors or 
how these may have impacted on the patient‟s level of acceptance/perceived 
impairment. Further research is needed to replicate these findings but overall there is a 
lack of research into gender differences in MS patients and so future research should 
include big enough samples to allow for statistical analysis between the sexes.  
 
Overall the studies reviewed indicate that on the whole the patient‟s own attitude to 
their illness, specifically illness uncertainty and illness representation, has more of an 
effect on their mood than their partner‟s attitude to illness on patient well-being. Partner 
adversarial growth has been shown to impact on patient growth and vice versa, and 
being married has been associated to greater acceptance of the illness and lower 
perceived impairment in men, but not women. Therefore discrepancies or similarities in 
Broome – Relationship Factors in MS 
 
 
51 
 
attitude to illness between partners may be less important when compared to other 
aspects within the couple‟s relationship which impact on the patient‟s well-being. It 
seems that the patient‟s own perception of their illness is more important and should be 
a key area for clinical intervention.  
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Discussion 
Overview of Research Findings 
This review aimed to explore which aspects within a couple‟s relationship impact on the 
patient‟s psychological and physical functioning. In line with this aim the findings from 
the review will be discussed under two headings; how aspects within the relationship 
affect the patient‟s physical functioning and psychological functioning.  
 
Which aspects within the couple’s relationship impact on the patient’s physical 
functioning? 
 
There were only a few studies that specifically investigated the association between 
relationship factors and the physical functioning of the individual with MS. The studies 
reviewed suggest that if the patient is in a happy, well-adjusted relationship then they 
are more likely to experience better physical functioning (McPheters & Sandberg, 
2010). This was found to be more relevant and significant for men in Harrison et al.‟s 
(2004) study. Schwartz and Kraft (1999) also found that the patient‟s family 
environment was an important factor to consider when assessing a patient‟s physical 
wellbeing. They found a strong association between families who were more controlling 
and/or demonstrated higher conflict and a decrease in patient physical and 
psychological functioning. Furthermore, if the patient‟s partner is suffering from 
depression then the patient was found to experience greater deterioration in their 
physical, emotional and overall health status (Pozzilli et al., 2004; McPheters & 
Sandberg, 2010). Partner depression was also associated with increased severity of MS 
symptoms (Pozzilli et al., 2004). Lastly, the way in which a partner responds to the 
patient‟s disability could be detrimental to the patient‟s physical functioning. It has been 
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suggested that if the partner provides more solicitous responses to the patient this may 
encourage greater disability and lessen the possibility that the patient would partake in 
„well behaviours‟ (Schwartz & Kraft, 1999). Well behaviours are activities that are 
challenging but possible for the patient to complete such as walking further than 
anticipated or pushing themselves to go to a social event when they lack confidence in 
their abilities. Patients are more likely to engage in „well behaviours‟ when partners 
express happiness and encouragement when the patient completes or attempts these 
activities. 
 
Therefore the partner‟s mood and response to the patient, and the patient‟s perception of 
the quality of their relationship, are important factors to consider when assessing patient 
physical functioning. Studies have suggested that if the patient‟s relationship is of low 
quality then the patient is likely to experience more symptoms of physical distress 
during difficult times in their lives which may lead to poorer health outcomes (Gulick, 
1994). Additionally, the studies reviewed support previous research into other health 
patients who found that high marital functioning was related to improved survival rates 
after heart failure (Coyne et al., 2001) and enhanced physiological functioning (Uchino, 
Cacioppo & Kiecolt-Glaser, 1996).  
 
The clinical implications of this research are substantial. Pozzilli et al (2004) suggest 
that patients should receive multi-disciplinary home care which would then facilitate 
increased coping in partners and therefore reduce carer burden and depression, which 
would in turn improve the patient‟s health status and reduce service involvement in the 
long-term. They go on to advise that both partners and patients would benefit from 
education and information about emotional support and practical help and when one 
coping strategy may be more appropriate in different situations. These interventions 
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should be specific and personalised to the couple‟s relationship. As relationship 
difficulties may have a pronounced impact on the patient‟s physical and emotional 
wellbeing it has also been recommended that partners and patients should be equally 
involved in therapeutic input. This may also help alleviate any psychological or 
physiological distress the partner may be experiencing (McPheters & Sandberg, 2010).  
 
It cannot be overlooked that Woollett and Edelmann (1988) found no relationship 
between physical disability, life satisfaction and marital satisfaction. These results 
suggest the influence of relationship satisfaction/quality may not be as reliable or 
consistent as suggested in the other studies reviewed. It is also important to remember 
that none of the studies reviewed could determine a causal relationship between the 
relationship quality and patient physical functioning due to their cross-sectional designs. 
This interconnection between biological and social factors is less defined and has been 
researched least compared to the association between social factors and patient 
psychological well-being. Therefore future research should focus on including both 
physical and psychological outcomes for patients when investigating how aspects of the 
couple relationship impact on patient well-being. 
 
Which aspects within the couple’s relationship impact on the patient’s psychological 
functioning? 
 
Most of the studies reviewed examined aspects of the couple relationship in relation to 
the patient‟s psychological functioning, such as depression, self-esteem, adjustment to 
their illness and end-of-day mood. The findings from these studies will now be 
summarised.   
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There were a number of aspects within the couple relationship which were found to 
increase the likelihood of the patient developing depression. Schwartz & Kraft (1999) 
found that the patients were more likely to become depressed if partners responded 
negatively to patients and if patient „well behaviours‟ were not encouraged by the 
partner. Kleiboer et al. (2007) furthered these findings as they found that if the partner 
offered emotional support subsequent to their negative response then the likelihood of 
patients becoming depressed or low in mood was reduced. Also, greater conflict and 
low independence levels within the family were associated to poorer patient 
psychological functioning. In addition to these findings, overall relationship satisfaction 
was associated to patient mood, as poorer relationship satisfaction was found to be 
related to increased patient depression scores (McPheters & Sandberg, 2010). 
 
The type of support offered to patients by their partners also impacted on patient mood. 
It was found that if patients received excessive amounts of instrumental (practical) help 
then they were more likely to score lower on measures of self-esteem, possibly as this 
reminded the patient of their increased dependence on their partner (Kleiboer et al., 
2006). Patient end-of-day mood was improved if patients were able to provide 
emotional and instrumental support to their partners. Hence, both the patient‟s ability to 
provide support to their partner and the response and support offered by partners are 
equally important in moderating the patient‟s end-of-day mood. Furthermore, patients 
reported that the most helpful form of support from their partners were expressions of 
love, concern and understanding (Lehman & Hemphill, 1990). Clinicians should reflect 
on these findings if the patient and their partner are struggling to find helpful ways of 
supporting one another.  
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The coping styles employed by the partner and patient have been found to influence and 
shape each other‟s adjustment in clients suffering from different health conditions 
(Coyne & Smith, 1991). In patients with MS, it was found to be more adaptive if 
partners had dissimilar coping styles, specifically when the problem-solving coping 
style was utilised. Dissimilar problem-solving coping style was related to lower levels 
of collective depression and better adjustment to the MS (Pakenham, 1998). The 
researcher suggested that this coping style was more adaptive due to the changeable 
nature of MS and diverse range of difficulties which the couple are faced with 
throughout the disease course. Increased avoidance of identifying and expressing 
emotions (emotion coping style) was associated to increased global distress, however 
further research into emotional coping is needed as other forms of emotion coping styles 
may be beneficial, e.g. expressing emotions to one another. The researcher suggested 
that the key to adapting to MS is to use both styles of coping and remain flexible 
dependent on the situation (Pakenham, 1998). If both partners are focused on 
overcoming the same problem this may not be an effective coping strategy as the 
couple‟s resources are less likely to be co-ordinated. Whereas a more efficient division 
of labour may be if one partner supports the other to solve the problem and offer 
emotional support, the two styles of coping would then complement one another.  
 
Caregiver depression has been well-documented in MS research (McPheters & 
Sandberg, 2010). The association between health status of the patient and depression of 
the caregiver could be two-way. Increased caregiver depression may be influenced by 
greater severity in health status of the MS patient, however inversely; health status of 
the patient may be exacerbated by a decrease in the psychological functioning of their 
caregiver (Pozzilli et al., 2004). The causal direction of this relationship remains 
unknown and further longitudinal and intervention studies are necessary. Despite the 
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fact it is uncertain whether caregiver depression impacts on the physical or 
psychological functioning of the patient, there is research which suggests caregiver 
depression is a common occurrence and so it should be recommended that both the 
patient and partner receive therapeutic input.  
 
Illness representations (Leventhal et al., 1997) have been found to affect the patient‟s 
adaptation to the illness in a wide range of conditions (Orbell & Hagger, 2003). It is 
hoped that by processing information about their illness and developing a range of 
cognitive representations, that patients can make sense of their symptoms and develop 
effective coping strategies. Positive interpretation and seeking emotional support has 
been related to positive psychological outcomes (Moss-Morris et al., 1996). However, it 
is not solely the patient‟s illness representations that may influence how they cope with 
their illness. It has been found in patients suffering from psoriasis that if patient and 
partner illness representations are dissimilar then this can lead to increased 
psychological distress for both (Richards et al., 2004).  
 
Conversely, Ackroyd et al. (2011) found that dissimilar scores between patients and 
partners illness representations, specifically the „consequences of the MS‟ item, were 
related to partner positive growth but not patient growth. The results from this study 
suggest that patient illness representations are more influential to their adjustment to 
their illness than their partner‟s illness representations. Therefore, illness representations 
should be considered when working individually with a patient and it may be useful to 
explore how this is managed within the couple‟s relationship. As mentioned previously 
partner response to the patient‟s illness was found to impact on patient mood (Kleiboer 
et al., 2006) and it may be that the partner‟s illness representations influence how they 
respond to the patient. Hence it may still be beneficial to explore partner illness 
Broome – Relationship Factors in MS 
 
 
58 
 
representations, despite no significant correlation being found between partner illness 
representation and patient growth (Ackroyd et al., 2011). 
 
In addition to partner illness representations, partner illness uncertainty was also found 
to be a minor aspect within the couple‟s relationship when considering the impact on 
the patient‟s psychological functioning. It was found that patient illness uncertainty was 
more related to patient low mood and reduced family satisfaction than partner illness 
uncertainty (Wineman et al., 1993). However, greater incongruence between patient and 
partner illness uncertainty was found to relate to deterioration in family satisfaction and 
possibly worsened relationship quality (Wineman et al., 1993). This may then indirectly 
lead to poorer patient psychological functioning, as relationship quality has been 
strongly related to patient well-being (McPheters & Sandberg, 2010; Harrison et al., 
2004). Hence, as with partner illness representations, it is still important to discuss the 
uncertainty of the disease as this could indirectly impact on patient mood. Furthermore 
offering more information about the disease and helping manage the couple‟s 
uncertainties could help both partners develop a greater understanding of MS and 
subsequently better prepare the couple for possible challenges which may arise.  
 
Research has also shown that when faced with adversity such as a chronic illness some 
patients develop positive changes to the self and their philosophy of life; this has been 
termed as posttraumatic or adversarial growth (Tedeschi & Calhoun, 2004). Ackroyd et 
al. (2011) found that partner adversarial growth impacted on the level of growth in the 
patients and vice versa, therefore supporting the notion that partners share a communal 
search for a positive meaning and can support one another‟s adjustment to the illness. 
These findings are in line with previous research which demonstrated that adversarial 
growth has been shown to occur and to be adaptive in MS patients (Mohr et al., 1999).  
Broome – Relationship Factors in MS 
 
 
59 
 
Summary and Clinical Implications 
The studies reviewed support the notion that there is an interaction between social 
relationships and the patient‟s physical and psychological functioning. Certain aspects 
within the couple relationship have been found to impact on the patient‟s well-being and 
severity of the illness. Therefore it is useful for clinicians to reflect upon the 
biopsychosocial model (Engel, 1977) when working with MS patients to encourage 
them to explore the wider systemic impact and influence on MS rather than focusing on 
MS as an illness that resides solely with the patient.  
 
Specific aspects of the couple‟s relationship that impact on both the patient‟s 
psychological and physical functioning include marital satisfaction, the family 
environment, congruency and style of coping styles used, negative partner responses, 
partner emotional support which may moderate any detrimental impact of negative 
responses, partner depression and lastly the patient‟s perceived quality of their 
relationship.  
 
These findings highlight the importance of clinicians offering partners either joint or 
individual therapeutic input. The MS guidelines by NICE (2004) have a recurring theme 
of offering support to those caring for patients with MS. However the evidence used in 
these guidelines are based on research with patients who have suffered a stroke, 
therefore the recommendations cannot be generalised to people caring for those with 
MS. Also the impact of relationship factors on the patient are not discussed and thus 
there are no recommendations that partners should be offered couple therapy. There 
were no intervention or randomised-control trials used in this review and so it is beyond 
the scope of this review to suggest the effectiveness of clinical interventions based on 
the couple relationship. However, the findings from the studies reviewed can highlight 
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possible clinical implications that may be useful for clinicians to consider 
implementing.  
 
The form of support offered to the couple is dependent on the couple‟s wishes and 
needs, therefore a full multi-disciplinary assessment should be carried out which takes 
into account not only the physical health of the patient but also the quality and 
supportive nature of the patient‟s relationships. It is then the clinician‟s responsibility to 
offer the patient the option of including their partner in their on-going support 
throughout the disease course.  
 
McPheters and Sandberg, (2010) suggest that preventative family and couple therapy 
could be offered alongside the support provided by the health care team. It may be 
useful for the family and couple to have support when topics that are usually unspoken 
arise such as disability, death and dying which will inevitably surface. Some couples 
may not need additional support however for others these topics may trigger difficult 
emotions which may lead to conflict in the relationship. Clinicians could offer the 
couple support with the aim of increasing physical and emotional well-being for both 
the patient and their partner. It has also been recommended that it could be helpful for 
clinicians to focus on the couple‟s strengths and encourage more positive emotions and 
thoughts about their hopes and future aspirations. It may be that when a family are 
struggling the focus is on trying to solve a problem and they get drawn into ruminating 
on the negative aspects of their situation. Also normalising and offering more 
information about what couples usually find challenging may be helpful to the couple. 
Overall, the clinician should focus on the resiliency the couple have demonstrated in the 
past and how this may help reduce hopelessness in the present (Pozzilli et al., 2004). 
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The couple may need further support on their acceptance and attitude to the illness. Key 
factors that may contribute to poorer relationship quality may be dissimilar illness 
representations and illness uncertainty within the couple. In this case it may be 
beneficial to offer more psycho-education on MS and help clarify any misinterpretations 
that may have arisen. The studies reviewed also highlighted the possible differences 
between how men and women cope with being diagnosed with MS and how men may 
depend more on the support provided from their marital relationship (Harrison et al, 
2004). Therefore, in addition to clinicians exploring the aspects of the relationship 
already discussed it should also be noted that gender differences may be relevant to how 
the couple are coping.  
 
In summary, couple‟s may find it useful to be given the opportunity to discuss difficult 
emotions and topics within a safe, therapeutic environment. The aim of the clinician is 
to facilitate improved communication between the partners around difficult topics such 
as the patient‟s disabilities and how their relationship may not always have a positive 
influence on both their physical and psychological functioning. A multi-disciplinary 
approach is not always possible due to service limitations. However, this review 
highlights the importance of relationships to MS patients and so individual clinicians 
who are working directly with the patient can use a biopsychosocial approach to guide 
their assessment and way of working. If the service is unable to offer support to the 
couple or wider system around the patient then other services should be signposted.  
 
Limitations and Methodological Issues of Studies Reviewed 
There were both methodological and theoretical limitations to the studies used in this 
review. Firstly, the participants used in the studies were mainly recruited from an MS 
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Society branch which consequently led to a selection bias of mostly well-adjusted 
couples who were in stable relationships. This is unsurprising as most these participants 
had been receiving support from the Society and were in long-term relationships, the 
majority had also been diagnosed with MS for at least ten or more years. Therefore, 
couples who had been together less than ten years, who were not accessing the available 
support and who may be struggling most were under-represented in the studies 
reviewed. However, the results from the studies reviewed remain relevant to the wider 
MS population as aspects within a relationship were found to be important to the 
patient‟s well-being, even in relatively well-adjusted couples. Even so, future studies 
should aim to recruit participants from more than one base such as neurology 
departments, different hospitals or through out-patient clinics to obtain a diverse range 
of couples who may not be coping as well as those attending support groups and who 
may not have been together for more than ten years. 
  
There were two other keys limitations, other than selection bias, which existed in the 
participants recruited. Patients who were experiencing moderate to severe physical 
disabilities and those who had just been diagnosed with MS were underrepresented in 
the study samples reviewed. These patient characteristics may provoke or cause 
different difficulties or emotions within a relationship between partners and so clinical 
interventions may vary for these couples. Hence future research should also try to 
recruit patients experiencing more severe physical symptoms of MS and those who have 
been newly diagnosed. It may be that there are preventive interventions or support that 
could be offered to couples at this early stage in the disease course which could impact 
on how the couple later copes with their adjustment to the illness and increase patient 
well-being. 
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In addition to the limitations discussed a number of smaller methodological issues were 
found. None of the studies used in the review reported a sample size calculation and 
some studies did not fully describe the characteristics of their participants. Additionally, 
the studies considered in this review employed a mixture of old and new measures and 
few used the same measure to assess the same aspect, e.g. relationship quality or 
disability. This made it difficult to compare the findings of the studies used in this 
review and also the power in these studies could have been too low to detect a 
significant relationship that may have otherwise existed. Also three studies did not 
include data from the patient‟s partner and so the information collected was from the 
patient‟s perspective. It may be more reliable to collect data from both partners in order 
to gain a full picture of the couple‟s functioning.  
 
Whilst searching for studies to use in this review it became clear that there is a lack of 
longitudinal studies or studies implementing interventions and randomised-control trials 
which investigate the aspects within a couple‟s relationship. In order to clarify any 
causal relationship between couple relationship factors and patient well-being more of 
these types of studies are necessary. A longitudinal study would be able to investigate 
how relationship factors influence changes in disease activity of if increased disease 
activity leads to greater strain on the patient‟s relationships. In order to clarify cause and 
effect more intervention studies are needed and would help clarify which clinical 
interventions are most effective. It would be beneficial to explore the effectiveness of 
offering support to the couple versus individual support to the patient or a combination 
of both. Additionally, more studies are needed which employ a qualitative design. This 
would provide a more detailed account of what couple‟s find most difficult or helpful 
about their relationships. 
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Lastly, there were only a small number of studies which investigated the effects of MS 
using a biopsychosocial approach. Most studies only focused on the psychological 
impact of difficulties in the couple relationship and did not consider others outcomes 
such as increased physical symptoms or change in disease activity. MS has been shown 
to affect the individual in a number of different areas of their life, including cognitively, 
physically and socially (Rao et al., 1991), therefore it seems logical to assume that these 
factors could be interlinked and therefore should be investigated (McPheters & 
Sandberg, 2010). In order to comprehensively investigate the impact of relationship 
factors on the patient, a full range of outcomes should be assessed, including physical 
disability and other MS symptoms such as fatigue. Future research in this area would 
help clarify the interconnection between social relationships and physical functioning in 
MS patients.  
 
Limitations of Review 
There were a number of limitations to this systematic literature review. Firstly, the 
search terms used produced a large number of search results which led to a large 
number of article abstracts being searched for relevancy. Implementing the use of the 
database limit options reduced the number of articles but a substantial number still 
remained. The vast number of articles searched makes the replication of this review 
difficult however it was important to search through the articles in order to confirm that 
relevant information was not missed. Many of the studies searched appeared to explore 
relationship factors however after further reading of the abstract it was clear that the 
focus of the article was not the couple relationship or focused on sexual difficulties.  
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The review did not include studies which investigated the relationship between patient 
well-being and sexual difficulties experienced in the couple‟s relationship due to the 
vast number of studies in this area. This does not signify that the sexual aspect to the 
couple‟s relationship is irrelevant as Harrison et al. (2004) highlighted the importance of 
sexual satisfaction in male MS patients and how this impacts on their psychological 
functioning, however it was beyond the scope of this review to include studies which 
solely investigated the sexual relationship in MS patients. Furthermore, this review did 
not specify or investigate the differences in relationship factors for patients who had 
different types of MS. This would be a useful factor to consider when working with 
patients as type of disease may have different implications for patients and their 
partners, factors to consider include; the severity and type of symptoms experienced, the 
speed of deterioration, the changeable nature of the disease and the disease activity in 
general. A more in depth analysis of the physical and psychological outcomes for 
patients with different disease types would help further develop more detailed clinical 
interventions. 
 
An additional limitation to this review is that studies were included if they had a 
majority of the participants were in a couple relationship. Therefore two study samples 
(Pakenham, 1998; Pozzilli et al., 2004) investigated other relationships such as siblings, 
friendships or parents, although the majority of participants were married or being cared 
for by their partner. The results of these two studies remain relevant to aspects of the 
couple relationship however in the future, when more studies exist, it may be beneficial 
to replicate this systematic review and only include spousal relationships. 
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Future Research 
Further areas of interest have been touched upon throughout this review. In summary 
intervention studies which investigate the effectiveness of couple therapy with the aim 
of reducing patient psychological distress and offering support to the patient‟s partner 
which may have an indirect impact on the patient‟s well-being. It may be useful to 
investigate the effectiveness of group sessions for partners, support groups or individual 
couple therapy. Future studies need to make a conscious effort to explore gender 
differences when coping with MS and how the impact of their relationship may differ 
between sexes. This may have clinical implications for how clinicians work with male 
and female MS patients or at least offer a more comprehensive account of which factors 
may be more important to the different sexes. In addition, research should include up to 
date measures that, if possible, have been validated with an MS population.  
 
It is hoped that further research will help clarify the cause and effect of the association 
found between relationship factors and patient well-being. Additional research should 
continue to investigate whether an interconnection between the couple relationship and 
patient physical and psychological functioning exists so that services can offer 
appropriate support and advice. This would provide a more detailed account of what 
couple‟s find most difficult or helpful about their relationships. Lastly, more studies 
using a qualitative approach would help clinicians and researchers gain a better 
understanding of other possible aspects of the couple relationship which may impact on 
the patient‟s well-being.   
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Abstract 
 
Background: This study aimed to investigate the impact of memory and information 
processing speed (IPS) deficits on social functioning in individuals with multiple 
sclerosis (MS), taking into account physical disability and mood. The current study also 
investigated participant insight into how their memory difficulties influenced their 
social functioning.  
Method: Thirty-four participants completed the Hospital Anxiety and Depression 
Scale, the Barthel Activities of Daily Living Index, the Environmental Status Scale 
(ESS) and a subjective measure of how they perceive their memory impacts on their 
everyday functioning. They then completed the BMIPB. 
Key Findings: IPS predicted a significant proportion (24.8%) of the variance in 
participants‟ scores on the ESS. The subjective measure of memory significantly 
correlated with social functioning (ESS) and actual memory scores. IPS, when 
compared to memory scores, explained a greater proportion of the variance in scores on 
the subjective questionnaire.  
Conclusions: These results indicate that IPS and perceived memory abilities are 
significantly associated to the individual‟s completion of everyday social tasks such as 
work and social activities. This research suggests implications on rehabilitation and 
therapeutic input for individuals with MS. The strengths and potential challenges of 
using the BMIPB are discussed.   
 
Keywords: MS, BMIPB, social functioning, subjective memory. 
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Introduction 
 
 
Multiple sclerosis (MS) is characterised by inflammation, demyelination and neuronal 
loss in mainly white matter and some grey matter areas [1]. The broad range of 
symptoms reported in MS are due to the widespread development of plaques or lesions 
in the brain or spinal cord. Symptoms include physical and cognitive deterioration, 
although cognitive deficits can occur without severe physical disability and can be 
equally if not more debilitating to the person‟s social and everyday functioning [2, 3].  
 
Previous neuropsychological studies have found various aspects of cognitive 
functioning to be affected in patients with MS [1, 4, 5]. It has been reported that overall 
cognitive impairment is related to a decline in everyday functioning, quality of life and 
affects the individual‟s ability to work [5]. Consequently, cognitive deficits may have 
an enormous impact on a person‟s functioning and possible future rehabilitation and 
therapeutic input [6]. It is therefore essential that neuropsychologists detect cognitive 
deficits early in the disease progression due to the potential negative impacts of such 
deficits. This study aims to focus on two of the most commonly reported cognitive 
deficits which affect approximately 43%-70% [7] of patients with MS; information 
processing speed (IPS) and memory. 
 
Memory and Information Processing Speed (IPS) in MS 
Memory impairment in MS has been characterised by long-term retrieval deficits with 
the primary problem being in initial learning of information rather than the storage and 
retrieval of information [8, 9].  MS patients usually have relatively intact short-term and 
semantic memory, recognition and implicit learning [1]. Additionally, reduced IPS is 
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considered a distinguishing cognitive deficit in MS with patients reporting slower 
reaction times and difficulty processing everyday life and job activities quickly [10].  
 
Research investigating the difference between verbal and visual memory in MS remains 
varied. A number of studies have found visual memory performance to be significantly 
poor, in particular with respect to geometric figures [11, 12]. In contrast, Higginson et 
al. [6] reported that participants performed better on visual memory than verbal memory 
subtests and Diamond, DeLuca, Kelley and Kim [13] found no difference between 
performance on visual and verbal working memory tasks. Whereas Clemmons, Fraser, 
Rosenbaum, Getter, and Johnson, [14] found both verbal and visual-spatial memory to 
be impaired. The inconsistent findings in verbal and visual memory performance may 
be the result of different tests used to assess these aspects of memory and therefore 
assessing different functions, e.g. motor speed or ability to write as opposed to assessing 
visual memory. Furthermore, the different types of stimuli found in verbal and visual 
memory tasks may require the participant to engage in different types of processing as 
opposed to assessing impairments in verbal or visual memory.   
 
Hence, an additional aim of the current study was to explore the differences between 
verbal and visual memory scores. The location of lesions in MS are varied and as 
highlighted there is no clear research indicating that one is more affected than the other; 
any differences in scores may be more indicative of the type of test stimuli rather than 
verbal and visual memory functioning.  
 
Consequently, the current study aims to investigate memory and IPS deficits in MS and 
explore if any differences exist between verbal and visual memory in MS, taking into 
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account a critical analysis of the stimuli used and processing required for the subtest in 
question.  
 
Impact of Memory and IPS on Everyday Functioning in MS 
MS has been found to disrupt the overall lifestyle and employment status of individuals 
[15]. Physical disability alone cannot account for all the difficulties patients with MS 
encounter in their daily functioning [6]. In support of this view point, LaRocca, Kalb, 
Scheinberg, and Kendall [16] found that physical disability and demographic factors 
only explained 14% of the variance in employment status in 312 individuals with MS, 
hence is it possible that cognitive impairments in MS may have diverse effects on their 
daily functioning.  
 
Overall, research shows that cognitive dysfunction, as an umbrella term, is closely 
associated with everyday functioning in MS [2, 17, 9]. Kalmar et al., in 2008 
investigated the relationship between cognitive difficulties and the ability to perform 
everyday life activities in individuals with MS. They found that individuals with and 
without cognitive impairment differ in everyday functioning and proposed that aspects 
of cognition are predictive of the ability to complete everyday activities in MS patients. 
Furthermore, Rao et al. [2] found that cognitive impairment was important in 
determining the work status of individuals with MS, even when groups were matched 
on several measures of disease severity (the expanded disability status scale scores, 
disease course, and disease duration). Therefore, physical disability is important for the 
performance of everyday activities, but it cannot account for the extent of difficulties 
that individuals with MS encounter for many everyday activities [3, 18]. 
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As Higginson et al. [6] states most studies investigating the impact of cognition on 
everyday functioning use global indices of cognitive impairment and fail to use specific 
individual measures. Kessler et al. [9] is an exception as they looked specifically at how 
memory impacted on everyday functioning. They found that variance of everyday 
functioning could be accounted for by memory loss, independent of demographic or 
physical disability variables. Higginson et al. [6] also found that deficits in memory and 
attention signficantly predicted functional impairment in 31 individuals with MS. 
Lastly, Kalmar et al., [15] found that a combination of deﬁcits in executive functions, 
new learning, and processing speed deficits predicted the degree of independence on 
activities of daily living.  
 
Memory deficits were found to be associated to everyday functioning in the three 
studies highlighted. As previously stated in this study, IPS deficits in MS are commonly 
reported and yet few studies have specifically investigated if both memory and IPS 
deficits impact on social functioning in MS. It is evident that the relationship between 
the detrimental effects of memory and information processing deficits on everyday 
functioning is under researched [6, 9, 15]. Therefore the primary aim of the current 
study is to expand this research.  
 
As previously stated physical functioning has been found to account for at least 14% of 
difficulties in daily functioning [16]. Hence, this study, similar to Higginson et al., [6] 
and Kessler et al., [9] wanted to take physcial disability into account when investigating 
the impact of specific cognitve domains on everyday functioning. However, previous 
studies have used a variety of measures to assess physical functioning. The majority of 
studies have used the Extended Disability Status Scale [19] but this is a time-consuming 
and difficult measure to administer which also needs a neurologist to be present at 
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assessment. Therefore a different measure of physical disability was utilised in this 
study; the Barthel Index, (BI) [20]. The BI is an ordinal scale that measures functional 
independence in the domains of personal care and mobility. The BI has been shown to 
be a valid and reliable measure for assessing functional impairment in stroke patients, 
and changes in the scale correlate well with physician assessment of progress [21]. 
Additionally, in MS patients it has been found to be sensitive enough to detect change 
in functional status in patients receiving inpatient rehabilitation [22]. Therefore this 
measure was chosen to assess physical disability. Mood was also taken into 
consideration when assessing the impact of cognition on social functioning as previous 
research [6, 7] has demonstrated that depression also accounted for some of the variance 
in MS patients‟ social functioning. 
 
The current study administered the Environmental Status Scale [23] as a measure of 
social functioning. This scale was chosen because it assesses daily and social activities 
which are affected by cognitive as well as physical impairments, unlike other measures 
such as the Activities of Daily Living Scale [24] used in Kessler et al.‟s [9] which is 
mainly focussed on the assessment of motor function. The term „social functioning‟ 
used in this study relates to the participant‟s ability to function socially within their 
community, including the ability to work and attend social events. This differs from 
measures investigating „functional disability‟ such as the IADL which does not assess 
the participant‟s ability to complete both daily and social activities.   
 
Lastly, in addition to the objective measure of cognitive abilities (BMIPB) and social 
functioning (ESS), this study developed a short questionnaire to investigate whether 
participants‟ perception of how their memory affects their ability to complete everyday 
tasks was accurate. The current study did not aim to design a new questionnaire, but 
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rather to investigate participant‟s beliefs about their memory in a qualitative fashion 
using a series of simple general questions. 
 
A small number of studies have found a lack of association between patient-completed 
memory questionnaires and cognitive performance [25, 26, 27]. Furthermore, research 
has found that many MS patients often underestimate their memory difficulties on a 
memory questionnaire [28]. Therefore previous research suggests that participants may 
lack insight into their memory difficulties. However, the weak association between 
perceived and actual memory performance may be due to inadequate subjective 
memory questionnaires being used in previous research. Additionally this research has 
not been replicated and their findings are limited as the objective measures were 
administered over the telephone and small samples were used [25, 28].  
 
This study proposes to ask participants directly if they perceive themselves to have 
memory impairments, and if so do their memory difficulties impact on specific social 
functioning tasks e.g. conversations and remembering events. It is thought that as 
participants are asked directly how their memory difficulties impact on their social 
functioning, that they would accurately report how much of an impact memory deficits 
accounted for the variance in their social functioning. If there is no relationship found 
between actual and perceived performance then participants may lack insight into their 
difficulties which may have clinical implications for further interventions. It is predicted 
that participants will accurately report their social and memory functioning as the 
questions used focus on asking participants about how memory affects specific social 
functioning tasks, which are also assessed in more general terms by the ESS. The ESS 
has two domains that correspond to the memory questionnaire questions; social 
activities and work status. It is hypothesised that scores on the memory questionnaire 
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will significantly correlate only with the work status question as this represents 
participant‟s ability to complete social tasks (e.g. unable to do work). Whereas the 
social activities question asks participants about how many social activities they are 
partaking in, rather than their ability to complete social activities. Therefore, it is 
hypothesised that scores on the subjective memory questionnaire will significantly 
correlate with the total ESS score (general social functioning), specifically the work 
status question and with participants‟ objectively measured memory scores (BMIPB). 
 
In summary, the ESS will be used to investigate the relationship between social 
functioning, memory and IPS scores, whilst taking into account physical disability (BI) 
and mood (HADS). Participants will also be asked questions regarding their perception 
of whether their memory impacts on their social functioning to investigate participants‟ 
insight into their difficulties.    
 
The BMIPB 
As previously discussed the impact of cognitive deficits on individuals with MS may be 
substantial. Therefore, it is important to detect these impairments as early as possible in 
order for clinicians to help the individual develop coping strategies to develop and 
maintain a better quality of life. Hence, an objective assessment for assessing 
impairments in memory and information processing is necessary. 
 
A relatively new measure, the BMIPB [29] is widely used to assess memory and 
information processing in neuropsychological settings, including patients with MS. The 
BMIPB is a useful measurement when assessing MS patients as there are four parallel 
forms (versions); hence re-assessments can be carried out without the contamination of 
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practise effects [30]. Re-assessments are especially important when offering the 
appropriate treatment to MS patients due to the quick and changeable nature of the 
disease course [7]. 
 
The current study aims to investigate memory and IPS deficits in MS and how these 
may relate to the participant‟s social functioning. As previously highlighted research 
has rarely investigated both IPS and memory functioning in MS. Furthermore, only one 
study found a relationship between IPS and social functioning and this study proposes 
this may be due to the measure used. Higginson et al., [6] used the Paced Auditory 
Serial Addition Test (PASAT) to measure IPS. This assessment tool has been 
recommended for testing IPS in MS patients [31]. However, Higginson et al., [6] 
reported that five participants were unable to complete the measure. Furthermore, 
Clemmons et al., [14] stated that in their research only 18 of 37 participants were able to 
complete the PASAT in their assessment. Many of the participants reported being 
frustrated or confused by the test. Therefore it is not surprising that IPS was found to be 
unrelated to everyday functioning in Higginson et al.‟s [6] study. The previous version 
of the BMIPB, the AMIPB, has been proposed as a more effective measure of IPS in 
individuals with MS [32] as it is less stressful for participants to complete. 
Consequently, all participants should be able to complete the IPS subtest on the BMIPB 
unless they suffer from severe motor impairment, yet this is an exclusion criterion for 
participant recruitment in this study. Therefore, it is hoped that the IPS subtest on the 
BMIPB will obtain a more accurate account of IPS in individuals with MS. 
 
The BMIPB is beneficial to MS patients as it assesses for numerous cognitive deficits 
which have been associated to MS, such as impairments in memory and information 
processing speed. Previous research has highlighted the need for an early screening 
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measure which would assess for these deficits, this in turn would better inform 
rehabilitation programmes and enhance appropriate support for the individual [1]. 
Consequently, the potential advantages or disadvantages of using the BMIPB in an MS 
population will be discussed.  
 
The Current Study 
It is important to further explore the relationship between cognitive deficits and social 
functioning. If social functioning is significantly affected by cognitive impairment then 
this will highlight the importance of assessing cognitive ability early in the disease 
course. This will in turn enable clinicians to administer intervention strategies early in 
the disease course [33] and allow patients to prepare for problems that may occur in the 
future.  
 
It is the researcher‟s aim to expand on Higginson et al.‟s [6] research by using the 
BMIPB to investigate both IPS and memory deficits in individuals with MS. The 
relationship between specific cognitive domains and social functioning will be 
investigated, whilst taking into account the impact of physical disability and mood. The 
current study will also assess the participant‟s insight into how their memory difficulties 
influence their social functioning. Lastly, this study will also explore if any differences 
exist between verbal and visual memory in MS, taking into account a critical analysis of 
the stimuli used. Demographic variables, mood, and disease factors, such as type and 
duration will also be considered in the analyses. 
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Hypotheses 
It was hypothesised that; (a) IPS and memory impairment will account for a significant 
portion of the variance in scores on the social functioning measure (ESS); and (b) 
participants‟ subjective memory score will significantly correlate with actual 
performance on the objective measure of memory and ESS scores, specifically work 
status. 
 
Method 
Design 
The study took a quantitative approach and employed a cross-sectional design to 
investigate relationships between mood, education, age, disease type, disease duration 
and everyday functioning and cognitive impairments. „Disease type‟ was on three 
levels; primary progressive MS, secondary progressive MS and relapsing-remitting MS.  
 
Participants 
Thirty-four participants were recruited, and all had a clinically definite diagnosis of 
relapsing-remitting MS (RRMS), secondary progressive MS (SPMS) or primary 
progressive (PPMS), according to McDonald criteria [34]. The inclusion criteria for all 
participants included; must be proficient in English, above 18 years of age, and able to 
give full informed consent. Participants were excluded from the study if they had not 
been diagnosed for at least one year as it was deemed inappropriate to discuss possible 
cognitive impairments so close to the time of diagnosis. The exclusion criteria included: 
(a) unable to comprehend or produce speech to the levels necessary for the tasks, (b) 
severe motor or visual impairment that might interfere with cognitive testing, (c) under 
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the influence or had a history of drugs or alcohol abuse, (d) diagnosis of any 
neurological disease besides MS, (e), unable to give consent to take part, and (f) a 
previous history of severe mental health difficulties (defined as care of a community 
mental health team or an inpatient admission). The study was approved by the National 
Research Ethics Committee and local Research and Development Ethics Committees 
(see Appendix 3).  
 
Sample Size Calculation 
There was no published research that used the BMIPB and ESS in an MS population 
available to accurately estimate effect sizes in the current study. Also, due to the patient 
group and testing taking up to 2 hours to complete it was realistic that only a small 
sample could be obtained. The following sample size calculation was based on the 
primary research question; will IPS and memory scores, predict a significant amount of 
the variance in ESS scores (i.e. a significant increase in R-squared) after controlling for 
disease disability and mood? (Hypothesis a). Higginson et al.‟s [6] research is the 
closest match to this research question as they also investigated the impact of cognitive 
deficits on social functioning. Therefore, based on this previous research it was 
expected that after accounting for the R-squared change in physical disability (33%) and 
mood (8%), that memory would elicit an R-squared change of 11%. Higginson et al., 
[6] found that IPS did not predict scores on the ESS. However, Kalmar et al., [15] 
reported that IPS predicted an R-squared change of 6% in everyday functioning scores 
in individuals with MS. Therefore, the current study anticipated an R-squared increase 
similar to those found in Higginson et al., [6] and Kalmar et al., [15] studies. 
Consequently, a calculation using GPower (Version 3.1) software [35] showed that, 
with a sample size of 28, 80% power could detect an increase in R-Squared of 17% 
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attributed to the 2 independent variables; information processing speed and memory, 
when controlling for disease disability and mood, which are assumed to give an R-
Squared increase of 41% in a multiple regression model for everyday functioning, using 
a 5% significance level. According to guidelines [36], this is a large effect size.  
 
Measures 
 
 
Demographic Questionnaire 
All participants completed a questionnaire which obtained demographical and disease 
related information (see Appendix 5.1). The questionnaire also included four questions 
relating to their subjective experience of their memory and how they think it affects 
their everyday functioning; the questions were: (a) do you feel your memory has 
deteriorated?  (b) do you feel your memory affects your ability to complete everyday 
tasks, such as remembering where you put things, remembering a shopping list? (c) do 
you feel your social activities are affected by your memory, such as planning events, 
remembering appointments? (d) do you feel your ability to have a conversation is 
affected by your memory, such as remembering what someone has said previously or 
following a conversation? The questions were scored on a 3-point Likert scale ranging 
from 0 (not at all), 1 (a little) and 2 (yes, significantly) to obtain a total score of 8. 
Higher scores reflect greater functional impairment due to memory deficits from the 
participant‟s point of view.  
 
Hospital Anxiety and Depression Scale [HADS, 37]  
The HADS was used to explore differences in the level of anxiety and depression 
among participants (see Appendix 5.2). The measure is designed specifically for use 
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with physically ill patients and has been shown to have good internal consistency, with 
Cronbach alphas of 0.80 to 0.93 for the anxiety sub-scale and 0.81 to 0.90 for the 
depression subscale [38]. It consists of 7 items for each subscale and is self-rated on a 4-
point scale ranging from 0 (no evidence of symptoms) to 3 (strong evidence for of 
symptoms). 
 
Environmental Status Scale [ESS, 23] 
The ESS is a broad measure of higher, more demanding, social and everyday activities. 
It is based on an interview with the patient and was developed specifically for patients 
with MS (see Appendix 5.3). It has been found to have high internal consistency 
reliability with Cronbach‟s alpha of 0.83 [39].  Kidd et al., [39] also reported that the 
ESS is a valid measure of social functioning in patients with MS. It consists of seven 
items on a 0 (no difficulty) to 5 (significant difficulty) Likert Scale. The scale assesses 
MS patients‟ ability to perform everyday tasks across eight dimensions; work status, 
financial/economic status, transportation, changes to personal home, community 
assistance, and social activity. Higher scores reflect greater impairment in completing 
social and everyday activities.  
 
 
Barthel Index [20] 
 
The Barthel Index (BI) is a measure of independence in performing various self-care 
and mobility tasks (see Appendix 5.4). It is used in this study to summarise the 
participant‟s level of physical disability. It is widely used in neurological rehabilitation 
and assesses overall functional disability [40]. The Index consists of 10 items; bowel, 
bladder, grooming, feeding, mobility, transfers, stair climbing, bathing, dressing and 
toilet use. The total score ranges from 0 to 20. The BI has been shown to be a reliable, 
valid and sensitive measure of basic physical functioning in patients with stroke [41]. In 
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MS patients it has been found to be sensitive enough to detect change in functional 
status in patients receiving inpatient rehabilitation [22]. Lower scores reflect greater 
impairment in physical functioning. 
 
BMIPB [29] 
The BMIPB is commonly used in clinical practise to assess the cognitive abilities of 
patients with MS. As mentioned previously the BMIPB is useful as it consists of four 
parallel forms thus enabling the clinician to re-test patients. Form one was used for this 
study which contains three verbal memory tasks (story recall, list learning and list 
recognition), three visual memory tasks (figure recall, design learning and design 
recognition), and an information processing (number cancellation) and motor speed 
task. There is no overall memory quotient produced, instead, the individual‟s strengths 
and weaknesses are produced which can then be related to everyday tasks the individual 
may find difficult, this is especially useful in rehabilitation settings.  Furthermore many 
of the subtests have been reported as reliable with inter-rater reliability being r =1.0 for 
many of the subtests and r =.9 on the more subjectively scored measures (i.e. story 
recall and figure recall) [29].  
 
Procedure 
 
Participants were recruited through MS Specialist Nursing staff working in outpatient 
services from the Hull Royal Infirmary (NHS Hull and East Yorkshire Hospitals) and 
the York Teaching Hospital (Foundation NHS Trust). The Nurses were informed of the 
inclusion and exclusion criteria and given a criteria checklist. Once the participants had 
read the information sheets (Appendix 5.5 and 5.6) they then sent a reply slip to the 
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researcher or contacted their MS Nurse to agree the researcher could contact them 
directly to arrange an assessment time. Participants were given the opportunity to ask 
further questions before the researcher obtained formal consent (Appendix 5.7). 
Participants also had the option of receiving their BMIPB results via a letter subsequent 
to completing the research. 
 
The researcher administered the assessment schedule, in the same order, for all 
participants. Participants were able to complete the assessment measures on their own 
and in a quiet setting either at the University of Hull, at the hospital or in their own 
home. The administration of measures was not counter-balanced as previous studies had 
found no impact of fatigue on the completion of cognitive or social functioning 
measures in MS participants [6]. Therefore it was felt that fatigue would not impact the 
results of the cognitive testing.  Also, regular breaks were offered to participants. To 
begin with, the demographic questionnaire was completed by participants, followed by 
the completion of the HADS, ESS and BI.  Participants‟ HADS score were discussed 
with the participant before the end of the assessment schedule, enabling the researcher 
to give appropriate advice. The BMIPB was then administered using the standard 
written instructions from the manual, with a 40 minute interval between the immediate 
and delayed recall subtests. The overall time taken to administer the full assessment was 
between 1½ to 2 hours. 
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Results 
Data Analysis 
Preliminary analyses  
Established guidelines were applied for data screening in relation to accuracy and 
assessing normality [42]. Descriptive statistics were used to characterise the sample and 
examine the means and standard deviations of variables. The relationship between 
demographic variables, self-report measures (HADS), memory/IPS scores, social 
functioning (ESS) and physical disability (BI) were investigated using Pearson product-
moment correlations and Spearman rank-order correlations when data showed Shapiro-
Wilk test to be p < .05. An alpha level of .05 was used for all statistical tests. 
 
BMIPB scores 
BMIPB test scores for MS participants were converted to z scores based on the means 
and standard deviations from the aged UK norms developed by [29]. Cognitive 
impairment was operationally defined as performance at or below the 2nd percentile of 
the published aged normative sample [29]. The data for BMIPB subtest scores for the 
three different disease type groups was not normally distributed. Therefore the Kruskal-
Wallis test was used to determine whether there were any statistically significant 
differences between the three different MS type groups. 
 
Principal Components Analysis  
Preliminary analyses showed that the four subtests of the BMIPB were highly correlated 
with one another. The story immediate and story delay subtests were normally 
distributed (Shapiro-Wilk test; p= .156, p= .287 respectively) and so Pearson product-
moment correlations were used to analyse this data. The figure immediate and figure 
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delay subtests were not normally distributed (Shapiro-Wilk test; p<.001) and so 
Spearman rank-order correlations were used to analyses this data. These correlations 
can be found in Table 1. Therefore it was possible that some of the variables were 
measuring the same underlying construct and a single memory composite score may 
more appropriately represent participants‟ memory scores as a whole. Consequently, the 
researcher decided that a principal components analysis (PCA) would be implemented. 
This is a variable-reduction technique which reduces a larger set of variables (figure 
immediate, figure delay, story immediate and story delay) into fewer variables, called a 
principal component which accounts for most of the variance in the original variables 
[43].  
 
Table 1. Pearson product-moment and Spearman rank-order correlations between 
BMIPB subtests.  
 
Subtest Story immediate Story delay Figure immediate 
Story delay r = .953**   
Figure immediate rho = .255 rho = .348*  
Figure delay rho = .230 rho = .391* .852** 
*p < .05. **p < .001. 
 
The PCA revealed that one component explained 68% of the total variance. This 
component represented an average of the memory scores as the components matrix 
highlights all the scores are around 0.8, see in Table 2. The four subtests, in addition to 
memory component 1, were used in the following data analysis.  
 
Table 2. Components Matrix to illustrate component 1. 
Subtest Component 1 
Story immediate .802 
Story delay .860 
Figure immediate .823 
Figure delay .813 
Broome – Memory, IPS & Social functioning in MS 
 
 
97 
 
Research Hypothesis A 
Spearman rank-order correlations were used to investigate the relationship between ESS 
scores and BMIPB scores as the data was not normally distributed (Shapiro-Wilk test; p 
< .05). Multiple linear regression analysis was used to investigate the impact of 
memory and IPS on social functioning, when controlling for physical disability and 
mood. As recommended by Field [42] a number of assumptions were checked. 
Assumptions tested include; linearity, no significant outliers, homoscedasticity of 
residuals (equal error variances), and normality of residuals. Individual questions on the 
ESS will also be investigated for differences using the Friedman Test and Wilcoxon 
Signed-Rank Tests due to data being not normally distributed. The relationship between 
individual ESS questions and the measures; IPS, memory, physical disability and mood 
scores, will be investigated using correlations and multiple linear regressions will be 
subsequently used to explore which variable explains the most variance in specific ESS 
domains.  
 
Research Hypothesis B 
Correlations were used to investigate the relationship between the subjective memory 
score and ESS total scores and individual questions. Correlation analyses were also 
used to investigate the relationship between the subjective memory score and objective 
memory scores as measured by the BMIPB. Multiple linear regression analyses were 
used to investigate the amount of variance in subjective memory scores explained by 
objective IPS and memory scores.  
 
Verbal and Visual Memory 
In order to investigate significant differences between verbal and visual memory 
subtests, paired t-tests and the non-parametric alternative to the paired t-test, the 
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Wilcoxon signed-ranks test were used. The test used was dependent on normal 
distributions of the data, both verbal memory subtests were normally distributed 
(Shapiro-Wilk test; p < .05) whereas visual memory subtests were not normally 
distributed (Shapiro-Wilk test; p > .05). 
 
Preliminary analyses - Participant Characteristics 
An overview of participant characteristics, including self-reported measures and clinical 
symptomatology can be found in Table 3. The number of females (62%) in the sample 
was reflective of the MS population [44]. The sample lacked ethnic diversity as 95% of 
participants were Caucasian. The majority of participants had education up to degree 
level and were unable to work due to their MS symptoms. None of the participants were 
experiencing a relapse at the time of testing or 6 months previous to completing the 
measures, therefore disease activity was not investigated. Participants‟ scores on the BI 
(range = 0-20), (M = 15.59, SD = 2.7) and ESS (range = 0-55), (median = 16, IQR = 11-
18) suggest participants had a „low to moderate‟ physical disability/dependency [45] 
and moderate functional impairment [22]. Mean scores on the HADS suggest that 
participants were not clinically depressed (M = 3.7, SD = 2.2) or anxious (M = 5.2, SD = 
3.3) and were found to be in the normal range [46].  
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Table 3. Participant Characteristics. 
 
Variable 
Total sample (n=34) 
Gender, % (n)  
   Male 38% (13) 
   Female 62% (21) 
Age, mean (SD), min-max 50.62 (10.14), 33-71 
Educational attainment, % (n)  
   No qualifications 3% (1) 
   GCSE level 20% (7) 
   Up to 2 A levels  12% (4) 
   2+ A levels 15% (5) 
   Degree 41% (14) 
   Higher degree 9% (3) 
Employment status, % (n)  
   Full-time work 9% (3) 
   Part –time work 12% (4) 
   Retired 3% (1) 
   Unable to work 76% (26) 
Disease duration (from    
  diagnosis), median (IQR), min-max 
7.5 years (3 – 14), 1-33 
Admitted to hospital in last 6 months? No 
HADS  
   Anxiety, mean (SD) 5.2 (3.3) 
   Depression, mean (SD) 3.7 (2.2) 
   Total Score, mean (SD), min-max 8.9 (4.5), 1-17 
BI, mean (SD),  15.6 (2.7) 
ESS, median (IQR), min-max 16 (11-18), 3-24 
Notes: IQR = interquartile range. Median and IQR scores were reported when the 
variable had a skewed distribution.  
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Correlations for overall sample 
Relationships between measure scores and demographic variables were examined using 
correlations for continuous demographic variables. Spearman rank-order correlations 
and Pearson product correlations were used dependent on the distribution of the data as 
tested by the Shapiro-Wilk test. Weak yet significant relationships were found between 
education and the memory subjective score (rho(32)= -.421, p = .013), and IPS 
(rho(32)= .396, p = .020) suggesting there is a weak association between higher 
education and better perceived memory abilities and quicker IPS. There were significant 
negative correlations found between ESS and figure immediate (rho(32)= -.392, p = 
.022), and IPS (rho(32)= -.502, p = .002) indicating that there is an association between 
poor social functioning and decreased IPS and visual memory. There was found to be a 
significant positive correlation between IPS and visual memory (figure immediate: 
rho(32)= .437, p = .01; figure delay: rho(32)= .561, p = .001). In relation to the 
relationship between IPS and recognition and recall subtests, there were two significant 
correlations found between IPS and visual recall (design subtest, rho(32)= .517, p = 
.002) and verbal recognition (list subtest, rho(32)= .558, p = .001). There was also a 
positive correlation found as expected between disease duration and age (rho(32)= .359, 
p = .037). The BI and ESS strongly correlated (rho(32)= -.596, p < .001) suggesting that 
as physical functioning increased, social functioning also increased. There were no 
significant correlations between BMIPB scores and participants‟ scores on the BI. 
Additionally, physical disability (BI) did not correlate with any demographic variables 
including disease duration, disease type or mood.   
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Analyses between groups 
Using the Kruskal-Wallis test, the only significant differences between MS type were 
on the ESS (H(2)=7.56, p=.023) and disease duration (H(2)=10.003, p=.007). One-way 
ANOVA tests demonstrated there were significant differences between MS type on the 
BI (F(2,31) = 3.793, p = .034) and age (F(2,31) = 12.171, p < .001). The means and 
standard deviations for each group can be found in Table 4. The RRMS group was less 
functionally impaired on both measures (ADL and ESS) than the PPMS and SPMS 
groups. The RRMS group also had the shorter disease duration and had younger 
participants than the PPMS and SPMS groups. The SPMS group had the longest disease 
duration which is understandable as approximately 65% of RRMS develops into SPMS, 
therefore it is expected that this group would have a longer disease duration [47]. No 
other measure scores significantly related to age, gender, education, mood, MS type or 
duration disease. 
 
Table 4. Mean and standard deviation scores for each group/disease type. 
 Disease Type 
 PPMS RRMS SPMS 
Age, mean (SD) 57.7 (8.6) 42.4 (5.6) 54.2 (9.2) 
 
Disease duration (from 
diagnosis), median 
(IQR), min-max 
6 years (2-11) 1-
33 
4 years (2-6), 1-
20 
14 years (10-20) 5-
29 
 
BI, mean (SD) 
 
14.8 (2.6) 17.1 (2.2) 14.6 (2.7) 
ESS, median (IQR), 
min-max 
18 (14-21) 9 -23 13 (5-16) 3-17 17 (14-22) 4-24 
Notes: PPMS = Primary progressive MS; RRMS = Relapsing-remitting MS; Secondary 
progressive MS; SD = standard deviation; IQR = interquartile range. Median and IQR 
scores were reported when the variable had a skewed distribution.  
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Table 5. Percentage of sample impaired, mean, standard deviation, median and IQR 
scores for BMIPB subtest and memory composite scores. 
 
Scale Percentage 
impaired 
Mean SD Median IQR (min -max) 
Story Immediate 11.8% -.46 .94   
Story Delay 8.8% -.38 .97   
Figure Immediate 5.9% -.37 1.1 -.38 -.75 - .27 (-4.89 – 
1.52) 
Figure Delay 2.9% .01 1 .09 -.33 - .55 (-.4.7 – 
1.42) 
List Recall 8.8% -.26 1   
Design Recall 8.8% -.06 .86 .07 -.37 - .46 (-2.27 - 
1.29) 
List Recognition 2.9% -.61 1.3 -.5 -1.2 - .45 (-5.56 – 
1.08) 
Design 
Recognition 
2.9% .31 .83 .59 .41 - .69 (-3.28 - 
.86) 
IPS 26.5% -.61 1.3 -1 -1.6 - .4 (-2.48 - 
2.29) 
Memory 
composite 1 
2.9%   -.07 -.39 - .47 (-3.7 - 
2.24) 
Notes: IQR = interquartile range. Median and IQR scores were reported when the 
variable had a skewed distribution.  
 
BMIPB Scores 
An overview of participants‟ scores on the BMIPB, including percentage of the sample 
classified as impaired, can be found in Table 5. Any percentile of 2 or below was 
classified as impaired using Coughlan et al.‟s [29] aged norms. As demonstrated in 
Table 5, the study sample was more impaired on the measure of IPS (26.5%), followed 
by the story immediate subtest (11.8%). 
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Hypothesis A:  IPS and memory impairment will account for a significant portion 
of the variance in the social functioning measure (ESS) 
 
As previously stated social functioning significantly correlated with the figure 
immediate subtest (rho(32)= -.392, p = .022), and IPS (rho(32)= -.502, p = .002). There 
was also a moderate positive correlation found between scores on the BI and ESS 
(rho(32)= -.596, p < .001). As only figure immediate correlated with ESS it was decided 
that only figure immediate would be used in the regression to represent memory scores. 
However, subsequent to inspecting scatterplots it was determined that a linear 
relationship existed between memory composite 1 and ESS, in addition to figure 
immediate and physical disability. Therefore, two separate multiple linear regressions 
were conducted, one for figure immediate and one for memory composite score, to test 
if memory and IPS scores significantly predicted participants‟ ratings on the ESS when 
controlling for physical disability. Before conducting the regressions assumptions were 
checked. Regressions had no significant outliers, homoscedasticity of residuals (equal 
error variances) were found, and subsequent to checking the Normal P-P plots and 
histograms, normality of residuals was also assumed.  
 
Table 6 and Table 7 summarise the regression statistics. Physical disability significantly 
accounted for 35.2% of the variance in ESS scores (R
2
 change = .352, β = -.423, SE = 
.279, t(28) = -3.400, p = .002). Mood did not account for any of the variance in ESS (R
2
 
change = .000, β = .069, SE = .158, t(28) = .575, p = .570). Memory composite 1 and 
figure immediate scores were put into two separate regressions to investigate if IPS or 
memory predicted any of the variance in ESS. In the first regression (Table 6) the 
overall model was significant (F(4,29)=11.029, p < .001). Memory composite 1 was 
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found to not be a significant predictor (R
2
 change = .003, β = .058, SE = .744, t(28) = 
.468, p =.643) and IPS significantly accounted for 24.8% (R
2
 change = .248 ,β = -.547, 
SE = .600, t(28) = -4.214, p < .001) of the variance in ESS scores. In the second 
regression (see Table 7), the overall model was found to be significant (F(4,29)=10.937, 
p < .001). Figure immediate was found to not be a significant predictor (R
2
 change = 
.001, β = -.036, SE = .731, t(28) = -.270, p =.789) and IPS significantly accounted for 
24.8% (R
2
 change = .248, β = -.515, SE = .630, t(28) = -3.774, p = .001) of the variance 
in ESS scores. These results indicate that greater physical disability and IPS impairment 
are associated with poorer social functioning. Memory scores did not significantly relate 
to social functioning. 
  
Table 6. Results of regression analysis for memory composite 1 predicting ESS total 
score. 
 
Scale R
2
 Change β SE t p 
 0     
Physical 
disability (BI) 
.352 -.423 .279 -3.400 .002 
Mood (HADS) .000 .069 .158 .575 .570 
IPS .248 -.547 .600 -4.214 < .001 
Memory 
composite 1 
.003 .058 .744 .468 .643 
Total R
2
 = 60.3 
 
 
Table 7. Results of regression analysis for figure immediate subtest predicting ESS 
total score. 
 
Scale R
2
 Change β SE t p 
 0     
Physical 
disability (BI) 
.352 -.420 .281 -3.344 .002 
Mood (HADS) .000 .080 .161 .660 .514 
IPS .248 -.515 .630 -3.774 .001 
Figure 
immediate 
.001 -.036 .731 -.270 .789 
Total R
2
 = 60.1 
Broome – Memory, IPS & Social functioning in MS 
 
 
105 
 
Individual questions on the ESS were examined and it was found that participants‟ MS 
symptoms impacted most on their social activities, need for more personal assistance 
and ability to work. Table 8 summarises the median scores for the different ESS 
domains, the higher scores indicate poorer functioning in that social functioning 
domain. As the Shapiro-Wilk test indicated that the data from individual questions on 
the ESS were not normally distributed the Friedman Test was used to investigate if the 
median scores on the ESS were significantly different. There was a statistically 
significant difference in ESS domains, X
2
(6, N = 34) = 125.53, p < .001. The three 
highest scores, so the participants‟ poorest social functioning domains were chosen to 
be investigated further; work status, social activities and personal assistance. Post-hoc 
analysis with Wilcoxon Signed-Rank Tests was conducted with Bonferroni correction 
applied resulting in a significance level set at p < 0.017. There was a significant 
difference between work status and need for personal assistance (Z = -3.745, p < .001) 
and social activities (Z = -3.070, p = .002) therefore work status was statistically the 
most affected social functioning domain. 
 
Table 8. Median and Interquartile range (IQR) for ESS domains. 
Work 
status 
Economic 
Status 
Home 
changes 
Personal 
assistance 
Transport 
Community 
help 
Social 
activities 
5 (4.8-
5) 
1 (0-2) 2 (1-4) 3 (2-4) 1 (0-2) 0 3 (2-4) 
 
Table 8 demonstrates that none of the participants required help from the community 
such as social or care workers helping them at home. Although, participants reported 
that they often required personal assistance from family members or friends. 
Furthermore, the majority of participants reported that the severity of their MS 
symptoms meant they were unable to work. 
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Correlations were used to investigate the relationship between individual ESS questions 
and the measures; IPS, memory, physical disability and mood scores. Table 9 
summarises the Spearman-rank order correlations between measures and ESS domains.  
 
Table 9. Spearman rank-order correlations (rho) between measures and individual ESS 
questions.   
 
Subtest 
Work 
status 
Economic 
Status 
Home 
changes 
Personal 
assistance 
Transport 
Social 
activities 
Physical 
disability 
-.389* -.355* -.345* -.541*** -.340* -.454** 
Mood .150 .259 -.226 .118 -.110 .292 
IPS -.644*** -.397* -.387* -.324 -.412* -.266 
Memory 
Composite 
1 
-.205 -.156 -.143 -.090 .021 -.023 
*p < .05. **p < .01, ***p < .001. 
 
As is evident from Table 9 physical disability significantly correlated with all of the 
ESS domains. Memory and mood did not correlate with any of the ESS domains. 
Lastly, IPS significantly correlated with work status, economic status, home changes 
and transport. The most clinically significant of these findings is that both IPS and 
physical disability correlated with work status so a multiple linear regression was used 
to explore how much of the variance in the work status was explained by IPS and 
physical disability. Before conducting the regressions assumptions were checked. 
Linear relationships existed between physical disability and IPS with work status. The 
regression had one outlier (on IPS) but it was left in the regression as it had no 
significant impact on the regression statistics when removed. Homoscedasticity of 
residuals (equal error variances) were found, and subsequent to checking the Normal P-
P plots and histograms, normality of residuals was also assumed. The results are 
highlighted in Table 10.  
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Table 10. Regression for IPS and physical disability predicting work status. 
Scale R
2
 Change Β SE t p 
Physical 
disability (BI) 
.116 -.340 .112 -2.047 .049 
 
IPS 
.344 -.616 .193 -4.446 < .001 
 
The regression model was significant overall (F(2,31)=13.209, p < .001). IPS predicted 
more of the variance (34.4%) in work status scores than physical disability (11.6%). 
Therefore IPS and work status are significantly related (from Table 9) and this 
relationship is maintained when physical disability is controlled for in a regression 
model. There was no significant relationship between IPS and the social activities 
question in the ESS. 
 
In summary, IPS and physical disability did account for a significant amount of the 
variance in ESS scores. When ESS domains were investigated individually it was found 
that IPS explained a significant amount of the variance in work status, more than the 
amount explained by physical disability. However, physical disability correlated with 
all of the ESS domains. Overall memory scores and individual memory subtests, except 
figure immediate, and mood scores did not correlate with ESS scores.  
 
Hypothesis B: Participants’ subjective memory score will significantly correlate 
with actual performance on the objective memory and ESS measures. 
 
Correlations were used to investigate the relationship between total ESS scores, ESS 
individual questions and the memory subjective score. As the Shapiro-Wilk test 
indicated that the data from individual questions on the ESS were not normally 
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distributed Spearman rank-order correlations were used, the results from these are 
summarised in Table 11. 
 
Table 11. Spearman rank-order correlations (rho) between ESS and subjective memory 
scores.   
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.431** .627*** .439** .334 .286 .204 .275 
*p< .05, **p < .01, ***p < .001. 
 
Therefore participants‟ perceptions of how their memory abilities impact on their social 
functioning significantly correlated with their ability to work and need for more 
financial help. Additionally, there was no relationship found between level of social 
activities and participants‟ subjective memory score.  
 
Subjective memory scores were then analysed using Spearman rank-order correlations 
to investigate the relationship with objective memory scores from the BMIPB. The 
results from these correlations can be found in Table 12. 
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Table 12. Spearman rank-order correlations (rho) between BMIPB scores and subjective 
memory scores.   
*p< .05, **p < .01, ***p < .001. 
 
The results from Table 12 suggest that participant‟s subjective memory score did 
correlate significantly with all memory subtests. However, when preliminary analyses 
were carried out it was found that IPS correlated strongly with the subjective memory 
score (rho(32) = -.694 .000). Therefore multiple linear regression analyses were used to 
test if memory and IPS scores significantly predicted participants‟ ratings on the 
subjective memory questionnaire. Before conducting the regressions assumptions were 
checked. Linear relationships existed between IPS and memory composite score 1 with 
scores from the subjective memory questionnaire. The regression had one outlier (on 
IPS) but it was left in the regression as it had no significant impact on the regression 
statistics when removed. Homoscedasticity of residuals (equal error variances) were 
found, and subsequent to checking the Normal P-P plots and histograms, normality of 
residuals was also assumed. The results indicated that the two predictors explained 
64.1% of the variance (R
2
 change =.641, F(2,31)=27.639, p<.001). IPS scores 
significantly accounted for 54.8% (R
2
 change =.548, β = -.640, SE = .191, t(28) = -
5.656, p<.001) and memory composite 1 significantly accounted for 9.3% (R
2
 change 
=.093, β = -.321, SE = .248, t(28) = -2.834, p =.008) of the explained variability in 
perceived memory ability scores. These results suggest that IPS scores are impacting 
more on participants‟ overall subjective memory score than memory difficulties. 
Therefore participants may misinterpret reduced IPS for memory difficulties.  
 
Memory 
composite 1 
Story 
Immediate 
Story 
Delay 
Figure 
Immediate 
Figure 
Delay 
Subjective 
memory 
score 
-.524*** -.392* -.460** -.491** -.466** 
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Verbal and Visual Memory  
 
Wilcoxon signed rank and paired t-tests were conducted to investigate differences 
between verbal and visual measures on the BMIPB. Significant differences were found 
between story immediate and figure immediate (Z = -5.086, p<.001), and story delay 
and figure delay subtests (Z = -2.342, p=.019). Table 5 illustrates mean and standard 
deviations for the subtests investigated. These results indicate that participants scored 
significantly better on measures of visual memory compared to verbal memory.  
 
Post-hoc analyses 
Wilcoxon signed rank tests and paired sample t-tests were conducted, dependent on 
normal distributions of the data, to investigate differences between recall and 
recognition measures, and delay and immediate subtests on the BMIPB. The mean and 
standard deviations for the subtests investigated can be found in Table 5. There was no 
significant difference between list recall and list recognition subtests (Z = -1.376, p 
=.169). However there was a significant difference found between design list and design 
recognition subtests (Z = -2.413, p =.016). These results indicate that participants scored 
significantly better on measures on visual recognition than visual recall.  
 
Lastly, the study sample scored significantly better on the figure delay subtest when 
compared to figure immediate scores (Z = -4.155, p <.001). The difference between 
story immediate and story delay subtests was found to be not significant (t(33) = -
1.550, p = .131). Therefore participants scored higher on the visual delay memory 
measures compared to the visual immediate recall measures.   
Broome – Memory, IPS & Social functioning in MS 
 
 
111 
 
Summary of Findings 
An overview of the findings from this study can be found in Table 13.                      
Table 13. Summary of Findings. 
 Main findings 
Demographic 
variables  
 
 The study sample included more females, lacked ethnic diversity, and had low to 
moderate physical disability (BI) and moderate functional impairment (ESS). No 
participants were experiencing relapses during the time of assessments. Overall 
participants were not clinically depressed or anxious. 
 Only significant differences between MS type were on measures of ESS, BI, age 
and disease duration. 
 Weak relationships were found between education and perceived memory abilities 
and IPS. 
 
Social 
functioning, 
physical 
disability, 
memory and 
IPS 
 
 BI and ESS were positively correlated. 
 Physical disability did not correlate with any scores on the BMIPB.  
 A significant negative correlation was found between IPS, the figure immediate 
subtest and ESS. 
 Physical disability significantly explained 35.2% of the variance in ESS scores. 
 Memory scores did not significantly explain variance in ESS scores. 
 IPS explained 24.8% of the variance in ESS scores after controlling for physical 
disability. 
 Participants‟ ESS scores suggest that individuals‟ MS symptoms impacted most on 
social activities, ability to work and needing more personal assistance. 
 Physical disability correlated with all ESS questions however IPS predicted more 
of the variance (34.4%) in work status scores than physical disability (11.6%). 
 
 
Subjective 
measure of 
memory on 
everyday 
functioning 
 
 Participants‟ perceptions of how their memory abilities impact on their social 
functioning significantly correlated with their ability to work and need for more 
financial help. There was no relationship found between level of social activities 
and participants‟ subjective memory score. 
 IPS (54.8%) and memory (9.3%) explained variance in perceived memory ability 
scores. Therefore participants may be misinterpreting reduced IPS for memory 
difficulties. 
 
Memory and 
IPS 
 
 Overall the sample was more impaired on IPS than memory. 
 
Verbal vs. 
visual 
memory 
 Participants scored higher on visual memory measures compared to verbal 
memory. 
 
Post-hoc 
analyses 
 
 Participants scored significantly higher on visual recognition compared to visual 
recall.  
 Participants scored higher on measures of visual delayed memory than visual 
immediate recall measures.  
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Discussion 
Overview of Findings  
The current study aimed to investigate the relationship between specific cognitive 
domains and social functioning in individuals with MS.  
 
Demographic variables 
This study took into account demographic variables such as mood, disease type and 
disease duration when investigating relationships between variables. Findings were 
consistent with Kessler et al.‟s [9] research as disease type, disease duration and age did 
not significantly correlate with any cognitive measures. Similar to Higginson et al.‟s [6] 
research no relationship was found between more years in education and longer disease 
duration with social functioning. These results may be due to the majority of 
participants in this sample attended higher education and the majority of participants 
were diagnosed with RRMS which was found to have the shortest disease duration and 
smallest amount of social and physical impairments.   
Education did however correlate with the subjective memory questionnaire and IPS 
suggesting there may be an association between higher education, better perceived 
memory abilities and quicker IPS. These results may support previous research which 
has suggested that cognitive reserve (higher education or premorbid intelligence) may 
moderate the negative effect of MS on cognitive functioning [48]. They found that 
cognitive reserve significantly predicted better IPS and those participants with higher 
reserve were better able to withstand the neurological changes in MS without 
Broome – Memory, IPS & Social functioning in MS 
 
 
113 
 
experiencing cognitive impairment. This is an interesting area of further research which 
may have important clinical implications for patients with MS, such as whether 
cognitive interventions (cognitive training and cognitive leisure activities) could 
improve cognitive reserve, thus delaying the onset of cognitive impairment [48]. 
 
Social functioning, memory and IPS 
 
This study aimed to replicate and further the findings from Higginson et al.‟s [6] study 
which found a relationship between ESS and participants‟ memory scores. Similar to 
Higginson et al.‟s study, physical disability was the best predictor of social functioning. 
Due to the nature of MS symptoms mainly affecting motor and sensory impairment it is 
not surprising that these difficulties impacted on participants‟ social functioning.  
 
It was hypothesised that IPS and memory may explain a significant proportion of the 
variance in social functioning scores. The most affected domains of social functioning 
were the participant‟s ability to work, need for personal assistance and level of social 
activities. This study, in contrast to previous research [9, 6]  found no relationship 
between social functioning and memory scores. However, the current study did find a 
significant relationship between IPS and social functioning as measured by the ESS. In 
addition to these findings, IPS predicted a significant amount of the variance in work 
status, even when compared to the impact of physical disability. These findings can be 
explained by looking at several social abilities that depend on an efficient IPS [49]. 
Reduced IPS may impact on the individual‟s ability to take in information quickly and 
to respond to questions in an appropriate time frame. These abilities could be seen as 
essential skills for completing and maintaining a successful job. Also, processing 
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sentences may become difficult due to reduced IPS and therefore having a conversation 
may become problematic. These difficulties may lessen the possibility of the individual 
wanting to socialise or being able to work effectively. Therefore it is understandable 
that IPS difficulties could impact an individual‟s ability to work or socialise.  
 
Given the pervasive memory complaints among MS patients [9, 7], the finding that 
there was no relationship between memory difficulties and social functioning was 
surprising. These findings may relate to the sample used in this study having more IPS 
difficulties than memory problems. However, a more likely explanation may be that 
memory deficits are easier to identify and therefore individuals are more able to 
effectively compensate for them. For example throughout this research participants 
often commented that they were using coping strategies such as taking notes, making 
lists, using mnemonics and various electronic reminders, to help them overcome for 
their memory difficulties. Whereas reduced IPS is less identifiable and is more resistant 
to compensatory techniques as it affects cognition across various domains. IPS can 
affect the individual‟s ability to quickly problem solve, comprehend and produce 
language, react and respond effectively to others and may impact on focusing and 
dividing attention in busy environments [50]. As such IPS is more likely than memory 
to interfere with an individual‟s social functioning. These results are also supported by 
the finding that participants seemed to misinterpret reduced IPS for memory difficulties 
on the subjective memory questionnaire. 
 
In summary, this study found that after controlling for physical disability, IPS 
accounted for a significant amount of the variance in social functioning scores, 
specifically participants‟ ability to work. These findings highlight the need for 
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individuals with MS to be assessed for IPS deficits and further educate individuals on 
the differences between memory and IPS difficulties. It may also be beneficial to inform 
and provide guidance to organisations in order to better support the individual with MS 
at work and offer coping strategies specific to overcoming IPS difficulties.    
 
Subjective memory questionnaire  
 
It was hypothesised that participants‟ subjective memory scores would significantly 
correlate with their actual performance on their objective measure of memory and ESS 
scores, specifically work status. This hypothesis was supported to a certain extent. 
Participants‟ subjective memory score significantly correlated with their total social 
functioning score and their ability to work and need for more financial support. 
Furthermore, subjective memory scores significantly correlated with participants‟ 
objective assessment of memory. These results suggest participants‟ perceptions about 
the extent to which their memory difficulties impact on their social functioning were 
accurate as they were significantly related to their work status and objective memory 
scores. However, when analysed further it was found that the results of the 
questionnaire were explained more by IPS scores than memory scores. Therefore, 
despite the questions referring to memory abilities, it seems that participants 
misinterpreted IPS difficulties for deficits in their memory, hence supporting Higginson 
et al.‟s [6] findings that participants lack an accurate perception of their cognitive 
difficulties. This finding may also be related to the previously mentioned possibility that 
memory difficulties are more identifiable and more commonly known than IPS 
problems.  
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Given the strong correlation found between work status (unable to work) and the 
subjective memory scores, these results suggest a perception of memory problems (even 
if they are in fact IPS deficits) may produce poorer social functioning, specifically their 
ability to work. These results could be explained by participants not attempting to 
complete work activities because they feel unable to due to their perceived (mostly 
accurate) memory difficulties. Alternatively, if they were not working participants may 
have been more focused on their difficulties and so perceived greater deficits in their 
memory.  
 
Despite being unable to confirm a causal relationship, these results indicate that 
psychologists should consider an individual‟s perception of their difficulties in addition 
to also investigating memory and IPS difficulties objectively. The findings also suggest 
individuals with MS may need psycho-education on the differences between IPS and 
memory and then be offered both IPS and memory coping strategies to help them 
improve their social and occupational functioning. 
 
As expected there was no relationship found between level of social activities and 
participants‟ subjective memory score. This indicates that the social activities question 
on the ESS does not represent the social skills necessary in order to function socially; 
rather it measures the number of activities the individual still attends. Whereas the 
subjective memory questionnaire asked participants about specific social tasks affected 
by memory impairments, e.g. going shopping, making an appointment, or having a 
conversation.  Therefore the ESS is a useful measure for a general overview of a 
person‟s social functioning but the subjective memory questionnaire may elicit more 
information about specific social tasks the individual can or cannot complete. This study 
is not suggesting the subjective memory questionnaire should be used as an alternative 
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but it highlights the need for a more detailed measure of assessment of social 
functioning when an individual is demonstrating memory or IPS difficulties. The 
Everyday Memory Questionnaire-revised [51] may be such a measure. It is quick and 
may obtain a detailed account of which social activities the individual with MS is 
struggling with on a daily basis due to their memory or IPS difficulties.  
 
Verbal and Visual Memory 
 
Participants scored significantly higher on visual memory subtests than verbal memory 
measures. These findings may indicate that visual memory is less susceptible to the 
effects of MS and therefore individuals with MS perform better on visual memory tasks. 
However, as stated previously these results should be taken cautiously as differences in 
test administration may impact on the findings reported. In the verbal memory test 
participants hear the story once and are then asked to recall the story back to the 
researcher. In the visual memory task participants are asked to copy the figure first, and 
then recall it from memory. Therefore, the time participants spent looking and 
interacting with the visual stimuli may mean they are expected to perform better on the 
visual memory subtest than the verbal task; unless the participant is experiencing clear 
visual memory impairments as then there will be a distinct disparity between visual and 
verbal memory scores.  
 
Participants‟ scored significantly higher on measures of delayed visual memory 
compared to immediate visual memory. These results support the notion that individuals 
with MS experience „forgetting‟ not due to a defect in storage or consolidation but due 
to a primary deficit in acquisition or encoding [9]. Kessler et al. [9] suggests that this 
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acquisition deficit may be due to reduced IPS. Immediate memory may be more 
associated with demyelination in white matter areas but delayed memory is not 
necessarily affected due to it being more dependent on cortical representation [52]. 
Demyelination in white matter areas is also associated to IPS [1] therefore immediate 
memory may be more susceptible in individuals with MS. The current study found a 
moderate relationship between IPS and both immediate and delayed visual memory. 
This association may be due to reduced IPS impacting on the participant‟s ability to 
encode information during the immediate memory task which may then lead to a lack of 
information being available for later recall. However, the researcher cannot conclude 
from the findings from this study that acquisition deficits in MS are related to reduced 
IPS as other possible factors were not investigated such as motivation, attention or 
executive function deficits.  
 
Additionally, participants in the current study performed better on measures of visual 
recognition than visual recall. It has been reported that recognition requires less effortful 
processing than recall [53] and therefore supports the notion that acquisition deficits in 
MS may be due to reduced IPS. However, Kessler et al. [9] suggests lower immediate 
memory scores could also be explained by an executive function deficit or 
attention/motivation difficulties. This study did not investigate these additional deficits 
and found that IPS was significantly correlated to both recognition and recall measures. 
Hence, further research into this area is necessary and a wider range of cognitive and 
motivational measures should be implemented to fully investigate possible causal 
explanations for better recognition scores. 
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Researchers are often presented with the difficult task of making verbal and visual 
memory tests equally difficult and easily comparable so that the individual can be made 
aware of their cognitive strengths and weaknesses, this in turn would aid future coping 
strategies. The results from this study indicate the need for psychologists to take into 
consideration the differences in stimuli when interpreting psychometric results. Lastly, 
clinicians working with patients with MS are pressurised to complete a brief cognitive 
screening measure due to service limitations and the need for a quick screening measure 
[1]. The results from this study highlighted (Table 5.) that not all participants 
experienced difficulties in both memory and IPS functioning, i.e. some participants 
demonstrated IPS deficits but not memory deficits. Therefore in order to fully assess all 
possible cognitive deficits and offer patients appropriate interventions a „quick 
screening‟ measure will not suffice and a comprehensive neuropsychological 
assessment will most likely be needed.  
 
The BMIPB  
 
The BMIPB is a useful measure of memory and IPS in individuals with MS however it 
does present some challenges. As mentioned previously differences in the stimuli 
presented to participants for verbal and visual memory measures on the BMIPB must be 
considered when interpreting the results. It may be beneficial to take out the copy figure 
subtest, as long as visual neglect or impairments have been investigated using other 
tests, in order to make the visual memory subtest more comparable to the verbal 
memory subtest. The BMIPB is not alone as these difficulties are encountered by all 
memory assessments that investigate differences between verbal and visual memory. 
Another weakness of using the BMIPB with MS patients is that there are no 
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standardised norms for this specific population. Therefore, it is difficult to reliably 
interpret the results of the BMIPB for an MS population as current norms are based on a 
UK general population which was screened for neurological diseases such as MS. It 
would be beneficial in future research to develop a cut-off point of cognitive 
impairment specific to individuals with MS. As the BMIPB is used across the UK to 
assess MS patients it would be clinically useful to investigate the sensitivity and 
specificity of the BMIPB compared to other memory and IPS measures. 
 
Despite this potential challenge, the BMIPB is a useful, relatively quick measure of 
memory and IPS in individuals with MS. Results from the BMIPB offer the clinician a 
detailed summary of the client‟s strengths and weaknesses in IPS and various memory 
domains including verbal, visual, immediate, delayed, recall and recognition. Few 
memory assessments look into as many memory domains as well as IPS, and even 
fewer take into consideration the impact of motor speed on IPS. As many individuals 
with MS struggle with motor impairments this part of the BMIPB is extremely useful. 
Vlaar and Wade [32] investigated using verbal responses for the IPS subtest on the 
former version of the BMIPB, the AMIPB. They found that when using verbal 
responses as opposed to the patient writing their answers, the IPS subtest when used 
over 120 seconds, was still a reliable and reasonable test for major information-
processing deficits. Therefore, future research should consider the reliability and 
validity of using the IPS subtest on the BMIPB in this format in order to make 
administration less distressing and uncomfortable for individuals who are „moderately 
to severely‟ physically disabled.  
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The findings from this study are not that dissimilar to Kalmar et al.‟s [15] as they found 
IPS, as measured by the PASAT, was nearly significant at predicting 6% of the variance 
in everyday functioning. Kessler et al. [9] did not investigate IPS and Higginson et al. 
[6] used the PASAT to assess information processing. The downfall of using the 
PASAT is that it is a more distressing and confusing measure and participants often fail 
to complete the full test. Whereas, all participants in this study were able to complete 
the IPS subtest on the BMIPB, furthermore none of the participants complained or 
appeared distressed completing the test. As demonstrated in this study, IPS was found to 
be associated to social functioning. Therefore this study suggests that the IPS subtest in 
the BMIPB is a more sensitive measure for assessing IPS impairments. Consequently, it 
is recommended that the IPS subtest on the BMIPB should be used as one of the 
screening and monitoring measures in neurological settings. If the IPS is administered 
in addition to other objective screening measures in addition to subjective measures 
such as the Everyday Memory Questionnaire [51] and the ESS, the clinician would have 
greater understanding of which MS symptoms may be impacting on the individuals 
social functioning and which factor they should investigate further.  
 
Limitations  
 
The present study was subject to a number of important limitations. Firstly, 
unfortunately due to time and capacity restrictions the researcher was unable to recruit 
equal numbers of participants in each disease type group. This meant that analyses 
between group types were limited as the sample size was uneven and small; with a 
small sample it is more likely to find non-significant differences because of low power 
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when a real difference may exist. Therefore the reliability of these findings is 
questionable.  
 
A strength of this research is that the overall the sample size recruited was larger than 
the sample size calculation originally stated, therefore power was slightly increased, 
however this is still a relatively small sample size. Also, the study sample recruited 
lacked variability in level of physical disability and disease activity and so a lack of 
relationship between physical disability and disease activity with cognitive measures 
may be due to the sample bias. This impacts on the generalisability of the findings as it 
is unclear whether individuals with MS who experience more physically disabling MS 
symptoms have the same relationship to the cognitive variables assessed in this study. 
The study was also limited by the lack of ethnic diversity in the sample recruited. 
 
Additionally, the cognitive measures assessed were found to have large standard 
deviations. These results may reflect the huge variability in symptoms in MS due to the 
different pattern in lesion locations; nevertheless the variation in performance suggests 
that participants were not performing in a similar way and therefore reduces statistical 
power.  
 
The study is further limited as the measures used required participants to self-report 
their difficulties therefore it is unknown whether participants‟ reports of their everyday 
activities or physical abilities were accurate. It would be beneficial in future research to 
include the results from a significant other in order to compare perceived difficulties 
from a different perspective. Also there are many different versions of the Barthel Index 
used in research and so it is difficult to directly compare results to previous research. 
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Other studies [54, 55] have implemented the use of the ADL-MS [56] which may have 
been more appropriate to use as it was specifically designed to be used for the MS 
population. The measure takes into account MS symptom severity and how this impacts 
on the individual‟s ability to complete a range of everyday activities, including physical 
and social activities.  Unfortunately this measure was not found until after the research 
had been completed.  
 
The ESS is recommended as a useful measure of everyday social functioning. However, 
it would have been more beneficial when comparing social versus physical everyday 
functioning to have these different levels of functioning on the same scale. The 
Functional Independence Measure [FIM, 57] has been found to be a more reliable 
measure and the „gold standard‟ of physical and functional impairment in individuals 
with MS [58]. The Functional Assessment Measure (FAM) is an addition to the FIM 
and is used alongside the FIM; they have been developed into a UK version [59]. 
Together they are a global measure of disability, cognitive and psychosocial function 
and would therefore be appropriate for use in further research into MS and everyday 
functioning. This measure was considered in this study however it requires a full multi-
disciplinary team to score individuals and this was not possible due to service 
limitations. However, for future research it should be utilised due to its global measure 
of disability and everyday activities. Furthermore, as previously mentioned a more 
reliable and valid, detailed assessment of the specific social skills that are affected by 
memory and IPS impairments would be beneficial. This study suggests the use of the 
Everyday Memory Questionnaire-revised [51] as it has been shown to be a quick, valid 
and reliable tool that has good face validity for use with MS patients. It also takes into 
account activities which may be affected by memory and IPS difficulties therefore clear 
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intervention points and coping strategies relating to everyday activities can be offered. 
This study did not measure participants‟ level of fatigue due to previous studies finding 
no impact of fatigue on cognitive measures or social functioning [6]. However in order 
to complete a comprehensive assessment, participants could complete the Fatigue 
Severity Scale [60] which has been recommended for clinical use with MS patients 
[61]. 
 
Lastly, unlike many other studies this research included the patient‟s perspective on 
their cognitive and social functioning and it was concluded to be a useful measure to 
investigate patient insight. Yet, the subjective memory questionnaire has not been used 
in previous research and it has not been shown to be a reliable or valid measure of 
perceived memory abilities. The reliability and validity of the questionnaire is uncertain 
as participants may have been biased to thinking they had a memory deficit as the 
questions were focused on memory difficulties impacting on everyday activities. 
Participants who found completing everyday activities difficult may have automatically 
assumed it was a result of memory deficits due to the research topic. Therefore the 
findings from this questionnaire are not fully reliable or generalisable. However, 
descriptive statistics indicated that the results from the questionnaire were normally 
distributed and not skewed, suggesting good variability on the 3-point Likert scale used 
to answer questions. The questionnaire could be improved and developed to include 
open-ended questions to avoid response bias. Despite the measure relating more to IPS 
difficulties than memory impairments, the questionnaire was a useful indicator of 
participants‟ perception of how their cognitive difficulties, when compared to objective 
measures of cognition, impacted on their social functioning.  
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Clinical implications 
 
This study found that physical disability was found to be unrelated to measures of 
cognition. Therefore how someone presents physically was found to not be 
representative of their cognitive impairment. However, physical disability did relate to 
all measures of social functioning and so may reflect the individuals need for 
adaptations and easier access to additional support in the work place. This research 
highlights the need for clinicians to complete a comprehensive assessment of the 
individual‟s physical and cognitive abilities, in addition to considering their 
psychological functioning such as their perceptions of how their difficulties may be 
impacting on their social functioning. Without this comprehensive assessment clinicians 
may not be able to offer an effective intervention which could possibly improve the 
individual‟s quality of life.  
 
Previous research has highlighted the need for an effective monitoring measure which 
would assess for cognitive deficits, this in turn would better inform rehabilitation 
programmes and enhance appropriate support for the individual [1]. The BMIPB 
enables both the psychologist and patient to directly infer which everyday activities may 
be affected by such impairments as the tests used have been found to be relevant to 
everyday social tasks. The BMIPB has been shown to be a sensitive measure of IPS and 
a less stressful alternative to the PASAT and should therefore be used by psychologists 
as an assessment tool for IPS difficulties. The BMIPB is also a valuable test for 
investigating a variety of memory difficulties in MS patients. Additionally, parallel 
forms enable the clinician to easily re-assess patients and this is especially important 
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when offering the appropriate treatment to MS patients due to the quick and changeable 
nature of the disease course.  
 
This study found that patients may misinterpret IPS difficulties for memory difficulties. 
Therefore clinicians should offer psycho-education on the different types of cognition 
which may be impacting on the individual‟s everyday functioning.  Coping strategies 
can then be implemented to help patients overcome their specific cognitive difficulties. 
 
The notion that patients should have at least a brief neuropsychological screening 
assessment is supported by NICE guidelines [62]. The current study recommends that 
patients as part of their treatment should be continuously monitored for cognitive 
impairments and this study suggests IPS, in addition to memory, should be included in 
this comprehensive cognitive assessment battery. 
 
Furthermore, Rogers and Panegyres [1] report that certain medications, such as 
corticosteroids amongst others, may impact on cognition therefore patients with MS 
need to be regularly assessed for cognitive deficits. Research has also demonstrated that 
disease-modifying drugs such as glatiramer acetate (GA) or interferon (IFN) beta [63] 
and acetylcholinesterase inhibitors (AChEIs) [64] may have a beneficial impact on 
cognitive function. Hence, the continuous monitoring of cognitive impairments in MS is 
also useful when considering effective drug treatments. 
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Future research 
 
Future research should aim to further explore the relationship between specific 
cognitive impairments and social functioning in individuals with MS. As previously 
stated a wider range of cognitive and psychological measures should be used, including 
the assessment of executive function, attention, motivational factors, fatigue and a more 
detailed measurement of specific social tasks affected by cognitive deficits.  
 
Furthermore, as the subjective measure of memory is a new questionnaire further 
research testing the validity and reliability of the measure is needed. Also further 
research is necessary in order to clarify whether actual or perceived cognitive 
impairment, or a combination of both impacts more on everyday functioning. The 
findings from this study suggest actual IPS scores predict more of the variance in 
everyday social activities however these findings need to be replicated in a larger 
sample size before being able to generalise these findings. It is important to further 
investigate the possible impact of the patient‟s perceptions of their abilities. 
Maladaptive or unrealistic thoughts about their abilities and cognitive impairments may 
lead to greater anxiety or low mood and could affect the patient‟s ability or motivation 
to complete everyday tasks. If this is the case then clinicians can help the patient form 
more realistic and adaptive perceptions during therapy. Hence there are potentially 
important clinical implications which may arise from further research in this area.  
 
Also, due to the limited sample size this study did not investigate the impact of disease 
activity on cognitive variables. Both Higginson et al. [6] and Kessler et al., [9] support 
the notion that disease activity rather than disease type is more indicative of cognitive 
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difficulties. Therefore longitudinal studies should be used as these would monitor and 
record changes in disease course and activity such as number and severity of relapses, 
over time. It may then be possible to investigate whether disease activity is associated to 
cognitive deficits. Additionally, with a larger sample size it is hoped that there would be 
greater variation in physical disability and ethnicity, therefore improving the 
generalisability of results to the wider MS population.  
 
Lastly, this study has highlighted the importance of assessing the patient‟s perception of 
how their cognitive difficulties influence their social abilities as there was a strong 
relationship found between perceived and actual social abilities. However, if clinicians 
were to assess participants‟ perceptions previous research suggests a significant others‟ 
ratings may be additionally informative. Correlations with performance measures have 
been found to significantly increase when the questionnaires are completed by 
significant others [65, 66]. However, few studies have investigated the differences 
between significant other and patients‟ perceptions [6].  Therefore further research is 
necessary in order to clarify these differences and investigate the variance explained by 
both significant other and patient perceptions on performance on actual cognitive and 
social functioning measures.  
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Conclusion 
 
When working with individuals with MS it is important to recognise that deﬁcits in 
basic cognitive processes, such as processing speed, may detrimentally aﬀect 
performance in other areas, such as social activities in everyday life. There are now 
more and more fMRI studies investigating white matter regions and pathways related to 
MS [67]. It is beneficial to individuals with MS to map out and better understand MS 
symptoms in order to prepare them for what may occur in the future. However, this 
study has also highlighted the usefulness of psychometric testing, specifically the IPS 
subtest of the BMIPB, in informing individuals about specific cognitive impairments 
which may impact on their social functioning. Psychometric testing as opposed to scans 
is cheaper, quicker and can identify specific cognitive deficits. These test results then 
inform clinicians about which interventions would be most effective in improving the 
individual‟s ability to cope with changes in their cognitive and social functioning. These 
changes and interventions can be monitored and assessed at periodic time intervals. This 
type of on-going assessment and support is a necessity for individuals with MS given 
the possible impact that cognitive impairments could have on their social functioning 
and consequently, quality of life.  
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PART 3: Appendices 
Appendix 1: Reflective statement 
 
Throughout the research process I documented my reflections when facing the 
challenges and exciting milestones of completing such an exhilarating journey. It is the 
aim of this reflective statement to share this research journey, focusing on the initial 
planning stages, the experiences of recruitment and meeting with participants, and what 
I have personally learnt from this experience.  
  
Designing the Research 
The planning stage of the research was both exciting and daunting. I was keen to be 
involved and create a research project that would have both clinical and research 
implications not only for clinicians but also for service users.  I also wanted to focus my 
research on something which would reflect my interests in clinical psychology that I 
would like to pursue later in my career. However, finding a gap in the research specific 
to multiple sclerosis (MS) and an idea that was unique was difficult. My supervisor and 
I bounced some ideas around and it became clear that cognition, specifically memory 
and IPS difficulties were becoming more widely recognised in MS. I felt it was 
important at the early stages of the research to gain advice from service users 
themselves. After attending and meeting with a number of people at the MS centre it 
was apparent that the social impact of these deficits could be enormous and thus the 
focus of the research became clear.  
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Throughout the initial planning stages it was important to gain ideas and advice from 
various health professionals who worked directly and alongside individuals with MS. 
The working alliance and relationships I developed with the MS specialist nurses were 
especially valuable. The support and enthusiasm they gave me throughout the project 
was greatly appreciated. However, the wide range of ideas from my supervisor and 
other professionals meant that it was at times hard to balance everyone‟s expectations 
about the research. In the end a compromise was met and the study incorporated both 
the development of a psychometric measure and the investigation of the social impact of 
memory and IPS deficits. 
 
Whilst sharing the final research proposal it became evident that the aims of the 
research were over ambitious. The sample size needed, in order to make the norms valid 
and reliable, would have been above 90 which was unrealistic given the time-frame 
available. This was disheartening but I was reminded that I had to remain open and 
ready for unexpected changes in order to make the research possible, nothing was set in 
stone. So the research was downsized and made more practically realistic to complete.  
 
Throughout the research process it was important for me to keep in mind the possible 
clinical implications and experiences of the MS patients who would take part in this 
research. Due to service limitations psychological support (referral) was unavailable to 
the majority of participants taking part in the research. Hence, it was a major ethical 
issue to consider how to support participants subsequent to them receiving their 
memory test results. Therefore participants were offered the chance to discuss their 
results with the researcher and a one-off workshop was offered to all participants and 
their carers which offered help interpreting their results and basic coping strategies.  
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Gaining ethical approval for the study was a surprisingly straight forward experience. 
However, the process was time-consuming and it felt very much out of my hands. I used 
the time to think about my systematic literature review and organise the practicalities of 
testing participants, such as booking rooms and getting all the measures printed/ordered. 
Yet, I felt frustrated that I had everything ready to go in order to start recruiting and 
meeting participants but had to wait for each research site to approve the study. I was 
anxious about time but it was important to remain confident that the next stage would 
happen soon and that I‟d be able to cope with the reduced time to recruit participants. 
  
Data Collection 
I felt relieved but knew the hard work was only just about to begin when approval was 
obtained for both research sites. The MS nurses were fantastically organised and a wave 
of referrals to the study came in. It was difficult managing the demands of the research 
whilst on placement and alongside completing other pieces of work. It was also tiring 
travelling all around Yorkshire and the East Riding to visit participants and then 
inputting the data. But, it was completely worth it. The people I met whilst conducting 
this research were awe-inspiring. The participants, and their family members, welcomed 
me and were incredibly open to sharing their experiences, the good and the bad, with 
me. I learnt about how resilient and adaptive people are and was amazed by their 
strength to keep on going despite suffering very challenging and life-changing 
symptoms. I will not forget these inspiring stories. I learnt about the process of 
adjustment, different ways of coping and the importance of supportive family and 
friends.  
 
At times it was difficult working on my own when listening to highly emotional stories 
and so it was important that I had a reassuring supervisor and colleagues to support me 
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when needed. As opposed to my placement work, it was refreshing to work with a 
group of people who were coping relatively well. It was however difficult talking to 
someone about emotionally hard topics and not being able to offer any planned 
therapeutic input. Yet, I was struck by the importance of just listening and „being there‟ 
for someone and I knew the MS nurse was a great support to those participants who 
may have needed additional support.  
 
I would not have been able to recruit as many participants as I did without the support 
from the MS nurses. Despite my polite nagging and emails they were always 
enthusiastic and optimistic about recruiting more participants. I learnt the importance of 
building good working alliances and my confidence grew when liaising with other 
professionals and services. The referrals came in waves and as my pre-planned deadline 
for recruitment came closer it was obvious that I wouldn‟t reach my target sample size. I 
pushed the deadline back and continued to recruit participants. This was a stressful time 
as I was writing up the thesis at the same time as meeting participants and finishing my 
placement. Nevertheless I had faith the work would get done and the participants would 
be recruited. I was reminded of my own limitations and that I could only do so much in 
the time available and so decided to stop recruiting when I reached just over my target 
sample size. 
 
Overall, data collection was a tiring yet rewarding experience. I enjoyed meeting with 
the participants and listening to their stories, they reminded me about the importance of 
doing the research and I could reflect on this during the stressful times.   
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Choice of Journals 
I decided to write my systematic literature review (SLR) for the Clinical Psychology 
Review. This journal was chosen as my SLR paper highlights clinical implications 
specific to clinical psychologists who work with MS patients. It is hoped that by 
targeting this large audience that professionals who work therapeutically with MS 
patients will become more aware of the importance of involving partners in therapeutic 
work. 
 
The Journal of Neurological Sciences was chosen for the empirical paper due to my 
paper focusing on the psychological impact of cognitive deficits reported in MS 
patients. This journal has a multidisciplinary audience including professionals interested 
in medical, psychological, social and rehabilitation issues related to MS. The empirical 
paper has implications relevant to all these areas and so this journal was thought 
appropriate.  
 
Report Writing 
The time taken to input the data, organise the spreadsheets and arrange the data so that it 
could be easily analysed took longer than expected. However I soon got into a routine 
and I became more efficient. The analysis was definitely challenging due to the 
overwhelming amount of data that I had. It felt daunting at first trying to link and 
analyse the data whilst attempting to hold the different ideas and interpretations in my 
head. The support from other trainees and my supervisor was incredibly valuable during 
this time. At times it felt like the empirical paper was separating into two sections but as 
ideas came together it felt more interconnected.  
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It was exciting when findings were significant and I enjoyed talking to my supervisor 
about the interpretation and clinical implications of these findings. It was easier to hold 
the different findings together once they were written down, however getting the idea on 
paper was at times difficult. The constant feeling of on-going anxiety about the vast 
amount of work needed to complete the thesis was tiring but it also helped me manage 
my time better and I gained a better understanding of how to manage my own stress. 
My confidence about my research was boosted when I got the opportunity to share my 
findings at the first MS Cognition conference in France. It was nerve-wracking but also 
exciting to be surrounded by the people who had influenced by own study. It was a 
great opportunity to ask the lead researchers in this field of psychology about my 
findings and also listen to upcoming research areas. I was impressed by the amount of 
research going into this area of MS and I was glad that my findings seemed to interest 
people, despite it being one of the smallest studies there!  
 
When writing my SLR and reflecting on other people‟s research from the conference I 
was made more aware of the studies methodological flaws. I was mindful that the 
validity of subjective memory questionnaire was questionable and that it would have 
been useful to further validate the BMIPB by comparing it to other memory and IPS 
measures. I also wished I‟d used additional research sites to gain a more diverse sample 
population. Writing about my limitations was frustrating and but also made me keen to 
complete more research in this field of psychology and build on ideas that have 
developed whilst writing this research.  
 
Summary  
As I am nearing the end of this research journey I look back at this process with a sense 
of achievement but it will also be sad to move on and end the project. I have enjoyed 
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working in this area of psychology and learning about how to manage and develop a 
study from beginning to end. I have learnt to better manage the anxiety that arises from 
uncertainty and I feel I have developed my academic skills whilst writing up this thesis. 
Attending the conference made me realise that I am at the early stages of my career in 
clinical psychology and I have time to develop on ideas and learn from the limitations 
of this study. The importance of family and friends was made obvious when meeting 
participants but also personally it was important to reflect on the value of supportive 
relationships during times of stress.  
 
The most significant and valuable moments of this research for me are the times when 
participants were incredibly open and willing to share their story with me. I will never 
forget how inspiring their stories were and I am truly grateful for them sharing their 
experiences with me. My interest in MS continues and I hope I can further help 
individuals suffering from MS both clinically and through future research. 
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therefore be avoided, but if essential, they must be cited in full, without reference to the 
reference list. 
 
 
Graphical abstract  
 
A Graphical abstract is optional and should summarize the contents of the article in a 
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concise, pictorial form designed to capture the attention of a wide readership online. 
Authors must provide images that clearly represent the work described in the article. 
Graphical abstracts should be submitted as a separate file in the online submission 
system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × 
w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a 
regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office 
files. See http://www.elsevier.com/graphicalabstracts for examples.  
Authors can make use of Elsevier's Illustration and Enhancement service to ensure the 
best presentation of their images also in accordance with all technical 
requirements: Illustration Service.  
 
Highlights  
 
Highlights are mandatory for this journal. They consist of a short collection of bullet 
points that convey the core findings of the article and should be submitted in a separate 
file in the online submission system. Please use 'Highlights' in the file name and include 
3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). 
See http://www.elsevier.com/highlights for examples.  
 
Keywords  
 
Immediately after the abstract, provide a maximum of 6 keywords, using American 
spelling and avoiding general and plural terms and multiple concepts (avoid, for 
example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly 
established in the field may be eligible. These keywords will be used for indexing 
purposes.  
 
Abbreviations  
 
Define abbreviations that are not standard in this field in a footnote to be placed on the 
first page of the article. Such abbreviations that are unavoidable in the abstract must be 
defined at their first mention there, as well as in the footnote. Ensure consistency of 
abbreviations throughout the article.  
 
Acknowledgements  
 
Collate acknowledgements in a separate section at the end of the article before the 
references and do not, therefore, include them on the title page, as a footnote to the title 
or otherwise. List here those individuals who provided help during the research (e.g., 
providing language help, writing assistance or proof reading the article, etc.).  
 
Footnotes  
 
Footnotes should be used sparingly. Number them consecutively throughout the article, 
using superscript Arabic numbers. Many wordprocessors build footnotes into the text, 
and this feature may be used. Should this not be the case, indicate the position of 
footnotes in the text and present the footnotes themselves separately at the end of the 
article. Do not include footnotes in the Reference list.  
Table footnotes  
Indicate each footnote in a table with a superscript lowercase letter.  
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Electronic artwork  
 
General points  
• Make sure you use uniform lettering and sizing of your original artwork.  
• Save text in illustrations as 'graphics' or enclose the font.  
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Produce images near to the desired size of the printed version.  
• Submit each figure as a separate file.  
 
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions  
You are urged to visit this site; some excerpts from the detailed information are 
given here.  
Formats  
Regardless of the application used, when your electronic artwork is finalised, please 
'save as' or convert the images to one of the following formats (note the resolution 
requirements for line drawings, halftones, and line/halftone combinations given below):  
EPS: Vector drawings. Embed the font or save the text as 'graphics'.  
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.  
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 
dpi is required.  
If your electronic artwork is created in a Microsoft Office application (Word, 
PowerPoint, Excel) then please supply 'as is'.  
Please do not:  
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the 
resolution is too low;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content.  
 
Color artwork  
 
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS 
Office files) and with the correct resolution. If, together with your accepted article, you 
submit usable color figures then Elsevier will ensure, at no additional charge, that these 
figures will appear in color on the Web (e.g., ScienceDirect and other sites) regardless 
of whether or not these illustrations are reproduced in color in the printed version. For 
color reproduction in print, you will receive information regarding the costs from 
Elsevier after receipt of your accepted article. Please indicate your preference for 
color: in print or on the Web only. For further information on the preparation of 
electronic artwork, please see http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications which can arise by converting color 
figures to 'gray scale' (for the printed version should you not opt for color in print) 
please submit in addition usable black and white versions of all the color illustrations.  
 
Figure captions  
 
Ensure that each illustration has a caption. Supply captions separately, not attached to 
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the figure. A caption should comprise a brief title (not on the figure itself) and a 
description of the illustration. Keep text in the illustrations themselves to a minimum 
but explain all symbols and abbreviations used.  
 
Tables  
 
Number tables consecutively in accordance with their appearance in the text. Place 
footnotes to tables below the table body and indicate them with superscript lowercase 
letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data 
presented in tables do not duplicate results described elsewhere in the article.  
 
References  
 
Citations in the text should follow the referencing style used by the American 
Psychological Association. You are referred to the Publication Manual of the American 
Psychological Association, Sixth Edition, ISBN 1-4338-0559-6, copies of which may be 
ordered from http://books.apa.org/books.cfm?id=4200067 or APA Order Dept., P.O.B. 
2710, Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, WC3E 8LU, 
UK. Details concerning this referencing style can also be found at 
http://humanities.byu.edu/linguistics/Henrichsen/APA/APA01.html 
 
Citation in text  
 
Please ensure that every reference cited in the text is also present in the reference list 
(and vice versa). Any references cited in the abstract must be given in full. Unpublished 
results and personal communications are not recommended in the reference list, but may 
be mentioned in the text. If these references are included in the reference list they 
should follow the standard reference style of the journal and should include a 
substitution of the publication date with either 'Unpublished results' or 'Personal 
communication'. Citation of a reference as 'in press' implies that the item has been 
accepted for publication.  
 
Web references  
 
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a 
source publication, etc.), should also be given. Web references can be listed separately 
(e.g., after the reference list) under a different heading if desired, or can be included in 
the reference list.  
 
References in a special issue  
 
Please ensure that the words 'this issue' are added to any references in the list (and any 
citations in the text) to other articles in the same Special Issue.  
 
Reference management software  
 
This journal has standard templates available in key reference management packages 
EndNote ( http://www.endnote.com/support/enstyles.asp) and Reference Manager (
http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, 
authors only need to select the appropriate journal template when preparing their article 
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and the list of references and citations to these will be formatted according to the journal 
style which is described below.  
 
Reference style  
References should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in the 
same year must be identified by the letters "a", "b", "c", etc., placed after the year of 
publication. References should be formatted with a hanging indent (i.e., the first 
line of each reference is flush left while the subsequent lines are indented).  
 
Examples: Reference to a journal publication: Van der Geer, J., Hanraads, J. A. J., & 
Lupton R. A. (2000). The art of writing a scientific article. Journal of Scientific 
Communications, 163, 51-59.  
 
Reference to a book: Strunk, W., Jr., &White, E. B. (1979). The elements of style. (3rd 
ed.). New York: Macmillan, (Chapter 4).  
 
Reference to a chapter in an edited book: Mettam, G. R., & Adams, L. B. (1994). How 
to prepare an electronic version of your article. In B.S. Jones, & R. Z. Smith 
(Eds.), Introduction to the electronic age(pp. 281-304). New York: E-Publishing Inc. 
 
Video data  
 
Elsevier accepts video material and animation sequences to support and enhance your 
scientific research. Authors who have video or animation files that they wish to submit 
with their article are strongly encouraged to include these within the body of the article. 
This can be done in the same way as a figure or table by referring to the video or 
animation content and noting in the body text where it should be placed. All submitted 
files should be properly labeled so that they directly relate to the video file's content. In 
order to ensure that your video or animation material is directly usable, please provide 
the files in one of our recommended file formats with a preferred maximum size of 50 
MB. Video and animation files supplied will be published online in the electronic 
version of your article in Elsevier Web products, including 
ScienceDirect:  http://www.sciencedirect.com. Please supply 'stills' with your files: 
you can choose any frame from the video or animation or make a separate image. These 
will be used instead of standard icons and will personalize the link to your video data. 
For more detailed instructions please visit our video instruction pages 
athttp://www.elsevier.com/artworkinstructions. Note: since video and animation cannot 
be embedded in the print version of the journal, please provide text for both the 
electronic and the print version for the portions of the article that refer to this content.  
 
Supplementary data  
 
Elsevier accepts electronic supplementary material to support and enhance your 
scientific research. Supplementary files offer the author additional possibilities to 
publish supporting applications, high-resolution images, background datasets, sound 
clips and more. Supplementary files supplied will be published online alongside the 
electronic version of your article in Elsevier Web products, including 
ScienceDirect:  http://www.sciencedirect.com. In order to ensure that your submitted 
material is directly usable, please provide the data in one of our recommended file 
formats. Authors should submit the material in electronic format together with the 
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article and supply a concise and descriptive caption for each file. For more detailed 
instructions please visit our artwork instruction pages 
athttp://www.elsevier.com/artworkinstructions.  
 
Submission checklist  
 
The following list will be useful during the final checking of an article prior to sending 
it to the journal for review. Please consult this Guide for Authors for further details of 
any item.  
Ensure that the following items are present:  
One author has been designated as the corresponding author with contact details:  
• E-mail address  
• Full postal address  
• Telephone and fax numbers  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources 
(including the Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web 
(free of charge) and in print, or to be reproduced in color on the Web (free of charge) 
and in black-and-white in print  
• If only color on the Web is required, black-and-white versions of the figures are also 
supplied for printing purposes  
For any further information please visit our customer support site 
at http://support.elsevier.com.  
 
After Acceptance 
Use of the Digital Object Identifier  
 
The Digital Object Identifier (DOI) may be used to cite and link to electronic 
documents. The DOI consists of a unique alpha-numeric character string which is 
assigned to a document by the publisher upon the initial electronic publication. The 
assigned DOI never changes. Therefore, it is an ideal medium for citing a document, 
particularly 'Articles in press' because they have not yet received their full bibliographic 
information. The correct format for citing a DOI is shown as follows (example taken 
from a document in the journal Physics Letters B):  
doi:10.1016/j.physletb.2010.09.059  
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs 
are guaranteed never to change.  
 
 
 
Proofs  
 
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author 
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(if we do not have an e-mail address then paper proofs will be sent by post) or, a link 
will be provided in the e-mail so that authors can download the files themselves. 
Elsevier now provides authors with PDF proofs which can be annotated; for this you 
will need to download Adobe Reader version 7 (or higher) available free 
from  http://get.adobe.com/reader. Instructions on how to annotate PDF files will 
accompany the proofs (also given online). The exact system requirements are given at 
the Adobe site:  http://www.adobe.com/products/reader/tech-specs.html.  
If you do not wish to use the PDF annotations function, you may list the corrections 
(including replies to the Query Form) and return them to Elsevier in an e-mail. Please 
list your corrections quoting line number. If, for any reason, this is not possible, then 
mark the corrections and any other comments (including replies to the Query Form) on 
a printout of your proof and return by fax, or scan the pages and e-mail, or by post. 
Please use this proof only for checking the typesetting, editing, completeness and 
correctness of the text, tables and figures. Significant changes to the article as accepted 
for publication will only be considered at this stage with permission from the Editor. 
We will do everything possible to get your article published quickly and accurately – 
please let us have all your corrections within 48 hours. It is important to ensure that all 
corrections are sent back to us in one communication: please check carefully before 
replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading 
is solely your responsibility. Note that Elsevier may proceed with the publication of 
your article if no response is received.  
 
Offprints  
 
The corresponding author, at no cost, will be provided with a PDF file of the article via 
e-mail. For an extra charge, paper offprints can be ordered via the offprint order form 
which is sent once the article is accepted for publication. The PDF file is a watermarked 
version of the published article and includes a cover sheet with the journal cover image 
and a disclaimer outlining the terms and conditions of use. 
 
Author inquires  
 
For inquiries relating to the submission of articles (including electronic submission) 
please visit this journal's homepage. Contact details for questions arising after 
acceptance of an article, especially those relating to proofs, will be provided by the 
publisher. You can track accepted articles athttp://www.elsevier.com/trackarticle. You 
can also check our Author FAQs (http://www.elsevier.com/authorFAQ) and/or contact 
Customer Support via http://support.elsevier.com.  
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Appendix 2.2: Journal of the Neurological Sciences Author Guidelines 
Downloaded on 5
th
 October 2011 from  
http://www.elsevier.com/wps/find/journaldescription.cws_home/506078/ 
authorinstructions 
 
  Journal of the Neurological Sciences 
 
 Guide for Authors  
 Submission  
 
Electronic submission via the Web using EES. The preferred medium of 
submission to the accepting Editor is online with the accompanying manuscript, 
illustrations, tables and annexes. Submission of a paper to Journal of the 
Neurological Sciences is understood to imply that it has not previously been 
published (except in abstract form) and that it is not being published elsewhere. 
Submitted manuscripts should be accompanied by a statement undersigned by all 
listed authors that they concur with the submission and that the manuscript has 
been approved by the responsible authorities where the work was carried out. If 
accepted, the manuscript shall not be published elsewhere in the same form in 
either the same or any other language, without the consent of the Editor and 
Publisher. The decision of the Editor is final. The Editor cannot enter into 
correspondence about a paper considered unsuitable for publication. 
 
Journal of the Neurological Sciences uses an online, electronic submission system 
called EES (Elsevier Editorial System). By accessing the following 
website:  http://ees.elsevier.com/jns you will be guided stepwise through the 
creation and uploading of the various files. When submitting a manuscript to EES, 
authors need to provide an electronic version of their manuscript. The author 
should select from a list, the article type of their manuscript (Clinical Research 
Paper, Clinical Short Communication, Basic Research Paper, Review Article, 
Letter to the Editor etc.) and may provide keywords and comments to the Editor 
separately. Details of up to five potential reviewers should accompany the 
submission. These can be provided in the comments box or at a later stage when 
uploading the files for submission. It would not be appropriate to nominate 
individuals that have had any input into the manuscripts submitted or any recent 
collaboration with the authors. The Editors may or may not take these suggestions 
into account during the reviewing process. Authors may send queries concerning 
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the submission process, manuscript status, or journal procedures to the Editorial 
Office (e-mail: jns.el@med.wayne.edu). Once the uploading is done, the system 
automatically generates an electronic (PDF) proof, which is then used for 
reviewing. All correspondence, including the Editor's decision and request for 
revisions, will be by e-mail. 
There is an online tutorial for authors and online support for technical problems or 
questions via Elsevier's Author Support team (authorsupport@elsevier.com). 
 
Language Editing  
We have successfully negotiated with eight language editing companies to provide 
language editing services to our authors at competitive rates. 
American Journal Experts, Asia Science Editing, Diacritech Language Editing 
Services, Edanz Editing, International Science Editing, ScienceDocs Editing 
Services and SPI Publisher. 
Services provide language and copy editing services globally to authors who wish 
to publish in scientific, technical and medical peer-reviewed journals and would 
like assistance either before they submit an article for peer review or before it is 
accepted for publication. Use of an English-language editing service listed here is 
not mandatory, and will not guarantee acceptance or preference for publication in 
an Elsevier journal.  
Information can be found 
via http://www.elsevier.com/wps/find/authors.authors/languagepolishing  
Please note: Elsevier neither endorses nor takes responsibility for any product, 
goods or services offered by outside vendors through our services or advertised on 
this website. 
 
Illustrations  
Each illustration should be numbered in Arabic numerals (Fig. 1, Fig. 2, etc.) and 
must be referred to in the text. An illustration, together with its legend, should be 
understandable with minimal reference to the text. Lettering should be of 
professional standard and large enough to withstand reduction. All photographs 
must be submitted preferably no smaller than 4x5" (10 x 12 cm) and no larger than 
8x10" (20 x 25 cm). The degree of reproduction will be determined by the 
Publisher.  
 
Colour Reproduction  
Reproduction in colour will have to be approved by the Editor. Authors will be 
required to pay a fee towards the extra costs incurred in colour reproduction. The 
charges are Euro 300.00 for the first page involving colour, and Euro 200.00 per 
page for all subsequent pages involving colour in a given article (all prices 
including sales tax). 
If, together with your accepted article, you submit usable colour figures then 
Elsevier will ensure, at no additional charge, that these figures will appear in colour 
on the web (e.g., ScienceDirect and other sites) regardless of whether or not these 
illustrations are reproduced in colour in the printed version. For colour 
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reproduction in print, you will receive information regarding the costs from 
Elsevier after receipt of your accepted article. For further information on the 
preparation of electronic artwork, please see  http://authors.elsevier.com/artwork  
Please note: Because of technical complications which can arise by converting 
colour figures to 'grey scale' (for the printed version should you not opt for colour 
in print) please submit in addition useable black and white versions corresponding 
to all the colour illustrations. 
 
Preparation of Supplementary Data (Multimedia Components)  
Elsevier accepts electronic supplementary material to support and enhance your 
scientific research. Supplementary files offer the author additional possibilities to 
publish supporting figures, tables, applications, movies, animation sequences, high-
resolution images, background datasets, sound clips and more. Supplementary files 
supplied will be published online alongside the electronic version of your article in 
Elsevier web products, including ScienceDirect (  http://www.sciencedirect.com). 
In order to ensure that your submitted material is directly usable, please ensure that 
data is provided in one of our recommended file formats. Contact the Editorial 
Office prior to submission. 
 
Legends for Figures  
Legends for figures must be typed, also with double spacing, on separate pages. If 
illustrations from previous articles or books are to be used in papers submitted to 
the Journal of the Neurological Sciences, the written permission of both author and 
publisher must accompany each illustration. 
 
Tables  
Tables must be typed, with double spacing, on separate pages and should be 
provided with a short descriptive heading and, if applicable, a legend. 
 
Abstract  
An abstract of approximately 200 words is mandatory at the beginning of each 
article. Authors' full names, academic or professional affiliations, and complete 
addresses must be included on the title page. 
 
Keywords  
6-8 items must be included on the title page. Authors are encouraged to choose 
their own keywords, but Medical Subject Headings (issued with the January Index 
Medicus, latest edition) may be used as a guideline. 
 
References  
References to literature must be indicated by Arabic numerals which run 
consecutively through the paper. Where a reference is cited more than once in the 
text the same number should be used each time. Reference style should follow the 
"Vancouver" style described in the "Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals" (published in N Engl J Med 1997;336:309-
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315). The titles of journals should be abbreviated in conformity with Index 
Medicus. The following are sample styles: 
 
[1] Bondi M, Kaszniak A. Implicit and explicit memory in Alzheimer's disease and 
Parkinson's disease. J Clin Exp Neuropsychol 1991;13:339-58. 
[2] Wechsler D. Wechsler Adult Intelligence Scale. New York: Grune & Stratton, 
1976. 
[3] Hirst W, Volpe B. Automatic and effortful encoding in amnesia. In: Gazzaniga 
M, editor. Handbook of cognitive neuroscience. New York: Plenum Press, 
1984:369-86. 
Please ensure that references are complete, i.e. that they include, where relevant, 
the author's name, article or book title, volume and issue number, publisher and 
publisher's location, and page reference. 
This journal should be abbreviated as J Neurol Sci. 
 
Changes to authorship  
This policy concerns the addition, deletion, or rearrangement of author names in 
the authorship of accepted manuscripts: Before the accepted manuscript is 
published in an online issue: Requests to add or remove an author, or to rearrange 
the author names, must be sent to the Editor-in-Chief from the corresponding 
author of the accepted manuscript and must include: (a) the reason the name should 
be added or removed, or the author names rearranged and (b) written confirmation 
(e-mail, fax, letter) from all authors that they agree with the addition, removal or 
rearrangement. In the case of addition or removal of authors, this includes 
confirmation from the author being added or removed. Requests that are not sent 
by the corresponding author will be forwarded by the Editor-in-Chief to the 
corresponding author, who must follow the procedure as described above. Note 
that: (1) Editor-in-Chief will inform the Journal Manager of any such requests and 
(2) publication of the accepted manuscript in an online issue is suspended until 
authorship has been agreed. After the accepted manuscript is published in an 
online issue: Any requests to add, delete, or rearrange author names in an article 
published in an online issue will follow the same policies as noted above and result 
in a corrigendum. 
 
Funding body agreements and policies  
Elsevier has established agreements and developed policies to allow authors whose 
articles appear in journals published by elsevier, to comply with potential 
manuscript archiving requirements as specified as conditions of their grant awards. 
To learn more about existing agreements and policies please 
visit http://www.elsevier.com/fundingbodies  
 
Informed Consent/Ethics of Experimentation  
Authors reporting experimental studies on humans must specify that the research 
received prior approval by the appropriate institutional review body and that 
informed consent was obtained from each subject or patient. Manuscripts 
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describing investigations in animals must clearly indicate the steps taken to 
eliminate pain and suffering. Approval by the appropriate animal experimentation 
committee should be indicated. Authors have a duty to protect their subjects, 
animal or human, and to show clearly in their writing a recognition of the moral 
issues involved.  
 
Phase III Trials  
Manuscripts reporting the results of Phase III trials must follow the Consolidated 
Standards of Reporting Trials (CONSORT) guidelines. For more information on 
these guidelines, please refer to: Begg, C, Cho, M. Eastwood, S, et al. Improving 
the quality of randomized controlled trials: the CONSORT statement. JAMA 1996; 
276:637-639. 
Schulz, KF. The quest for unbiased research: Randomized clinical trials and the 
CONSORT reporting guidelines. Ann Neurol 1997; 41:569-573. 
 
Potential Conflict of Interest Disclosure  
Authors must include in the cover letter accompanying the article submitted for 
review a full disclosure of all conflicts of interest and commercial relationships 
including grants, honoraria, speaker's lists, significant ownership, and/or support 
from pharmaceutical or other companies such as manufactures of equipment, 
diagnostic or other laboratories whose products are directly or indirectly involved 
or affected by the article. Authors must explicitly acknowledge the source of 
support for the study submitted both in the letter and as a separate page of the 
manuscript. 
 
The principal author must declare in writing that he or she will take full 
responsibility for the data, the analyses and interpretation, and the conduct of the 
research; that he or she had full access to all of the data; and that he or she had the 
right to publish any and all data, separate and apart from the attitudes of the 
sponsor. Without these written assurances in the cover letter at the time of 
submission, we will not consider the paper for review. 
 
Proofs  
One set of page proofs in PDF format will be sent by e-mail to the corresponding 
Author (if we do not have an e-mail address then paper proofs will be sent by post). 
Elsevier now sends PDF proofs which can be annotated; for this you will need to 
download Adobe Reader version 7 available free from 
http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to 
annotate PDF files will accompany the proofs. 
 
If you do not wish to use the PDF annotations function, you may list the 
corrections (including replies to the Query Form) and return to Elsevier in an e-
mail. Please list your corrections quoting line number. If, for any reason, this is not 
possible, then mark the corrections and any other comments (including replies to 
the Query Form) on a printout of your proof and return by fax, or scan the pages 
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and e-mail, or by post. Please use this proof only for checking the typesetting, 
editing, completeness and correctness of the text, tables and figures. Significant 
changes to the article as accepted for publication will only be considered at this 
stage with permission from the Editor. We will do everything possible to get your 
article published quickly and accurately. Therefore, it is important to ensure that all 
of your corrections are sent back to us in one communication within 48 hours: 
please check carefully before replying, as inclusion of any subsequent corrections 
cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier 
may proceed with the publication of your article if no response is received. 
 
Contact details for question arising after acceptance of an article, especially those 
relating to proofs, are provided when an article is accepted for publication. 
 
Offprints  
The corresponding author, at no cost, will be provided with a PDF file of the article 
via e-mail. The PDF file is a watermarked version of the published article and 
includes a cover sheet with the journal cover image and a disclaimer outlining the 
terms and conditions of use. 
 
Author enquiries  
Authors can keep a track on the progress of their accepted article, and set up email 
alerts informing them of changes to their manuscript's status, by using the "Track a 
Paper" feature. Please go to http:///www.elsevier.com/trackarticle 
(http://www.elsevier.com/trackarticle.  
 
Full details for the electronic submission of artwork can be obtained from 
http://www.elsevier.com/authors   
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Foundation Trust 
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Appendix 4: Supplementary Information for the Systematic Literature 
Review 
 
Appendix 4.1: Rationale for the inclusion and exclusion criteria used within the 
systematic literature review 
Appendix 4.2: Data Extraction Form  
Appendix 4.3: Quality Assessment Checklist for Studies 
Appendix 4.4: Sources of items included in checklist 
Appendix 4.5: Quality Assessment by Rater A and Rater B for Studies 
Appendix 4.6: Reasons for rejected studies not used within the systematic literature 
review 
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Appendix 4.1: Rationale for the inclusion and exclusion criteria used within the 
systematic literature review 
 
Inclusion/Exclusion Criteria Rationale 
Studies were included if the majority 
of the sample were married or 
partners. 
 
- Due to the limited research in this field there is 
a variety in type of relationship in the samples, 
e.g. partner, family member, friend. Therefore, 
instead of rejecting all studies that had mixed 
relationship types, it was thought appropriate 
to include only those studies whose majority of 
the sample were married. The findings of these 
studies would therefore be appropriate for this 
review. 
 
Studies were not included if the 
outcome measures were based solely 
on caregiver/partner. Neither were 
studies included if the aim of a study 
was to investigate the impact of MS on 
the relationship or partner. 
 
- There are many previous studies focused on 
the impact of caring for an individual with MS 
for the caregiver/partner. This review is 
focusing on the limited research that exists that 
aims to investigate the impact of relationship 
factors on the individual with MS or their 
partner. 
 
Studies were not included if they only 
reported the prevalence of marital 
status in MS patients. 
 
- Marital status alone is not informative enough 
for informing clinicians on how best they can 
intervene in individual or couple therapy. This 
study is focusing on relationship factors within 
the couple‟s dyad rather than the effects of 
whether they are married or not. 
Studies were not included if they 
focused on the impact of MS on sexual 
relationships/satisfaction. 
- It has been well documented that MS can affect 
the individual‟s sexual relationship. The 
review‟s aim was to focus on the psychological 
and disease related impacts of psychological 
factors within the couples‟ relationship. 
Therefore the sexual element of the 
relationship was not the focus of this review. 
Furthermore there are a vast number of studies 
published in this area and it was felt that a 
separate systematic literature review focusing 
solely on the sexual relationship in MS would 
be more appropriate. 
Studies were not included if the 
sample included individuals with other 
medical conditions. 
- It has been highlighted that relationship factors 
impact on the well-being of other medical 
populations such as in cancer patients. 
Therefore this review aimed to investigate if 
these findings were also found in individuals 
with MS. 
Not printed in English 
- The articles could not be translated due to 
financial and time constrictions. 
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Appendix 4.2: Data Extraction Form 
 
Study title:  
Authors:  
Year of publication:  
Source (i.e. Journal: Volume / Pages / Country of Origin) and reference:   
  
 
Study Characteristics  
Research question/aims:  
Duration of study:  
Quality Score:  
  
Study design  
Quantitative/Qualitative:  
  
 
 
Participant Characteristics  
Number of people (or dyads):  
Age of participants: 
Relationship duration:  
Relationship type: 
Gender ratio (female:Male):  
 Ethnicity:  
Geographical region:  
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Disease type: 
Disease duration: 
Employment status:  
Other information:  
 
Participant Recruitment  
Recruitment methods:  
Inclusion criteria:  
Exclusion criteria:  
Participation rate:  
  
Procedure       
 
 
Details of data collected   
Method of data collection:  
What was measured?  
Which outcome measures were used?  
Number of times data collected :  
 
Results & Analysis  
Qualitative:  
Analysis method:  
Theoretical perspective:  
Themes/ Main findings:  
Quantitative:  
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Statistical tests?  
Summary of Results (main findings and statistical significance):  
  
Conclusions  
Interpretation of results:  
Limitations:  
Key links to theory/literature:  
Implications of findings:  
Further research:  
  
Notes/comments:
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Appendix 4.3: Quality Assessment Checklist for Studies 
Section Question 
Yes 
(1) 
No 
(0) 
Unable to 
determine 
(0) 
Abstract 1. Provides an informative and balanced summary of what was done and what was found? (Both)    
 
Introduction 
 
Methods 
Design 
 
 
 
 
 
 
 
Participants  
2. Does the study explain the scientific background and rationale for the investigation being reported? (Both)    
3. Is the hypothesis/aim/objective of the study clearly described?(Both)    
4. Are the main outcomes to be measured clearly described in the Introduction or Methods section? (Quan only)    
5. Were the main outcome measures used in the study valid and reliable? (Quan only)    
6. Is a qualitative approach appropriate? (Qual only)    
7. Is the qualitative methodology used appropriate to the research question(s)? (Qual only)    
8. Are the underpinning values and assumptions in relation to the qualitative method (questions used) discussed? (Qual 
only) 
   
9. Does the study describe a power calculation to determine sample size? (Quan only)    
10. Have the inclusion and exclusion criteria been clearly described?(Both)    
11. Are the characteristics of the participants included in the study clearly described? Must include at least; diagnosis type, 
duration of disease, age, gender, and relationship duration. (Both) 
   
12. Is the „relationship type‟ described? (Both)    
13. Is data collected from both partners, as opposed to just the carer or just the person with MS?(Both)    
14. Were the subjects asked to participate in the study representative of the MS population? Were participants recruited 
from more than just one MS Society? (Both) 
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Appendix 4.3: Quality Assessment Checklist for Studies continued  
Section Question 
Yes 
(1) 
No 
(0) 
Unable to 
determine 
(0) 
 
 
 
 
 
Results 
 
15. Does the study provide estimates of random variability in the data for the main outcome? (In non normally distributed data 
the inter-quartile range of results should be reported. In normally distributed data the standard error, standard deviation or 
confidence intervals should be reported. If the distribution of the data is not described, it must be assumed that the estimates 
used were appropriate and the question should be answered yes.) (Quan only) 
   
16. Has the strategy of statistical analysis been clearly stated? (Quan only)    
17. Is the statistical analyses strategy used to analyse the main outcomes appropriate? (Quan only)    
18. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the main outcomes except where the 
probability value is less than 0.001?(Quan only) 
   
19. If any of the results of the study were based on „data dredging‟, was this made clear? (Any analyses that had not been 
planned at the outset of the study should be clearly indicated. If no retrospective unplanned subgroup analyses were reported, 
then answer yes.) (Quan only) 
   
20. Is the data analysis sufficiently rigorous? (Qual only)    
21. Are the findings internally coherent, credible? (Qual only)    
22. Is the data analysis strategy reported, i.e. how themes and concepts were derived? (Qual only)    
23. Was there more than one rater? (Qual only)    
24, Are the findings relevant? (Qual only)    
Discussion 
25. Does the study summarise key results with reference to study objectives? (Both)    
26. Does the study discuss clinical relevance and generalisability of the results? (Both)    
27. Does the study give a cautious overall interpretation of results considering objectives, limitations, analyses, results from 
other relevant studies? (Both) 
   
28. Does the study discuss limitations? (Both)    
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Appendix 4.4: Sources of items included in checklist 
 
Section 
Question 
Type Original 
source* 
Abstract 1. Provides an informative and balanced summary of what was done and what was found? (Both) Reporting  STROBE 
Introduction 
 
 
 
Methods 
Design 
 
 
 
 
 
 
 
 
 
 
Participants 
2. Does the study explain the scientific background and rationale for the investigation being reported? 
(Both) 
Reporting  STROBE 
3. Is the hypothesis/aim/objective of the study clearly described?(Both) Reporting  D&B 
4. Are the main outcomes to be measured clearly described in the Introduction or Methods section? (Quan 
only) 
Reporting  D&B 
5. Were the main outcome measures used in the study valid and reliable? (Quan only) 
Internal 
validity 
D&B 
6. Is a qualitative approach appropriate? (Qual only)  NICE (2007) 
7. Is the qualitative methodology used appropriate to the research question(s)? (Qual only)  NICE (2007) 
8. Are the underpinning values and assumptions in relation to the qualitative method (questions used) 
discussed? (Qual only) 
 NICE (2007) 
(adapted) 
9. Does the study describe a power calculation to determine sample size? (Quan only) 
Power  D&B 
(adapted) 
10. Have the inclusion and exclusion criteria been clearly described?(Both) 
Reporting  STROBE 
(adapted) 
11. Are the characteristics of the participants included in the study clearly described? Must include at least; 
diagnosis type, duration of disease, age, gender, and relationship duration.(Both) 
Reporting  D&B 
  
176 
 
Appendix 4.4: Sources of items included in checklist continued 
 
 
 
 
 
 
 
 
 
 
 
 
Section Question Type Original source* 
P
a
rt
ic
ip
a
n
ts
 
12. Is the „relationship type‟ described? (Both) Reporting 
Specific extension 
of the question 
above 
13. Is data collected from both partners, as opposed to just the carer or just the person with MS?(Both) Reporting 
Specific extension 
of the question 
above 
14. Were the subjects asked to participate in the study representative of the MS population? Were participants 
recruited from more than just one MS Society? (Both) 
External 
validity 
D&B (adapted) 
R
es
u
lt
s 
15. Does the study provide estimates of random variability in the data for the main outcome? (In non normally 
distributed data the inter-quartile range of results should be reported. In normally distributed data the standard 
error, standard deviation or confidence intervals should be reported. If the distribution of the data is not 
described, it must be assumed that the estimates used were appropriate and the question should  be answered 
yes.) (Quan only) 
Reporting D&B 
16. Has the strategy of statistical analysis been clearly stated? (Quan only) Reporting 
STROBE 
(adapted) 
17. Is the statistical analyses strategy used to analyse the main outcomes appropriate? (Quan only) Reporting D&B 
18. Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the main outcomes except 
where the probability value is less than 0.001?(Quan only) 
Reporting D&B 
19. If any of the results of the study were based on „data dredging‟, was this made clear? (Any analyses that 
had not been planned at the outset of the study should be clearly indicated. If no retrospective unplanned 
subgroup analyses were reported, then answer yes.) (Quan only) 
Internal 
validity 
D&B 
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Appendix 4.4: Sources of items included in checklist continued 
 
*Type of question taken from the Downs and Black Checklist for measuring quantitative study quality; D&B:  Downs & Black Quality Checklist 
(1998); STROBE: Strengthening the Reporting of Observational studies (2007). The qualitative study quality questions were taken from NICE: 
Appendix H, Methodology checklist (2007). 
Section Question Type Original source* 
Results 
20. Is the data analysis sufficiently rigorous? (Qual only) 
 NICE (2007) 
21. Are the findings internally coherent, credible? (Qual only) 
 NICE (2007) 
22. Is the data analysis strategy reported, i.e. how themes and concepts were derived? (Qual only) 
 Specific extension of 
the question above  
23. Was there more than one rater? (Qual only) 
 Specific extension of 
the question above 
24. Are the findings relevant? (Qual only) 
 NICE (2007) 
Discussion 
25. Does the study summarise key results with reference to study objectives? (Both) 
Reporting  STROBE 
26. Does the study discuss clinical relevance and generalisability of the results? (Both) 
Reporting  STROBE 
27. Does the study give a cautious overall interpretation of results considering objectives, limitations, 
analyses, results from other relevant studies? (Both) 
Reporting STROBE 
28. Does the study discuss limitations? (Both) 
Reporting  STROBE 
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Appendix 4.5: Quality Assessment by Rater A (and Rater B) for Studies 
Key: 
1=yes, 
0 = no 
or 
unable 
to 
deter-
mine
Authors Item 
 Abstract Introduction Design Participants 
 1 2 3 4  
(Quan) 
5 (Quan) 6  
(Qual) 
7  
(Qual) 
8 
 (Qual) 
9  
(Quan) 
10 11 12 13 14 
Lehman & 
Hemphill (1990) 
1 (1) 1 (1) 1 (1) - - 1 (1) 0 (0) 1 (1) - 1 (0) 0 (0) 1 (1) 0 (0) 0 (0) 
Woollett & 
Edelmann (1988) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 0 (0) 1 (1) 1 (1) 1 (1) 1 (1) 
Kleiboer et al 
(2007) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 
Kleiboer et al 
(2006) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 
Pakenham (1998) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 
Ackroyd et al 
(2011) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 1 (0) 0 (0) 1 (1) 1 (1) 1 (0) 
Wineman et al 
(1993) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 0 (0) 1 (1) 1 (1) 1 (1) 0 (0) 
McPheters & 
Sandberg (2010) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 1 (1) 1 (1) 1 (1) 1 (1) 0 (0) 
Pozzilli et al 
(2004) 
1 (1) 1 (1) 1 (1) 1 (0) 1 (1) - - - 0 (0) 1 (1) 0 (0) 1 (1) 1 (1) 1 (1) 
Schwartz & Kraft 
(1999) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 1 (1) 0 (0) 1 (1) 0 (0) 0 (0) 
Harrison et al 
(2004) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - 0 (0) 0 (0) 0 (0) 1 (1) 0 (0) 1 (1) 
Percentage 
Agreement 
100% 100% 100% 90% 100% 100% 100% 100% 100% 81.8% 100% 100% 100% 90.9% 
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Appendix 4.5: Quality Assessment by Rater A (and Rater B) for Studies continued 
Authors Item Total score (20) 
 Results Discussion  
 15 
(Quan) 
16 
(Quan) 
17 
(Quan) 
18 
(Quan) 
19 
(Quan) 
20 
(Qual) 
21 
(Qual) 
22 
(Qual) 
23 
(Qual) 
24 
(Qual) 
25 26 27 28  
Lehman & 
Hemphill (1990) 
- - - - - 0 (0) 0 (0) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 1 (1) 14 (13) 
Woollett & 
Edelmann (1988) 
1 (1) 0 (0) 1 (1) 0 (0) 1 (1) - - - - - 1 (1) 1 (1) 0 (0) 0 (0) 14 (14) 
Kleiboer et al 
(2007) 
1 (1) 1 (1) 1 (1) 0 (0) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 18 (18) 
Kleiboer et al 
(2006) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 19 (19) 
Pakenham 
(1998) 
1 (1) 1 (1) 1 (1) 0 (0) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 0 (0) 17 (17) 
Ackroyd et al 
(2011) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 18 (16) 
Wineman et al 
(1993) 
1 (1) 1 (1) 1 (0) 0 (0) 1 (1) - - - - - 1 (1) 1 (0) 1 (1) 0 (0) 15 (13) 
McPheters & 
Sandberg (2010) 
1 (1) 1 (1) 1 (1) 0 (0) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 17 (17) 
Pozzilli et al 
(2004) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 18 (17) 
Schwartz & 
Kraft (1999) 
1 (1) 1 (1) 1 (1) 0 (0) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 15 (15) 
Harrison et al 
(2004) 
1 (1) 1 (1) 1 (1) 1 (1) 1 (1) - - - - - 1 (1) 1 (1) 1 (1) 1 (1) 16 (16) 
Percentage 
Agreement 
100% 100% 90% 100% 100% 100% 100% 100% 100% 100% 100% 90.9% 100%  100%  
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Appendix 4.6: Reasons for rejected studies not used within the systematic 
literature review 
 
 
 
King, K. E., & Arnett, P. A. (2005). Predictors of dyadic adjustment in multiple  
sclerosis. Multiple Sclerosis, 11, 700-707. 
Gold-Spink, E., Sher, T., & Theodos, V. (2000). Uncertainty in illness and optimism in 
couples with multiple sclerosis. International Journal of Rehabilitation and 
Health, 5(3), 157-164. 
Starks, H., Morris, M. A., Yorkston, K. M., Gray, R. F., & Johnson, K. L. (2010). Being 
in- or out-of-sync: Couples' adaptation to change in multiple sclerosis. Disability 
and Rehabilitation, 32(3), 196-206. 
Zeldow, P. B., & Pavlou, M. (1984). Physical disability, life stress, and psychological 
adjustment in multiple sclerosis. The Journal of Nervous and Mental Disease, 
172(2), 80-84. 
 
 
Rejected study Reason 
King and Arnett (2005) 
- Explored how factors associated with MS 
impacted on dyadic adjustment (wrong 
direction). 
Starks, Morris, Yorkston, Gray 
and Johnson (2010) 
 
- Identified strengths and possible risk 
factors that influence relationship stress 
within couple (wrong direction). 
Gold-Spink, Sher and Theodos 
(2000) 
 
- Mostly examined the psychological 
effects of MS on caregiver. 
Zeldow and Pavlou (1984) 
- Investigated how MS impacts on the 
person‟s interpersonal functions 
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Appendix 5: Supplementary Information for Empirical Paper  
Appendix 5.1: Demographics Questionnaire  
Appendix 5.2: Hospital Anxiety and Depression Scale (HADS) 
Appendix 5.3: Environmental Status Scale (ESS) 
Appendix 5.4: Barthel Index 
Appendix 5.5: Participant Information Sheet one 
Appendix 5.6: Participant Information Sheet two 
Appendix 5.7: Participant Consent Form 
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Appendix 5.1: Demographics Questionnaire  
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Appendix 5.1: Demographics Questionnaire continued 
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Appendix 5.2: Hospital Anxiety and Depression Scale (HADS)  
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Appendix 5.3: Environmental Status Scale (ESS) 
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Appendix 5.3: Environmental Status Scale (ESS) continued 
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Appendix 5.3: Environmental Status Scale (ESS) continued 
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Appendix 5.4: Barthel Index 
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Appendix 5.5: Participant Information Sheet one 
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Appendix 5.6: Participant Information Sheet two 
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Appendix 5.6: Participant Information Sheet two continued  
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Appendix 5.6: Participant Information Sheet two continued  
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Appendix 5.6: Participant Information Sheet two continued  
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Appendix 5.6: Participant Information Sheet two continued  
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Appendix 5.7: Participant Consent Form 
 
 
